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Improvements in experimental techniques have led to an explosion of information in 
biology research. The increasing number of measurements comes with challenges in 
analyzing resulting data, as well as opportunities to obtain deeper insights of biological 
systems. Conventional average based methods are unfit to analyze high dimensional 
datasets since they fail to take full advantage of such rich information. More 
importantly, they are not able to capture the heterogeneity that is prevalent in biological 
systems. Sophisticated algorithms that are able to utilize all available measurements 
simultaneously are hence emerging rapidly. These algorithms excel at making full use 
of information within datasets and revealing detailed heterogeneity. 
However, there are several important disadvantages of existing algorithms. First, 
specific knowledge in statistics or machine learning is required to appropriately 
interpret and tune parameters in these algorithms for future use. This may result in 
misusage and misinterpretation. Second, using all measurements with equal weighting 
  
runs the risk of noise contamination. In addition, information overload has become 
more common in biology research, with a large volume of irrelevant measurements. 
Third, regardless of the quality of measurements, analysis methods that simultaneously 
use a large number of measurements need to avoid the “curse of dimensionality”, which 
warns that distance estimation and nearest neighbor estimation are not meaningful in 
high dimensional space. However, most current sophisticated algorithms involve 
distance estimation and/or nearest neighbor estimation.  
In this dissertation, my goal is to build analysis methods that are complex enough to 
capture heterogeneity and at the same time output results in a format that is easy to 
interpret and familiar to biologists and medical researchers. I tackle the dimension 
reduction problem by finding not the best subspace but dividing them into multiple 
subspaces and examine them one by one. I demonstrate my methods with three types 
of datasets: image-based high-throughput screening data, flow cytometry data, and 
mass cytometry data. From each dataset, I was able to discover new biological insights 
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Chapter 1 Introduction 
1.1 Overview 
Biological systems are complex and cope with a complex and ever-changing environment. 
Hence, emerging multi-parametric measurement techniques with single-cell resolution 
reveal increasing complexity among and within cell types. For example, one of the most 
widely used single-cell technique – flow cytometry – is responsible for the discovery of 
the diverse types and functionality of immune cells [1]. Novel cell (sub)-types are 
continually being identified with the increasing number of cellular markers that can be 
simultaneously measured with flow cytometry (e.g., Th17 cells, follicle T helper cells, and 
stem memory T cells) [2-4]. Today, sophisticated experimental techniques enable in-depth, 
high-content and high-throughput single cell measurements in almost every field of 
biological research. As an example, the number of parameters that can be measured by 
flow cytometry increased from the original 2 ~ 3 to about 20, and will likely reach 50 in 
the near future [5]. Mass cytometry, which is a combinatorial technique based on mass 
spectrometry and flow cytometry further expands this number to 100 [6]. In addition, 
people have combined high-throughput screening techniques with modern microscopes to 
get cell images at single cell or even sub-cellular resolution from which hundreds of 
measurements can be made [7]. On the other hand, some techniques which are capable of 
very high-dimensional measurements (e.g., RNA sequencing) have increased their 
resolution to single cell level, enabling tens of thousands measurements on several 
thousand of single cells [8]. The increasing ability to generate a large amount of high-





The challenges of analyzing high-dimensional single cell data originate from two main 
factors: heterogeneity and high dimensionality. These two factors are in fact intertwined: 
to understand heterogeneous system requires more measurements and more measurements, 
in turn, reveal higher heterogeneity. For the first challenge, not all heterogeneities have 
biological significance [9]. Since the local environment for each cell is slightly different 
from another, the properties of cells, even from the same cellular type/state, would vary 
from cell to cell. There have been speculations that cellular status is not a collection of 
distinct states but a continuous change in response to outer stimulations [9]. However, it is 
not clear under what circumstances this heterogeneity is meaningful for the biological 
functionality of the cell or organism. In addition, experimental measurements are not 
accurate, random noise and systematic errors are ubiquitous, and all contribute to the 
heterogeneous signal we observe in experiments. As a result, the appropriate analysis 
methods should be able to capture the biologically meaningful heterogeneity of single cells 
while at the same time reduce the impact of random noise in experiments. For the second 
challenge, it has been shown that in high dimensional space the distance between two 
points “may not even be qualitatively meaningful” [10] – a phenomenon termed as “curse 
of dimensionality”, rendering any distance-based analysis (e.g., clustering) problematic. In 
addition, information overload is ubiquitous in biological datasets, with many redundant 
measurements or measurements that are irrelevant to the question of interest (or of 
unknown relevance). This adds to the already high noise level in biological datasets and 
further hinders the finding of real signals in data. As a result, dimension reduction methods 
are required for analyzing high dimensional data. Since most dimension reduction methods 





reduced dimensions are often linear or nonlinear combinations of all original measurements 
which impedes straightforward interpretation of data. What’s more, reducing high 
dimensional datasets to one definite subspace may result in overlook of small cell groups 
or subtle changes. Hence designing and applying dimension reduction methods to 
biological data should take interpretability and importance of subtle changes into 
consideration. Currently, most algorithms developed to deal with high-dimensional single 
cell data largely ignore information overload and “curse of dimensionality”. Instead, they 
fully embrace the large number of measurements and try to make full use of them (except 
algorithms to analyze single-cell RNA sequencing data where the problem of high 
dimensionality is extremely prominent). However, there has been a study showing that 
algorithms like this would pick up noise in data and lead to incorrect results [11]. In 
addition, these algorithms often produce results that are hard to interpret and hence difficult 
to experimentally validate. Thus, there is a need to build analysis methods between the two 
extremes of conventional methods, which tend to be oversimplified, average-based, and 
involve manual selection, and novel methods, which are complex and sensitive to noise 
and the “curse of dimensionality”. Here I introduce methods that are complex enough to 
capture some level of heterogeneity, but at the same time provide outputs suitable for clear 
interpretation. The methods I introduce also incorporate feature selection to avoid the 






Figure 1.1 Summary of this dissertation. Conventional average based, single variate analysis methods are 
not fitted to analyze high-dimensional single-cell data generated by current experimental techniques. Novel 
sophisticated methods developed specifically to incorporate high dimensionality can be too complicated for 
experts outside the field of bioinformatics/statistics to interpret and require specific knowledge of the model 
for them to appropriately tune the parameters for applying to their own data. In addition, these methods are 
sensitive to noise and may suffer from a more fundamental problem: the curse of dimensionality. The goal 
of this dissertation is to build analysis methods that are complicated enough to capture heterogeneity inside 
single-cell data, but not so complicated that impedes experts from different disciplines to understand and 
apply them to their own data. 
 
In this dissertation, I am going to address the challenges in analyzing high-dimensional 
single cell data in two parts. The first part deals with the functionally non-meaningful 
heterogeneity and aims to develop a method that captures similarity within cells that are 
various but don’t form functionally distinct subsets. The second part handles high 
dimensionality in flow and mass cytometry data by dividing the data into small subspaces 





develop methods that are able to automatically select important features, generate 
statistically meaningful results that are accessible to experts across disciplines for 
analyzing high-dimensional single-cell data.  
1.1 High-dimensional single-cell measurement techniques 
1.1.1 Image-based high-throughput screening/ High Content Screening (HCS) 
High-throughput screening (HTS) is a powerful technique routinely used in drug discovery, 
systematic analysis of cellular functions, and exploration of gene regulation pathways [12-
14]. The use of robotics instead of manual operation in HTS greatly reduces experimental 
variability, yet cellular heterogeneities persist. Combined with modern automated 
microscopes, image-based HTS (also known as high content screening, or HCS) allows for 
routine imaging of thousands of cells in multiple fluorescence channels [15-17]. HCS is 
one of the fastest growing techniques in biological and pharmaceutical research and is 
responsible for countless discoveries [18-21].  
1.1.1.1 Experimental procedure 
The typical experimental procedure of high content screening requires the following steps: 
sample preparation, image acquisition, and data handling [16]. Every step comes with its 
own challenges and requires proper planning with the overall goal of the experiment in 
mind. For sample preparation, it is important to figure out what type of cells is suitable for 
the experiment, how many samples (perturbations) should be tested, what perturbation 
reagents and/or fluorescent stain should be used, etc. [15]. Small-scale pilot screens are 
recommended before running the much larger whole screen. This step helps clear 
additional issues, test validity of the screen, optimize parameters in the experiment, and 
sometimes serves as a proof of concept for the experimental design. Sample preparation 





quality of image acquisition directly affects the overall quality of the screen. Thus it is 
crucial to make sure that parameters for image acquisition are set appropriately. For 
example, the resolution of image acquisition should be high enough to capture all required 
features, but the imaging should also cover a large enough area to capture a sufficient 
number of cells for robust statistics [15]. Downstream data analysis after image acquisition 
is also an important part of image-based high throughput screening, and usually takes more 
time than the experimental process.
 
Figure 1.2 Workflow of image-based high throughput screening (adapted from [16]). Image-based high 
throughput screening produces a large volume of single cell resolution image data. A great number of cellular 
features can be extracted from images. Due to noise in both the imaging and image analysis process, and due 





the same biological functionality. Hence, in order to understand the behavior of a certain cellular state, a 
method to reduce noise level and identify a typical description of the cellular state is needed. This is the 
problem I’m going to address in Chapter 2.  
1.1.1.2 Data analysis 
Data analysis for HCS can be divided into two parts: image analysis and downstream 
statistical analysis. Until recently manual scoring of images dominated the analysis of low- 
and medium throughput image screening studies, and it is still widely used today [16]. 
Building on the active and fast-growing field of computer vision, many algorithms have 
been developed for bio-image analysis. Some general purpose image analysis algorithms 
are included in widely used image processing programs such as ImageJ [22, 23], Fiji [24], 
and CellProfiler [25-28]. In addition to the general purpose image analysis platforms, a 
large number of algorithms have been developed for tackling specific image analysis 
problems in a specialized field of biology, especially in neuroscience. In fact, there are 
many specialized algorithms that can be found in several online listings, for example, 
image analysis tools for neuro-images (http://nitrc.org/) [29].  
After images are analyzed, and features are measured, the second part of HCS data analysis 
utilizes statistical tools or more recently machine learning tools to phenotype the measured 
cells and reveal biological insights. Unfortunately, compared to the sophisticated image 
analysis tools, downstream data analysis methods are still “not high content” enough [30]. 
Although hundreds of features can be routinely extracted in image analysis steps, only a 
few of these features can be used in conventional downstream analysis procedures [16]. 
Conventional methods further oversimplify the selected few features by feature averaging, 
ignore rich heterogeneity among cells. This situation has improved recently, with the surge 





analysis [31]. Some of the more recent approaches are starting to use multiple metrics via 
classifiers such as support vector machine (SVM) [32], hierarchical clustering [33], EM 
clustering with Gaussian mixture models to identify multiple cell subtypes to quantify 
cellular heterogeneity [34], or deep learning [35]. One caveat to keep in mind is that 
although the number of features that can be measured from images is large, some of these 
features can be redundant or irrelevant or both. So it is important to carry out feature 
selection along with machine learning.  
1.1.2 Flow cytometry 
Flow cytometry is a widely used technique that measures multiple parameters of 
fluorescently labeled single cells that flow in a stream through a photodetector system. 
Flow cytometry is routinely used in both basic biological and clinical research, due to its 
fast speed (50,000 cells/s [1]), relatively low cost, and amenability to standardization [36]. 
The past 50 years have yielded great improvements in flow cytometry techniques, in 
particular, the recent increase from 2 to 30 in the number of markers that can be measured 
simultaneously. The impact of this increase is far-reaching for our understanding of 
biological systems (including the immune system, cancer biology, cell signaling, etc.) and 
for medical applications and drug development [37]. Even with the emergence of other, 
more powerful, single-cell measurement techniques, flow cytometry is still the most widely 
used experimental technique.  
1.1.2.1 Experimental Procedure 
Flow cytometers can be roughly divided into three parts: fluidics, optics, and detectors. 
The fluidics is a cell distribution system that directs single cells in the sample to the light 
source.  It contains two parts: sheath fluid and pressured line. A pressured airline pump 





Since the pressure of sheath fluid is always lower than the sample flow, this process ensures 
cells align as a coaxial flow as they pass through several light sources (Fig 1.3a). The optics 
system is where measurements of the fluorescence intensity of each cell take place 
simultaneously or in rapid succession for different fluorescence wavelengths. In addition 
to fluorescent signal, two types of scattered light are also detected: forward scattering (FSC) 
and side scattering (SSC) (Fig 1.3b). The intensity of FSC is proportional to the size of the 
cell, a valuable piece of information often used in Immunophenotyping. SSC is the result 
of diffraction of light perpendicular to the incoming laser beam. SSC is proportional to cell 
granularity, i.e., the inner complexity of the cell. Together, FSC and SSC provide 
information to coarsely divide cells (mainly white blood cells) into basic phenotypes 
(differentiating lymphocytes from macrophages for example). The detectors detect the 
fluorescent signal and convert it to a digital data that is proportional to light intensity. For 
surface marker detection, a logarithmic amplifier is used to capture the wide range of 
surface marker expression levels. [38, 39] The resulting data is stored in a standard manner 







Figure 1.3 Fluorescent-based high throughput multi-dimensional quantification of protein expression 
(adapted from [38]). a) A cartoon for the fluidic system in a flow cytometer. The pressure difference between 
the sample chamber and sheath enables the flow of single cells past the light source(s), which enables high-
throughput single cell measurements. b) An illustration for forward scatter (FSC) and side scatter (SSC). c) 
A cartoon showing how fluorescent measurements are made. With the development of brighter dyes and the 
improvement in differentiating light spectrum, more and more fluorescent markers can be measured 
simultaneously with flow cytometry. 
1.1.2.2 Data processing 
Because of the amplification process, raw data in FCS files has a wide range (~0 – 105) 





make sense of the data [42]. Traditionally, flow cytometry data are presented on a 
logarithmic scale, and the so-called “negative populations” are near zero. There have been 
lots of studies and debate about the most appropriate way to transform and visualize flow 
cytometry data. Currently, the widely accepted and used method is an algorithm called 
“logicle transformation” [43]. In essence, the logicle transformation is a generalization of 
the hyperbolic sine function with tunable parameters to better suit flow cytometry data. 
These parameters can be determined based on the range of specific datasets. Another 
important aspect of pre-processing flow cytometry data is called compensation. The need 
for compensation arises from the fact that the wavelength of fluorescent light is a 
distribution instead of a single value. Hence there will be overlap in the light spectrum one 
of fluorochromes. Overlap in the fluorescent spectrum can result in false signals and false 
correlations between measurements, and it is a major source of error in flow cytometry. 
The process to detangle the spectrum overlap is called compensation. The currently used 
compensation method operates under the assumption that overlap of spectrum results in a 
linear combination of various light spectrums. Thus detangling the overlap equals solving 
a set of linear equations. Coefficients in these equations are stored in a matrix called 
compensation matrix and can be obtained via experiments. In addition to transformation 
and compensation, batch effects can be a real problem for flow cytometry data as well. 
Especially when combining samples tested in different experimental cores. Thus, it is 
important for the experimentalist to follow standard protocols, though algorithms designed 
to reduce batch effects exist [44]. These pre-processing steps are usually done manually in 
a commercial software platform like flowJo, though a package in R [45] that provides 





1.1.2.3 Data analysis 
The traditional analysis method for flow cytometry data, called “gating”, involves 
manually drawing regions of interest (ROI) through a sequence of 2D scatter plots (Fig 
1.4). Manual gating has long been criticized as being “subjective and biased”, “lack of 
reproducibility”, “inefficient and time consuming”, and has been considered one of the 
major source of variability in flow cytometry analyses [5, 46-48]. With the increasing 
number of measurements and the large volume of data to be analyzed, unbiased, automated, 
and reproducible algorithms are in great need for flow cytometry data analysis. Building 
such data mining tools has been called the “real challenge” in flow cytometry application 
[49, 50]. The last decade has seen a surge in new data analysis methods for flow cytometry 
[36, 51-53]. One important goal in flow cytometry data analyzing is identifying structures 
/ cell clusters in the high-dimensional space span by all measurements. There are 
algorithms trying to achieve this by combining density based thresholding in 1D [54, 55] 
hence exhaustively identifying all possible cell subsets. Other algorithms apply clustering 
algorithms for cell subset finding, e.g., k-means clustering [56, 57] or mixture modeling 
[58-61], etc. Tree or map-based algorithms have also been developed to mine the structure 
of flow cytometry data [62-64]. Finally, binning methods that aim to resolve the position 
of density peak have been proposed as well [65-67]. There has also been an effort to 
combine multiple algorithms in a workflow so that researchers can pick the method that 
best fits their needs [68]. With a large number of cell subtypes discovered by automated 
algorithms, methods to compare the biological importance of cell types have been 
developed [69, 70], and so are methods to automatically label the ontology of cell subtypes 
[71]. In addition to cell type identification, visualization is also an important aspect of 





Multiple visualization tools have been developed for this purpose [72-74]. Most clustering-
based methods that allow novel cell type discovery aim to identify regions with high cell 
density in multi-dimensional space [56, 58-60, 63, 66, 70, 72, 73, 75]. This assumes cells 
form distinct phenotypes and that only cells inside those relative high-density areas (peaks) 
are of importance. However, cells that are in between two high-density clusters (valleys) 
may also have potential biological significance [76]. Another limitation of clustering based 
methods is that batch effects from merging of multiple samples (which is a widely used 
strategy [62, 75]) can be problematic.  Batch effects are even less tractable for cross 
institutes datasets (which are common in clinical trials). In addition, these clustering-based 
methods require calculation of distance in high-dimensional space, which suffers from the 
“curse of dimensionality” and may lead to misleading results [77]. As a result, some groups 
have been calling for the return to lower dimensional methods such as gating based on 2D 
scatterplots [11]. 
 
Figure 1.4 Manual gating is a process of sequentially drawing a region of interest (ROI) manually with the 





for further analysis decreases in each step of manual gating.  Cells outside the ROI are discarded from 
downstream analysis, and the information they contain is lost. In addition, manual gating is a subjective 
process with low reproducibility, as ROIs are drawn manually. With the increasing number of measurements, 
manual gating is also becoming too labor intensive for large studies. However, due to its intuitive nature, 
manual gating is still the most widely used and understood method for analyzing flow cytometry data. 
Incorporating the increasing number of measurements, avoiding curse of dimensionality, while at the same 
time connecting the large volume of information biologists obtain from 2D scatterplots (manual gating) is 
the goal of Chapter 3. 
1.1.3 Mass cytometry / Cytometry by time of flight (CyTOF) 
Mass cytometry is a relatively new technique designed to overcome the bottleneck faced 
by flow cytometry to further expand the number of simultaneous measurements to about 
100 in theory [78]. It combines two well-established techniques: mass spectrometry and 
flow cytometry. Currently, the most widely used mass cytometer can measure more than 
40 cellular markers at the speed of 1000 cells/s [79].  Although “low throughput” compared 
to flow cytometry, the promise to measure more than 50 parameters is “yet unparalleled” 
[1] and is starting to get more and more attention and usage in both basic science research 
and clinical research.  
1.1.3.1 Experimental Procedure 
Mass cytometry uses rare earth metal isotopes instead of fluorescent stains as tags for 
cellular markers and uses mass spectrometry to detect signals instead of photodetectors. 
These rare earth metal elements do not naturally exist in cells hence are capable of being 
used as tags. In addition, the up to 100 distinguishable isotopes ensure an equal number of 
distinct measurements for each cell [6]. Fig 1.5 shows the experimental workflow of mass 
cytometry. Single cells are acquired and incubated with isotope tagged antibodies against 





cytometer. Ions in the droplets are liberated through an inductively coupled argon plasma 
(ICP). Then the ion cloud is filtered according to their mass, and light elements that are 
abundant in cells are discarded where the heavier elements used as tags remain to be 
measured by a time-of-flight mass spectrometry [79]. Data collected in mass cytometry 
experiment is also stored in flow cytometry standard (FCS) format, and hence can be 
analyzed like flow cytometry data [80].  
 
Figure 1.5 Experimental workflow for mass cytometry (adapted from [81]). By using rare earth metal 
elements that are usually not present in cells as indicators, mass cytometry further increases the number of 
measurements to about 100. With such a large number of measurements, redundant and irrelevant 
measurements become a real problem for analyzing mass cytometry data. It has been shown that the intrinsic 
dimension of mass cytometry data is much smaller than the number of total measurements. However, feature 
selection has been difficult for mass cytometry data since the value of a single measurement is not meaningful. 
In Chapter 4, I address the problem of feature selection in mass cytometry data by defining features as point 






1.1.3.2 Data processing/cleaning 
Since mass cytometry collects signal via mass spectrometry instead of fluorescent light 
intensity, there is no overlap of signals and hence no need for compensation. In addition, 
there is no light reflection and auto-fluorescence to take into consideration, so the 
background noise level is lower in mass cytometry data comparing to flow cytometry. 
However, due to the wide range of surface marker expression levels, a transformation step 
such as logicle transformation is still required to visualize and analyze mass cytometry data.  
1.1.3.3 Data analysis 
Mass cytometry shares the data storage format with flow cytometry, so the methods 
developed for analyzing flow cytometry data could be directly applied to mass cytometry 
data. However, due to the high dimensionality of mass cytometry data, analysis methods 
specifically designed for it are in need. Over the years, great progress has been made in 
developing methods that are customized for mass cytometry dataset [5]. One of the first 
methods specifically aimed to analyze mass cytometry dataset is SPADE [75]. SPADE 
utilizes an agglomerative clustering method to group cells into different subtypes. A 
minimum spanning tree (MST) based algorithm is then used for data visualization (Fig 
1.6). SPADE has been successfully applied to several mass cytometry datasets [82-84]. 
Another method called Citrus uses hierarchical clustering for cell type discovery and 
utilizes properties of these cell groups to determine a list of cell types that behave 
differently between two sample groups [85]. More recently, an algorithm called 
PhenoGraph has applied kNN (k nearest neighbors) to detect cell types in a given sample 
[86]. In addition, methods designed for flow cytometry, like FLAME [58], flowSOM [62], 
etc. have also been successfully applied to mass cytometry data [87, 88]. Most recently, 





distribution based stochastic neighborhood embedding (t-SNE) (Fig 1.7) [89] – to help with 
mass cytometry data analysis, e.g., viSNE [73] and one-SENSE [90]. In summary, these 
algorithms try to make full use of the large number of measurements in mass cytometry 
data, and they are successful in revealing the high level of complexity in biological 
systems. However, these methods ignore the existence of redundant and irrelevant 
measurements in mass cytometry data, which could result in high level of noise and false 
signal, and the curse of dimensionality. As a result, feature selection methods are needed 
as a pre-processing for mass cytometry data. However, feature selection for mass 
cytometry data is a tricky endeavor, since the expression level of single markers (that are 
usually meaningful features in other types of data) is not meaningful in mass cytometry. 
Instead, the meaningful information exists in the combined expression pattern of multiple 
markers (e.g., 2D scatterplots of two markers). Hence new definition is needed for features 
in mass cytometry data as well as feature selection method. 
 
Figure 1.6 An example of results given by SPADE (generated based on dataset and guidelines provided in 





agglomerative clustering methods to identify cellular subtypes in mass cytometry data with predetermined 
estimation of cluster numbers (each circle in the figure is a cluster). Each cluster is then represented by the 
mean expression level of markers (color coding in the figure shows the mean expression level for each 
marker). SPADE then uses a minimum spanning tree (MST) to visualize the clustering results as we see 
above. Though sophisticated, the results generated by SPADE lack clear biological interpretation, and require 
a good understanding of the underlying algorithms to extract robust information. Also, since SPADE utilizes 
all measurements simultaneously with equal weights, it suffers from the curse of dimensionality and extra 
noise buried in redundant and irrelevant measurements. 
 
 
Figure 1.7 An example of t-SNE plots (colored by the expression level of individual markers). t-SNE (t-
distribution based stochastic neighborhood embedding) is a dimension reduction algorithm introduced to 
embed high dimensional data into lower dimensional space while preserving similarities between data points. 
In other words, high cell density area in original high dimensional space should also be a high cell density 
area in the reduced dimension presentation. t-SNE is mainly used as a visualization tool for mass cytometry 
data, however, due to its similarity preserving property, there have been attempts to do manual gating based 
on dimension reduced t-SNE plots. t-SNE is a great method to visualize high dimensional data, nevertheless 
since the resulting dimensions are nonlinear combinations of all measurements, interpreting the results can 
be difficult. In addition, since t-SNE involves random process, the different realization of t-SNE may result 






Challenges in high-dimensional single cell analysis 
In this dissertation, I will focus on two major challenges in high-dimensional single cell 
analysis: heterogeneity and high dimensionality. These two challenges are inter-correlated, 
to fully understand heterogeneity one needs more measurements, more measurements 
(higher dimensionality) leads to higher level of heterogeneity as well as difficulties in 
analysis. 
1.1.4 Heterogeneity 
Heterogeneity is ubiquitous in biological systems, and its significance is starting to be 
recognized. However, the full extent of heterogeneity and its biological implications are 
still largely unknown. Taking tumor cells as an example, the heterogeneity of tumor cells 
has been identified more than 40 years ago [91], but how heterogeneity in genetic and 
epigenetic features of tumor cells affect the progress of cancer is still not fully understood 
[92].   
Simple methods that summarize cell population by its average behavior are not suitable for 
heterogeneous datasets since they oversimplify the data. The challenge of applying 
unsupervised methods to heterogeneous data lies in the fact that signals in these data come 
from a mixture of various cell phenotypes, but the exact number of phenotypes and best 
set of features to capture these phenotypes are both unknown. On the other hand, not all 
cell-to-cell variations result in meaningful cell phenotypes. Responses to the slightly 
different local cellular environments can also lead to variation which can be considered as 
noise [9]. However, when the difference in local environment is large enough, it could also 
induce cells to exhibit meaningful biological differences. As live cells constantly interact 
and respond to their surroundings, it is hard to determine when the noise stops and 





sophisticated multi-variate unsupervised methods may result in unnecessary complexity. 
As a result, a method in between that is able to capture some degree of heterogeneity but 
does not add more complexity is desired. 
1.1.5 High dimensionality 
The increasingly large number of features that can be simultaneously measured 
experimentally leads to two problems: information overload and high-dimensional analysis 
(e.g., curse of dimensionality). Information overload refers to the phenomenon that not all 
features measured are biologically important, and there exists redundancy in biologically 
meaningful measurements [93]. Both unrelated and redundant measurements contribute to 
noise in data analysis and can result in misleading interpretation. To address this problem, 
dimension reduction or feature selection methods are required to capture useful information 
in datasets. The most widely used dimension reduction methods include principal 
component analysis (PCA), t-distribution based stochastic neighborhood embedding (t-
SNE), and independent component analysis. Problems with dimension reduction methods 
for biological datasets are that: (1) the reduced dimensions are a combination of all original 
measurements. Thus it is difficult to generate direct biological interpretation. (2) These 
methods try to identify only one subspace that best captures information content in original 
datasets, and some subtle but meaningful patterns may be ignored. The problem with 
simpler feature selection methods is that the selection is usually done one feature at a time, 
and ignores the correlation between features. On the other hand, analysis of high-
dimensional data comes with its own problem – the curse of dimensionality - commonly 
used distance measurements (L2 distance, for example) loses their meaning in a high 





and are equal-distant from the center [77]. This further affects the estimation of point 
density and identification of nearest neighbors [11, 77] which is problematic for density-
based algorithms and clustering algorithms. Although lots of efforts have been made on 
understanding effects of dimensionality on single distribution data, the study of the curse 
of dimensionality on heterogeneously distributed datasets (as are most biological datasets) 
has just begun [94].   
1.2 Outline of this dissertation 
In this dissertation, I will tackle the problem of heterogeneity and high-dimensionality in 
single-cell data analysis with concrete examples.  
Chapter 2 will discuss the first example which concerns cellular heterogeneity in an image-
based high throughput screening dataset. This dataset records nuclear images of cultured 
cells with experimentally induced progeria (a premature ageing disease) in response to 
different RNAi perturbations. Cellular responses to the same RNAi perturbation can 
already be various, with some cells resemble healthy control, some cells resemble diseased 
control, and some cells may resemble neither controls. On the other hand, controls cells 
have a large cell-to-cell variation as well. The overall goal of this dataset is to identify 
RNAi hits that help progeria cells restore to a healthy status. To achieve this goal, I propose 
a notion called “typical cells” which are defined as cells around the center of multi-variate 
feature distribution. Under the assumption that variation in control cells are mainly caused 
by unimportant local fluctuations, I extract typical control cells and use them to build a 
stable classifier between healthy and diseased cells. This classifier is then used to assess 





perturbation is determined by the percentage of healthy-like cells after being perturbed by 
that RNAi.  
Chapter 3 deals with finding subtle differences in high-dimensional flow cytometry data. 
The dataset I use is a publicly available dataset that tries to clarify differences of immune 
cell composition in peripheral blood between old and young healthy donors. The most 
common workflow in dealing with this type of question is – first identify all possible 
(exhaustedly identified via automated methods) or related (judged by professional 
experience) cell subtypes in the data, and the compare their frequency in old and young 
groups one by one with statistical tests. Problems with this workflow are: (1) due to “curse 
of dimensionality”, clustering methods that use all measurements simultaneously can lead 
to false cell subtypes [11]. (2) There has been hypothesis that cell states belong to a 
continuum instead of distinct stages. Hence not only high cell density regions but also 
relatively low-density region that may be transitioning between two cell stages can be 
biologically meaningful. As a result, methods that only focus on high cell density regions 
may miss potentially important signal. Here I propose a method called “CytoBinning” that 
quantifies 2D point patterns. With the help of CytoBinning, I am able to compare point 
patterns between patients without calculation of cell density in data space, thus avoid 
focusing only on high-density regions. In addition, by analyzing patterns in 2D at a time, 
“curse of dimensionality” could be avoided as well. So instead of identifying all possible 
cell subtypes before comparison, I first identify cell regions/patterns that are different 
between old and young groups and clarify types of cells in these regions later.  
In Chapter 4, I try to tackle feature selection problem in mass cytometry data with a 





in eight types of human tissues. Although the problem of information overload in mass 
cytometry data has started to being recognized in mass cytometry data, not many methods 
have been proposed to perform feature selection for it. This is in part due to the fact that 
meaningful features in mass cytometry data lie not in single measurements, but the 
interplay between two or more measurements (point patterns). In addition, the only 
quantifiable measurements of the interplay between two variables are correlation 
coefficients and mutual information which oversimplify the pattern and provide no details. 
Here I use CytoBinning as a quantified, detail compatible method to capture the interplay 
between two variables that enables direct, the quantified comparison between two point 
patterns. I then define features in mass cytometry data as point patterns formed by two 
measurements at a time and am able to identify tissue-specific immune cell signatures in 
eight types of tissues with only 5 features (6 unique measurements).  
Finally, in Chapter 5 I will make short summaries for each the above examples, discuss the 
potential applications of the methods I developed, and talk about future directions with 






Chapter 2 RefCell: Using typical cells as reference for multi-
dimensional analysis of image-based high-throughput screens 
2.1 Overview 
In this chapter, I try to tackle cell-to-cell variation in image-based data using “typical cells,” 
a method I proposed to capture typical features of single cells within mono-state cell 
samples. The experiments were performed at NCI/NIH by Dr. Nard Kubben in the 
laboratory of Dr. Tom Misteli. This chapter is adapted from a manuscript submitting to 
BMC Bioinformatics. 
2.2 Abstract 
Image-based high-throughput screening (HTS) reveals a high level of heterogeneity in 
single cells and multiple cellular states may be observed within a single population. 
However, in biomedical and clinical practice most image-based HTS analysis is based on 
average behavior. While complex analysis methods that illustrate and capture this 
heterogeneity are under development, their reliability and predictive power are still 
uncertain. Here we introduce RefCell, a multi-dimensional analysis pipeline for image-
based HTS that focuses on reproducible capturing of the cell heterogeneity and automated, 
systematic reduction of the multidimensional HTS information into biomedically 
actionable figures.  Instead of averaging, RefCell selects single cells for which all cellular 
measurements are typical.  RefCell is based on both these “typical cells” and quantitative 
assessment of the heterogeneous deviations from this typical behavior. We apply this 
pipeline to the analysis of data from a high-throughput imaging screen of a library of 320 







High-throughput screening (HTS) is a powerful technique routinely used in drug discovery, 
systematic analysis of cellular functions, and exploration of gene regulation pathways [14, 
95-97]. With modern automated microscopes, image-based HTS allows for routine 
imaging of thousands of cells in multiple fluorescence channels. Due to the volume and 
complexity of imaging data, building analysis methods has become a big challenge.  
During the last decade, powerful new automated image analysis tools [13, 33, 98, 99] that 
reproducibly parametrize each cell started to emerge, as well as methods for analyzing 
high-dimensional data specifically applicable to image-based HTS [25, 32, 34, 100-107]. 
To identify multiple cell subtypes and quantify cellular heterogeneity, machine learning 
methods such as support vector machines (SVM) [32], hierarchical clustering [33], or 
clustering with Gaussian mixture models [34] have been introduced. While these methods 
are very successful in revealing cellular heterogeneity and identifying subpopulations, the 
“curse of dimensionality” dictates that for high dimensional systems clustering becomes 
ambiguous. Due to this curse of dimensionality as well as redundant and irrelevant 
measurements, these sophisticated analysis approaches may produce misleading results 
when applied to high dimensional data [11]. Furthermore, the outputs of advanced high 
dimensional analysis methods such as t-SNE or SPADE are not yet standardized, and 
biomedical and clinical researchers have little experience in how to derive actionable 
insights from the output graphs.  
Due to these challenges, recent publications are suggesting that conventional average-
based methods are sufficient for analyzing data collected from cell populations [9]. 
However, one major disadvantage of average-based analysis is that averaging is generally 





measurements for each cell are lost in the analysis. In addition, averaging tends to 
oversimplify the data by smoothing out potentially important cellular variations.  
Here we introduce a new method that incorporates multiple measurements simultaneously 
and captures similarities of cells in a single state population. Our flexible pipeline is 
focused on analysis of image-based HTS experiments of cellular phenotypes. Our approach 
captures the typical features of a single state cell population with single cell resolution. 
This is achieved by the introducing of “typical cells”.  
We introduce our approach in the context of an RNAi screen to identify cellular factors 
involved in the premature aging disease progeria. The starting point of the analysis is a set 
of single-cell metrics obtained through standard image-processing tools (e.g. [25, 108]). 
The main output of the analysis is identification of the most significant morphological 
features that together provide a holistic view of the disease phenotype, and a list of 
significant siRNA perturbations that partially rescue the disease phenotype, which we call 
“hits”. We compare our pipeline to one of the more complex methods for characterizing 
heterogenous cellular response [34] and found that our pipeline yields similar hits, yet is 
simpler, faster, and yields output graphs directly interpretable by biomedical researchers. 
2.4 Results 
We demonstrate our pipeline using datasets from an image-based high-throughput siRNA 
screen designed to investigate cellular factors that contribute to the disease mechanism in 
the premature aging disorder Hutchinson-Gilford progeria syndrome (HGPS), or progeria 
[109], a rare, fatal disease which affects one in 4 to 8 million live births [110]. HGPS is 
caused by a point mutation in the LMNA gene encoding the nuclear structural proteins 





results in a shorter mRNA which is later translated into the progerin protein – a mutant 
isoform of the wild-type lamin A protein [110, 111]. HGPS is thought to be relevant to 
normal physiological aging as well [112-117] since low levels of the progerin protein have 
been found in blood vessels, skin and skin fibroblasts of normally aged individuals [115]. 
The progerin protein is thought to associate with the nuclear membrane and cause 
membrane bulging [118]. In addition to nuclear shape abnormalities and progerin 
expression, two additional features that have been associated with progeria are the 
accumulation of DNA damage inside the nucleus [119], as well as reduced and 
mislocalized expression of lamin B1, another lamin that functions together with lamin A 
[114].  
These cellular hallmarks of progeria are evident at the single-cell level (Fig 2.1a; Fig A1). 
Typical nuclei from healthy skin fibroblasts with no progerin expression exhibit round 
nuclear shape, homogeneous lamin B1 expression along the nuclear boundary, and little 
evidence of DNA damage (Fig A1, top). In contrast, typical nuclei from HGPS patient skin 
fibroblasts show aberrant nuclear shape, reduced lamin B levels, and increased DNA 
damage (Fig A1, bottom). For a controlled RNAi screening experiment, a previously 
described hTERT immortalized skin fibroblast cell line was used in which GFP-progerin 
expression can be induced by exposure to doxycycline, causing the various defects 
observed in HGPS patient fibroblasts [120]. RNAi screening controls consisted of 
fibroblasts in which GFP-progerin expression was induced by doxycycline treatment, in 
the presence of 1) a non-targeting control siRNA, which allowed for full expression of 
GFP-progerin and formation of a progeria-like cellular phenotype in most cells, and from 





siRNA, which eliminated GFP-progerin, restored a healthy-like phenotype, and from here 
on will be referred to as the GFP-progerin repressed control. Progerin-induced cells were 
plated in 384-well plates and screened against a library of 320 ubiquitin family targeted 
siRNAs. In addition, 12 GFP-progerin expressing controls and 12 GFP-progerin repressed 
controls were prepared on each imaging plate which enables estimation of control 
variability. Four fluorescent channels were analyzed (DAPI to visualize DNA, far red: the 
nuclear architectural protein lamin B1, green: progerin, red: γH2AX as a marker of DNA 
damage). Images were taken at 6 different locations in each well, and each plate was 
imaged 4 times under the same conditions; the whole imaging procedure was applied to 4 
replicate plates with identical setup (see Methods). Details of the screening process are 
reported in [120]. 
2.4.1 Definition of stable classification boundaries based on typical cells 
Single cell heterogeneity is prevalent in our screen (Fig 2.1). While typical progerin 
expressing cells exhibit reduced and inhomogeneous lamin B1 expression, pronounced 
DNA damage, high expression of progerin, and a blebbed cell shape, some cells in this 
population look like a typical healthy cell, with normal levels of homogeneously distributed 
lamin B1, little or no DNA damage, little to no expression of progerin, and round nuclear 
shape (Fig 2.1). Conversely, the cellular population of GFP-progerin repressed controls 
consists mostly of healthy-looking cells. However, a small fraction of cells in this 
population display features characteristic of progeria (Fig 2.1a). This heterogeneity is a 
well-established feature of HGPS patient cells [114]. 
Quantification of single cell features shows the distribution of the mean intensity for all 





channel), the distribution of fluorescence intensities found along the nuclear boundary 
(boundary intensities; Lamin B1 channel), and the standard deviation of intensities inside 
nucleus (γH2AX channel) (Fig 2.1b). These metrics were extracted via automated image 
analysis tools (see Methods) from all images in all control samples. For each of the four 
channels imaged, we show the metric that best separates GFP-progerin expressing controls 
(red) from GFP-progerin repressed controls (green). Except for the intensity of progerin, 
distributions overlap significantly, highlighting substantial heterogeneity among nuclei 
within each control group. The heterogeneity is largest for γH2AX, followed by nuclear 
shape and lamin B1.  
Despite heterogenous cellular expression, the average behavior of GFP-progerin 
expressing and repressed control cells are significantly different. Since the goal of this 
screen (as many other screens for identifying potential drugs) is to identify important 
perturbations that reverse the states of diseased cells to healthy-like, we focus on 
similarities of cells in each type of controls. 
 
 
Figure 2.1 Single cell heterogeneity leads to overlapping cell populations. a) Each row corresponds to one 
fluorescent marker; columns show different nuclei selected from GFP-progerin repressed controls. Nuclear 





healthy cells (first six columns), exhibiting normal lamin B1 expression, little DNA damage, no expression 
of progerin, and round nuclear shape, as expected for GFP-progerin repressed controls. Atypical cells (two 
rightmost columns) exhibit characteristics of progeria, namely reduced lamin B1 expression, increased DNA 
damage in the γH2AX channel, expression of progerin, and blebbed nuclear shape. b) Distribution of the 
metric that best separates the two types of controls in each channel, based on all cells in the control samples 
(green: GFP-progerin repressed cells, red: GFP-progerin expressing cells). Note that the contours obtained 
from the DAPI channel appear slightly smaller and misaligned with the images obtained in the lamin B1 
channel (see Fig S2 for the analysis of cross-channel discrepancies). The scale bar is 5 µm.   
Classification of individual cells based on such overlapping distributions is challenging, as 
indicated by the fact that the analysis of multiple sets of 300 randomly selected cells of 
each of the two reference types via a Support Vector Machine (SVM) approach (see 
Methods) does not result in a stable classification boundary (Fig 2.2). To illustrate this 
limitation, we use 200 bootstrap samplings to identify a classification boundary using all 
metric dimensions simultaneously. We then extract the variability of the classification 
boundary in each channel (Fig 2.2b). We observe that classification boundaries rotated on 
average by more than 10 degrees between trials in the progerin channel, and by somewhat 
smaller amounts in the other channels.   
Note that the angle of the classification boundary determines the relative weight of the two 
metrics shown in the scatter plot:  for example, a vertical classification boundary indicates 
that the metric plotted along the vertical axis is not important for classification.  Thus 
uncertainty about the orientation of the classification boundary implies uncertainty about 
the relative weight of the metrics in distinguishing both controls. To provide a reliable 
weighting of metrics and to find reproducible classification boundaries, we use typical 





channel (see Methods). Typical cells lead to stable classification boundaries with variations 
of less than 5 degrees in all channels (Fig 2.2b).  
 
Figure 2.2 “Typical” cells yield robust metrics weighting and stable classification. a) A cartoon showing 300 
randomly selected cells for each of the two control populations and a putative classification boundary. The 
variability in angle for 200 repeats is shown in (b). The range of angles is substantially smaller when “typical” 
cells are used. 
2.4.2 Stable classification boundary enables identification of potential siRNA hits 
based on the fraction of healthy-like cells 
Once a stable classification boundary is drawn based on typical healthy-like (GFP-progerin 
repressed control) and progeria-like (GFP-progerin expressed control) samples, all cells in 
all samples can be analyzed using the classification boundary. Specifically, we measured 
the percentage of healthy-like cells in every sample (Fig 2.3). We define significant siRNA 
perturbations, or “hits”, based on the ability of the siRNA perturbation to significantly 






Figure 2.3 Identifying hits from the percentage of cells classified as healthy-like. A visual representation of 
the entire screen (320 siRNA samples, 12 GFP-progerin repressed control samples, and 12 GFP-progerin 
expressed control samples). Each dot represents a sample (green: GFP-progerin repressed control, red: GFP-
progerin expressing control, blue: siRNA samples), with the vertical axis showing the average percentage 
and the error bar showing standard deviation of healthy-like cells computed from the 4 independent replicates. 
False positive rate (FPR) for each siRNA is estimated from this standard deviation. The red horizontal line 
marks the upper boundary for GFP-progerin expressing control samples used to identify hits (5 standard 
deviations from the mean of all GFP-progerin expressing controls). Only siRNAs above this line with FPR 
< 0.05 are considered as hits. The green dashed horizontal line marks the lower boundary for GFP-progerin 
repressed control samples (5 standard deviations from the mean of all GFP-progerin repressed controls).  
In all channels, GFP-progerin expressing and repressed controls are well separated, with 
the healthy-like phenotype boundary (green dashed line in Fig 2.3) above the hit selection 
threshold (red solid line in Fig 2.3). The separation between GPF-progerin expressing and 
repressed controls are the largest in the progerin channel, as expected since GFP-progerin 





modulation. According to our criteria for the selection of siRNA hits (see Methods), the 
lamin B1 has the largest number of hits (75) and followed by progerin (31), nuclear shape 
(8), and γH2AX (5) (see details in A7).  
The fraction of healthy-like cells in each well in the screen constitutes a metric not yet 
widely used in screen analysis. This metric highlights the ability of the siRNA to 
significantly alter some of the cells, but not all, whereas the more traditional metrics – 
which were also used in the original analysis of this dataset in Ref. [120] – emphasize shifts 
in the overall behavior. To compare the two metrics, we determine the Z-scores of the shifts 
in average properties (Fig 2.4a). Both types of Z-scores are determined based on GFP-
progerin expressing control samples. For the traditional metric, the threshold is held at Z-
score of 2, while our threshold is at Z-score of 5 (by Chebyshev's inequality the probability 
that the hit is spurious is less than 0.04). Note that if we increase the Z-score threshold for 
traditional metrics to 5, there will be no hits identified. These two thresholds (gray lines) 
separate each panel of Figure 2.4a into four quadrants: perturbations identified as hits by 
both methods (upper right), hits identified only by traditional metrics (lower right), hits 
identified only by the fraction of healthy-like cells (upper left), and perturbations not 
identified as hits by either method (lower left). The bottom right quadrant is empty except 
for two siRNAs in the γH2AX channel, suggesting that our method captured nearly all hits 
determined by the traditional metric. On the other hand, points in the top left quadrant 
represent siRNA hits identified only by our approach, suggesting that our metric is more 
sensitive in the sense of identifying additional possible hits. 
In addition, we benchmarked our method against one of the existing multi-dimensional 





method in Ref [34] is based on more complex clustering of all cells into multiple cell types 
(Fig 2.4b). Using the method of Ref [34], we first identified multiple clusters (9 clusters in 
progerin and γH2AX channels, and 8 clusters in lamin B1 channel) in 10,000 combined 
controls cells (5,000 for each control type). We then calculated the profile of cell 
distribution in each cluster for all siRNA samples and compared with GFP-progerin 
repressed controls (healthy-like). Since the original workflows of Ref [34] did not include 
hits selection, we adapted the workflow of Ref [34] and introduce the inverse distance 
between each siRNA sample and GFP-progerin repressed controls as the metric for hits 
selection. Figure 2.4 shows a strong correlation between the metric derived from this 
benchmarking test (horizontal axis) and the RefCell analysis pipeline (vertical axis) (see 
details in Appendix A.8). 
 
Figure 2.4 Comparing the percentage of healthy-like cells with traditional average-based metrics and another 
multi-dimensional analysis approach. a) Each panel depicts one channel (nuclear shape (DAPI channel) is 
not taken into consideration in Ref. [120], hence it is not included here). Every point represents a siRNA 
sample; the value shows Z-scores calculated based on the distance from the mean of all GFP-progerin 





intensity measurements for all cells in a sample (x-axis) and our metric (y-axis). Gray lines indicate hit 
thresholds for the corresponding metrics. Note that our metric identifies every hit found by the traditional 
method (except for the two hits in the γH2AX channel). In addition, our metric selects additional potential 
hits (siRNAs in the upper left corner) missed by the traditional metric. b) Similar as in a) each panel shows 
one channel in the screen. Each circle depicts a siRNA sample. The horizontal axis shows inverse of the 
distance to GFP-progerin repressed (healthy-like) controls, the larger this value, the similar the siRNA to 
GFP-progerin repressed controls. The vertical axis shows the percentage of healthy-like cells, and the dashed 
lines are thresholds for hits in respective channels.  
2.4.3 Classification boundary and metric weighting obtained via typical cells is 
useful for characterization of all perturbations  
As explained above, we assess the phenotype for each perturbation in our high-throughput 
screen relative to two types of controls. Thus, the weighting of metrics given by the SVM 
classification boundary is based on both control phenotypes (Fig 2.2). In Figure 2.3, we 
had focused on subsets of cells that cross the classification boundary, i.e., that exhibit a 
shift in property perpendicular to the classification boundary.  
In our next step, we characterize shifts of the phenotype both perpendicular and parallel to 
the SVM classification boundary (Fig 2.5a). We find that most perturbations shift cell 
properties perpendicular to the classification boundary.  This indicates that the imaging 
metrics which are most important to distinguish typical cells in the two control phenotypes 
are also the imaging metrics that change most for the siRNA perturbations.  However, when 
the classification metrics are computed from randomly selected cells, - the blue points in 
Figure 2.5b – we observe shifts both parallel and perpendicular to the classification 
boundary. (Fig 2.5b). One notable exception is the progerin channel in which the two 
control cases are very well separated (Fig 2.1b). The analysis above indicates that the 320 






Figure 2.5 The shift of mean cell properties by siRNA perturbations for classification boundaries computed 
from (a) typical cells and (b) randomly selected cells. Each green and red point represents the mean of all 
cells in one GFP-progerin repressed (healthy-like) or GFP-progerin expressing (progeria-like) control sample, 
respectively. There are 12 samples for each control type. Each blue point represents the mean of all cells for 
one siRNA perturbation. The classification boundary is shown as a vertical dotted black line. Four siRNA 
samples that deviate significantly from both controls in each of the four channels are labeled (siPHF13 for 
progerin; siNEDD4 for lamin B1; siTRIML1 for DAPI (nuclear shape), and siRNF8 for γH2AX). Note that 
the range of the x-axis is the same as the range of the y-axis in all panels. a) Most points are preferentially 
shifted perpendicular to the classification boundary. Variation parallel to the classification boundary is small 
compared to the variation perpendicular to it. b) siRNA perturbations are shifted both parallel and 
perpendicular to the classification boundary when the classification boundary is computed from randomly 
selected cells.  
Figure 2.5a also identifies siRNA perturbations that yield unusual changes in phenotype. 
Four examples of such siRNAs are highlighted here, one for each channel: siPHF13 for the 
progerin channel, siNEDD4 for the lamin B1 channel, siTRIML1 for the DAPI channel, 
and siRNF8 for the γH2AX channel. From each of these siRNA samples, four typical cells 





Figure 2.6 (a, b, d, and e). For comparison, four typical cells in both progeria-like and 
healthy-like controls are also selected (Fig 2.6c and f). siPHF13 treated cells (Fig 2.6a) 
express even higher levels of progerin than cells in progeria-like controls and progerin 
aggregates in the nucleus. Upon examining lamin B1 levels expressed by cells treated with 
siNEDD4 (Fig 2.6b), we find that lamin B1 no longer localizes only to the nuclear 
boundary, but spreads throughout the nucleus in an inhomogeneous way. In addition, in 
this case, lamin B1 expression co-localizes with progerin expression. siTRIML1 is an 
outlier in both the progerin and nuclear shape channel, with overexpression of progerin 
similar to that observed in cells treated with siPHF13. Furthermore, cells treated with 
siTRIML1 have nuclear shapes that are even less regular than progeria controls’. Finally, 
for cells treated with siRNF8 DNA damage is more substantial but also more localized 
(isolated bright dots in the γH2AX channel) than in progeria-like controls. These results 
suggest that a classification boundary built from typical cells in controls is valuable to 
analyze the full perturbation screen and that outliers identified in this classification point 
to perturbations that yield unusual properties.  
 
Figure 2.6 Typical cells in siRNA perturbations identified as different from both controls. a) siPHF13 is an 





control cells (f), and the expressed progerin appears to be distributed differently from the progeria control. b) 
siNEDD4 is an outlier in the lamin B1 channel; cells treated by siNEDD4 express more lamin B1 than the 
healthy-like control cells (c), and the expression is less homogenous. In addition, the expression of lamin B1 
is spatially co-localized with the expression of progerin in siNEDD4-treated cells. d) siTRIML1 is an outlier 
in both DAPI (nuclear shape) and progerin channels. Cells treated by siTRIML1 tend to have elongated nuclei 
compared to the healthy-like and the progeria-like controls. Also, clusters and increased progerin expression 
(compared to the progeria-like control (f)) can be observed. e) siRNF8 is an outlier in the γH2AX (DNA 
damage) channel. Note that the contours obtained from the DAPI channel appear slightly smaller and 
misaligned with the images obtained in the lamin B1 channel (see Fig A2 for the analysis of cross-channel 
discrepancies). The scale bar is 5 µm.  
2.4.4 Integrating information from multiple channels increases hit detection 
accuracy 
So far we have considered multiple metrics separately for each channel. This means that 
we may have labeled a cell as healthy-like based on one channel, but progeria-like when it 
is analyzed in another channel. This approach reflects uncertainty regarding the progeria 
phenotype at the single cell level: although it is known that progeria is caused by the 
expression of the lamin A-mutant progerin, it remains unknown how progerin expression 
changes other features, such as blebbed nuclear envelope, DNA damage accumulation, and 
mislocalized lamin B1 expression at the single-cell level, and how these different features 
correlate with one another. For example, in one study progeria and healthy cells were 
distinguished using only nuclear shape measurements [121], implying that nuclear shape 
is a dominant criterion in detecting progeria. However, another study found that nuclear 






Thus, as a final analysis step, we study the relationships among the four features associated 
with progeria at the single-cell level. RefCell integrates single cell information from 
multiple channels in two different ways. First, we display the percentage of healthy-like 
cells for a primary marker vs. the percentage of cells identified as healthy-like according 
to the other three markers (Fig 2.7). The diameter of the circle represents the fraction of 
cells identified as healthy-like according to all four markers. As expected, GFP-progerin 
repressed controls (i.e., healthy-like controls, green circles) show a larger percentage of 
cells identified as healthy-like for all four markers than any of the 320 perturbations (blue 
circles).  Figure 2.7 shows that the percentage of healthy-like cells according to a given 
marker is correlated with the percentage identified as healthy-like according to the other 
three markers are correlated, although the correlation is weak in all channels except 
progerin. 
Second, we integrated image metrics from all channels together and applied our method on 
combined metrics. We found that the three metrics related to progerin (mean intensity, 
standard deviation of intensity and boundary intensity) are the most important metrics in 
separating GFP-progerin expressing and repressed controls, contributing more than 60% 
in the direction of classification boundary. Lamin B1 is next, contributing about 20%. In 
addition, we found that 99% siRNA hits identified by combining all channels are also 
identified by detecting hits separately for each channels; however, the combined analysis 








Figure 2.7 Integrating information from all channels:  Percentage of healthy-like cells in one channel vs. 
percentage of cells classified as healthy-like in the other three channels. Each circle stands for a sample (green: 
GFP-progerin repressed, red: GFP-progerin expressing, blue: siRNA). The size of the circle is proportional 
to the percentage of cells that are classified as healthy-like in all four channels (scales are shown in top-right 
panel). The dashed vertical lines are thresholds for hit selection in the corresponding channel. Shown in the 
upper right corner of each panel is the linear correlation coefficient (note that p < 0.01 after Bonferroni 
correction in all cases). 
2.5 Discussion 
One of the major usages of image-based high-throughput screening (HTS) experiments is 





major strength of image based HTS is that measurements of multiple parameters are carried 
out on each cell, thus promising insights into mutual information and correlations among 
parameters at the single cell level. However, newly developed analysis methods yield 
complex and hard to interpret end results, and may actually misrepresent the data due to 
the curse of dimensionality [11].  In fact, most current applications of image based HTS 
still rely on simple averaging of each parameter.  Here we introduce RefCell, a method that 
fills the gap between statistically sound average-based methods and statistically 
challenging high-dimensional methods. The underlying assumptions of RefCell are that the 
properties of typical cells are useful reference points for the biological or clinical question 
of interest and that the best approach to identify hits is to measure changes along a straight 
path (in high dimensions) between the references points.  
The first step in RefCell is the selection of two sets of controls and the choice of “typical” 
cells within these controls. Here we choose typical cells as cells that are average in all 
aspects of their phenotype, i.e., all the metrics are close to the mean. In our dataset, one 
control represents cell nuclei of a model for progeria which show several defects, and the 
other control approximates healthy cell nuclei. Since image-based metrics are 
heterogeneous, the corresponding distributions of measured values overlap significantly at 
the single-cell level (Fig 2.1). Selecting typical cells yields distributions that are well 
separated, enabling stable classification boundaries between healthy-like and progeria-like 
cells.  The classification boundary reveals both the value of each metric that marks this 
transition and the relative weight of each metric (Fig 2.2).   
For the HTS used in this investigation, we find that surprisingly the metrics we identified 





representation of this observation is shown in Figure 2.5a, where the two controls (green 
and red dots) lay out a straight path between a progeria-like phenotype and a healthy-like 
phenotype.  All siRNA perturbations (blue dots in Fig 2.5a) fall along this straight path 
indicating that the metrics that were identified as important are the ones that are changing 
most in the 320 siRNA perturbations. On the other hand, if all cells rather than typical cells 
are used for classification and weighting, classification boundaries are less stable (Fig 2.2), 
and the 320 siRNA perturbations do not change the highly weighted metrics more than 
other metrics (the blue dots in Fig 2.5b form a cloud). This indicates that the screen does 
not involve random perturbations but perturbations targeted specifically to progeria.    
With these weights and a stable classification boundary, we were able to quantify the 
heterogeneity of all cells in all samples. This analysis yields a simple parameter: The 
fraction of cells identified as healthy-like in each sample. The fraction of normal cells had 
been identified in other studies as a useful parameter [122]. In RefCell, this parameter is 
used in multiple steps and is first determined separately for each channel to identify 
potential “hits” in the siRNA perturbation screen (Fig 2.3). 
Our new parameter, the fraction of healthy-like cells represents an ensemble metric for a 
cell population and correlates with the average-based metrics traditionally used in most 
HTS.  However, the classification boundary location and weight of metrics are tuned to the 
specific classification challenge by identifying two control populations. RefCell identifies 
all hits selected by an average-based method, but with higher statistical significance (Z-
score). In addition, RefCell identifies additional hits even when the cutoff Z-score for hits 






Furthermore, RefCells focus on the fraction of healthy-like cells means that any 
perturbation that makes a substantial fraction of cell nuclei appear healthy-like is included 
as a possible hit, even if the average cell properties do not change. This allows us to include 
all perturbations that are capable of making at least a subset of cells appear healthy-like, 
even if the same perturbation is ineffective or detrimental for other cells.   
The final step in RefCell focuses on integrating information from multiple imaging 
channels (Fig 2.7). When considering all siRNA perturbations and all channels 
simultaneously, our analysis confirms that the progerin level is the most important feature 
in progeria disease, and that decreasing progerin expression levels is the most efficient way 
of removing all four principal phenotypes associated with progeria.  However, we also note 
significant variability in how effectively a given perturbation leads to healthy-like 
phenotypes in each channel. This information helps prioritize hits that have been identified 
separately in each channel. 
In addition, we compared RefCell with a published method that aims to characterize 
heterogeneity in cells using EM clustering with Gaussian mixture models (GMM) [34].  
Since the published method did not provide a metric for hits selection, we used inverse 
distance to GFP-progerin repressed controls. This distance is calculated using symmetrized 
KL divergence as used in [34]. The higher the inversed distance, the more important the 
perturbation. We show that in both progerin and lamin B1 channel, our metric agrees well 
with the other method (see Appendix A.8) with Spearman correlation coefficient 0.98 for 
γH2AX channel and 0.91 for lamin B1 channel (p value << 0.05 in both cases). However, 
the complex clustering approach does not allow us to integrate information from all 





dimensionality of metrics is too large for meaningful clustering with “only” thousands of 
cell images in each sample).  
In summary, RefCell represents a simple but useful computational approach for analyzing 
image-based HTS datasets. RefCell is broadly applicable to single-cell-based high-
throughput screens that focus on perturbing cells from one distinct phenotype to another. 
RefCell uses image processing and machine learning algorithms to identify hits that 
substantially increase the fraction of cells that regain one of the two reference phenotypes. 
RefCell can be used to analyze each fluorescent channel separately, and also to integrate 
the single-cell information from all channels. Applied to a progeria HTS dataset, RefCell 
reveals a complex interplay among the four standard indicators of proteria (measured in 
four independent fluorescence channels), revealing that the list of hits depends strongly on 
the choice of indicator.  RefCell analysis further revealed that the screen was not unbiased, 
but focused on a pathway with known links to the disease.  
2.6 Methods 
2.6.1 Experimental procedure 
hTert immortalized doxycycline GFP-progerin inducible human skin fibroblasts (P1 cells) 
were generated and induced (96 hr). Reverse siRNA transfections were carried out in 
quadruplicate in a 384-well format (Perkin Elmer Cell carrier plates) in the presence of 
doxycycline (1 mg/ml) with pooled siRNA oligos (50nM; 4 siRNAs/target) from the 
Dharmacon siGENOMESMARTpool siRNA Human Ubiquitin Conjugation subset 1 and 
2 libraries. Positive and negative controls consisted of GFP-targeting and non-targeting 
siRNA (50nM; Ambion, #AM4626, #AM4611G), respectively. Transfected cells were 





medium was added, and cells were incubated for another 3 days (37 oC, 5% CO2). Details 
of the experiments are reported in [109]. A full list of screened siRNAs can be found in 
Appendix A Section 9. 
2.6.2 Image analysis 
While metrics similar to the one used in this study could be obtained with commercial 
software, we used a custom image analysis method modified from methods in [123]. 
Details are described in Appendix A Section 3. A list of measurements and short 
descriptions are shown in Table 1.  
Table 2-1 Image measurements used in this study. 
 Name of measurement Description 
Nuclear 
shape 
Area Area of nucleus 
Circularity 
Ratio of perimeter to area, normalized so that a circle 
would have ratio 1 
Eccentricity Eccentricity of nucleus 
Invaginations Number of invaginations along the nuclear boundary 
Major Axis Length 
Major axis length of the best fit ellipse to the nuclear 
boundary 
Mean Curvature Mean curvature along the nuclear boundary 
Mean Negative Curvature 
Average of only negative curvatures along the nuclear 
boundary 
Minor Axis Length Minor axis length of the best fit ellipse 
Perimeter Perimeter of nucleus 
Solidity 
Percentage of pixels inside the convex hull that are 
inside the boundary 
Std of Curvature The standard deviation of curvature 
Tortuosity Tortuosity of nuclear boundary 
Intensity 
BP Intensity Mean intensity of points along the nuclear boundary 
Mean Intensity Mean intensity inside the nucleus 
Std of Intensity Standard deviation of intensity inside nucleus 
2.6.3 Analysis of the two control groups 
Selection of typical control cells. Within each control population, typical cells were 
defined as a core of n=300 cells closest to the mean based on the L1 (Manhattan) distance, 
calculated separately for each channel. We pooled all control samples together for typical 
control cell selection. On average there are about 20,000 cells in each type of controls. 





controls, show HGPS characteristic nuclear defects (increased progerin expression, 
misshapen nuclei, reduced lamin B1 protein levels, and increased DNA damage shown by 
expression of γH2AX). Typical healthy-like cells, selected from GFP-progerin repressed 
controls, show no sign of HGPS nuclear defects. This selection procedure was carried out 
independently for each replicate plate. Additional details are provided in Appendix A 
Section S4. 
Classification using Support Vector Machines (SVM). The sets of typical cells were 
used to classify healthy- and progeria-like phenotypes via SVM, an efficient and robust 
supervised machine learning algorithm for classification [124]. Using a linear kernel, SVM 
finds the optimal linear boundary in instance space (straight line in 2D, planes in higher-
dimensional spaces) that separates two classes of instance data points, while maximizing 
the margin of class separation. We performed SVM using the ksvm() function in kernlab 
package in R (version 3.1.1). After rescaling all nucleus metrics to zero mean and unit 
variance, a classification boundary was obtained between typical healthy and typical 
progeria cells. The distance from each nucleus to the classification boundary, which is a 
linear combination of all the measurements, can be used as a score to classify the proximity 
of that cell to each phenotype (healthy- or progeria-like). In order to distinguish between 
the two sides of the classification boundary, we define positive distances as associated with 
healthy-like cells, and negative distances with progeria-like cells. The SVM analysis also 
yields the relative importance of each metric in distinguishing between the two phenotypes 
as shown in Appendix A Section 5. 
2.6.4 Identification of significant perturbations 
Determination of the fraction of healthy-like cells. Having obtained a classifier 





control samples and siRNA perturbations samples). For this, we first normalize all cells to 
be classified using the z-score transformation determined from typical control cells (i.e., 
subtracting the mean of typical control cells and dividing by their standard deviation). Next, 
we calculate the distance from each cell to the classification boundary and use the sign of 
the distance to classify individual cells as either healthy- or progeria-like. Finally, we 
calculate the percentage of healthy-like cells in each sample. This percentage is obtained 
separately for each replicate plate.  This allows us to report the mean percentage (averaged 
over all replicate plates) and its estimated uncertainty (resulting from the variance over 
multiple replicates). The number of cells in each perturbation sample ranges from 500 to 
2000. For more details, see Appendix A Section 6. 
Identification of siRNAs that generate significant healthy-like perturbations (“hits”). 
We repeated the screen 4 times (yielding 4 independent replicates), and the analysis 
described above was done separately for each plate (i.e., given a sample, there are 4 
independent estimates for each parameter). To carry out the hit selection process, we first 
averaged each parameter over the 4 replicates. Then we excluded potentially cytotoxic 
siRNA samples, by excluding those that contain less than 50% of cells compared to GFP-
progerin repressed samples (the number of cells is similar in each sample at the start of the 
experiment). Next, a siRNA hit was selected based on the following two criteria: 1) the 
fraction of healthy-like cells is above a threshold (a mean and standard deviation were 
computed based on the percentage of healthy-like cells in each of the 12 GFP-progerin 
expressing control samples, the threshold was set to 5 standard deviations higher than the 
mean); 2) the false positive rate (FPR) based on the variation among the 4 replicates is less 





Chapter 3 CytoBinning: immunological insights from multi-
dimensional data 
3.1 Overview 
In this chapter, I try to reconcile the conflict between difficulty in interpreting sophisticated 
high dimensional analysis methods and the impression of the low information content of 
2D scatterplots by introducing a binning method I termed “CytoBinning”. The increasingly 
large number of measurements that can now be made simultaneously using cytometry 
platforms have created the impression that 2D scatter plots, which used to be the center 
stage of cytometry data analysis, don’t contain enough information. However, 
sophisticated methods that fully embrace large numbers of measurements are hampered by 
the difficulties of interpreting high-dimensional datasets, and this limits their practical 
utility. CytoBinning fills the gap of complexity between conventional manual analysis and 
complex automated analysis to extract deep content in scatter plots which can be later 
cascaded into more complicated clustering or classification algorithms to obtain novel 
biological insights. The experimental data were obtained from the online repository: 
https://flowrepository.org/. This chapter is adapted from a manuscript submitted to PLOS 
Computational Biology. 
3.2 Abstract 
New cytometric techniques continue to push the boundaries of multi-parameter 
quantitative data acquisition at the single-cell level, particularly in immunology and 
medicine. Sophisticated analysis methods for such ever higher dimensional datasets are 
rapidly emerging, with advanced data representations and dimensional reduction 
approaches. However, these are not yet standardized, and clinical scientists and cell 





of statistical validity is not yet fully established.  We, therefore, propose a new method for 
the automated and unbiased analysis of high-dimensional single-cell datasets that is simple 
and robust, with the goal of reducing this complex information into a familiar 2D scatter 
plot representation that is of immediate utility to a range of biomedical and clinical settings. 
Using publicly available flow cytometry and mass cytometry datasets, we demonstrate that 
this method (termed CytoBinning), recapitulates the results of traditional manual 
cytometric analyses and leads to new and testable hypotheses. 
3.3 Introduction 
Cytometry is a multi-parameter single-cell measurement technique that is widely used in 
biological and clinical studies [37, 125-129]. One of the main uses of flow cytometry, 
which has had a major impact across the fields of immunology and medicine, is to 
differentiate immune cells compositions among cell types or patients. Modern flow 
cytometers can routinely measure 15-20 cellular markers on millions of cells from dozens 
of samples in one experiment and can sort cells into subpopulations based on those 
markers. Recently mass cytometry has expanded the number of markers that can be 
measured simultaneously to 100, though the technique is destructive to cells and does not 
allow for sorting. The conventional way of analyzing flow cytometry data uses a gating 
strategy which requires the manual selection of regions of interest (ROI) on sequential 2D 
scatterplots. This type of analysis is very labor intensive and inefficient for such large 
datasets and also suffers from subjectivity in both the sequence of 2D scatterplots and 
selection of thresholds (ROI) [5, 37, 45, 51, 52, 127]. Therefore, as both the number of 





decade, novel, automated and unbiased analysis methods for flow cytometry data are 
emerging [1].  
These novel analysis methods can be divided into two categories based on the problem 
they address: 1) methods trying to mimic and automatize the process of manual gating [54, 
55, 61, 64, 69, 130, 131]; and 2) methods trying to identify cell populations using all 
markers simultaneously without prior biological knowledge [58, 59, 132, 133]. Some 
cutting-edge approaches to automating manual gating, such as flowDensity [54], are very 
successful in re-identifying cell subsets that match with manually gated subsets in an 
automatic, reproducible way. However, gating (both manual and automatic) relies heavily 
on prior experience to inform the sequence of markers to gate. Furthermore, in gating, 
researchers must define the cell phenotypes to look for in advance of their analysis, hence 
hindering discovery of novel cell types and not tapping into the full potential of the 
acquired data. Gating methods also only explore a very limited portion of the total data 
space, though unsupervised methods have been published that enhance the efficiency of 
data usage, with the potential to reveal otherwise hidden differences between datasets [70]. 
Most unsupervised methods that allow novel cell type discovery aim to identify regions 
with high cell density in multi-dimensional space [56, 58-60, 63, 66, 70, 72, 73, 75]. This 
assumes cells form distinct phenotypes and that only cells inside those relative high-density 
areas (peaks) are of importance. However, cells that are in between two high-density 
clusters (valleys) may also have potential biological significance [76]. Another limitation 
of clustering based methods is that concatenating different samples (which is a widely used 
strategy [62, 75]) with potential batch effects can be problematic, hence limiting the 





trials). In addition, these clustering-based methods require estimation of nearest neighbors 
in high-dimensional space which suffers from “curse of dimensionality” and may lead to 
misleading results [77]. As a result, people have been calling for the use of lower 
dimensional methods such as gating based on 2D scatterplots [11]. 
In this paper, we present a new method for analyzing cytometry data that utilizes such 2D 
scatter plots. Instead of gating, we dig deeper into the scatter plots mining the information 
that is largely bypassed by other methods. This method is useful for the majority of 
comparative studies that aim to elucidate the difference between two groups of samples. 
Our method, which we term CytoBinning, identifies the most information-rich 2D scatter 
plots and extracts biological insights from them. We show that biologically relevant 
differences can be discovered from the pairs of markers identified with this approach. First, 
we introduce CytoBinning with a synthetic dataset, and then apply it to two public high-
dimensional single-cell datasets, a flow cytometry dataset comparing composition in 
immune cells between old and young healthy human donors [59], and a mass cytometry 
dataset analyzing the immune signature of eight types of human tissues [134]. 
3.4 Results 
We synthesized two point-patterns based on the expression of two virtual markers: maker 
A and marker B. Ten samples were generated for each point-pattern. The first point-pattern, 
called pattern A, consists of three point-clusters. Two large clusters each contain 5,000 
points and a third relatively small cluster contains about 2,000 points. The three clusters 
are randomly sampled from Gaussian distributions that centered at point (0, 4), (0, -4) and 
(4, 0) with standard deviation 2, 2, and 1 respectively. The second point-pattern, called 





same way as point-pattern A. However, the third smaller point-pattern only contains 200 
to 500 points, sampled from a Gaussian distribution centered at point (-4, 6) with standard 
deviation 1 (Fig. B1).  
 
3.4.1 Percentile-based binning is a coarse-grained representation of point patterns 
An example of percentile-based binning is shown in Figure 3.1 using one synthetic sample 
with point-pattern A. Points inside the point-pattern were first binned into 3 levels based 
on the expression of marker A and B independently, each level containing one third of 
points. The 3 levels for marker A and B were then combined on a 2D scatter plot to form 
9 sub-regions (these sub-regions are called boxes). The percentage of points in each box 
changes depending on the point-pattern. This binning method has been used as an 
alternative method to calculate mutual information (MI) in a robust and computationally 
efficient way [135]. MI is a measure of dependence between two random variables widely 
used in gene network inference [136] as a general measure of interdependency between 
genes. In our method, instead of summarizing the binning information into one number 
(MI), we used percentage of points in each box as a coarse-grained representation of point-






Figure 3.1 An example of percentile-based binning as a representation of 2D point-pattern (number of bins 
= 3). (a) Synthesized point-pattern formed by expression of marker A and marker B. (b) Points are binned 
into 3 bins each containing 1/3 (33.3%) of the total points. The bins are labeled numerically based on the 
expression level of the related marker, with 1 the lowest and 3 the highest (similarly if points are divided into 
5 bins then the highest level is 5). This binning is done independently for marker A and marker B based on 
their expression. (c) Bins obtained in (b) are combined so that 9 sub-regions referred as boxes are formed. 
The percentage of points inside each box is calculated, and the matrix of percentages is straightened to a 
vector so that the 2D point-pattern shown in panel (a) is coarse-grained to the vector in (d). 
3.4.2 Applying percentile-based binning to multiple samples enables meaningful 
classification 
After we demonstrate how to represent point-patterns with percentile-based binning, next 
we show that this representation is able to capture real differences in point-patterns. Figure 
3.2a shows two examples of the synthetic point-patterns. In total, 10 samples were 
generated for each point-pattern, and each sample was analyzed using percentile-based 





to cluster the two point-patterns into distinct groups, and correctly identifies the most 
significant difference (Fig. 3.2b & c). Boxplots of cell percentage in each box show that 
the box with most distinct difference between the two point-patterns is box B32 which 
contains the third cluster of point-pattern A (lower panel of Fig. 3.2b). This is the most 
significant difference between these two point-patterns, and it was captured without 
referring to density distribution of points. Minor differences between these two point-
patterns (the small cluster located at the top left corner) were not spotted, since the 
percentage of points in box B13 is similar in both point patterns (Fig. 3.2b). However, this 
third cluster in pattern B (~ 2% to 5%), was identified when the number of bins was 






Figure 3.2 Percentile based binning is able to detect real differences between point-patterns. (a) Example of 
the two synthesized point-patterns A and B. The two large clusters in pattern A and B contain same number 
of cells and were generated with the same distribution. Pattern A contains a relatively large third cluster (10% 
to 20% of cells) at center right of the pattern and pattern B includes a smaller third cluster (2% to 5% of cells) 
on the top left corner. (b) Upper panel shows a heatmap of point percentage in each box for all samples, and 
lower panel shows boxplots of point percentage in each box between the groups of point-patterns. (c) Labels 






3.4.3 The maximum number of bins for binning depends on the number of samples 
(patients) 
We’ve seen in the previous section that the depth of analysis depends on the number of 
bins used. And here we are going to show that the maximum number of bins we could use 
depends on the total number of samples (patients), for using a large number of bins to 
classify a small set of samples would cause overfitting. We see that false positive rate (FPR) 
increases with the numbers of bins used for binning (Fig. 3.3a). However, the maximum 
number of bins with tolerable FPR (FPR < 0.05) increased when we increase the number 
of samples from 20 to 60 (Fig. 3.3a). While with 20 samples we can only use as many as 3 
bins to keep FPR under 0.05, with 60 samples this number increased to 6. And using 6 bins, 
our method is able to identify both of the differences we artificially generated between 
point-pattern A and B (Fig. B3). To get a general picture of how the maximum number of 
bins relates to number of samples, we calculated the maximum number of bins with FPR 
= 0 (we use this stringent condition because i) Synthetic data is easier to classify; ii) Real 
dataset contains more than 2 markers, and multiple tests correction should be taken into 
consideration) for various number of samples. We found that when the two groups to be 
classified contain the same number of samples (patients), the maximum number of bins is 
around the square root of half the sample size (Fig. 3.3b). In reality, the number of samples 
(patients) in different groups is rarely equal. However, we can overcome this inequality by 
assigning different number of samples to cross validation set for different groups so that in 
training dataset each group will have the same number of samples. Thus, once we know 
the number of samples in training dataset, we get a reasonable estimate for the number of 






Figure 3.3 The maximum number of bins depends on the number of samples (patients). (a) Estimated false 
positive rate (FPR) vs. number of bins for 20 samples (red) and 60 samples (blue). The dotted black line 
represents FPR = 0.05. The number of bins that leads to a high FPR (>0.05) is considered overfitting the 
dataset. (b) The maximum number of bins with FPR = 0 vs. total number of samples used in the dataset. Blue 
dots show simulation results with our synthetic datasets and red dots shows the estimated number of bins 
using the rule of thumb: 𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑖𝑛𝑠 =  𝑟𝑜𝑢𝑛𝑑(√𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑎𝑖𝑛𝑖𝑛𝑔 𝑠𝑎𝑚𝑝𝑙𝑒𝑠/2). 
3.4.3.1 Application to two real human cytometry datasets 
Next, we applied our method to two real flow cytometry datasets. Both datasets aim to 
identify differences between two biologically different patients/donor groups. In general, 
in order to get rid of debris and dead cells, some pre-processing steps should be taken 
before applying our method (e.g. manual/automatic gating to get live cells). In addition, 
depends on the question of interest, further gating can be applied to get more focused cell 
types, e.g. T cells, CD4+ T cells, etc. The pre-processed datasets are then the input for our 
method. We first determine the appropriate number of bins to use based on the number of 
samples in a dataset. Next, we apply the binning method showing in Figure 1 to the pre-
processed dataset. Unlike the simulated dataset showing above which only contains two 





more marker pairs. The binning method is applied to every possible pairs of markers. Then, 
in order to identify the important marker pairs, we separated the dataset into training and 
testing subsets. Using a classification algorithm called support vector machine (SVM) 
[124], we define important marker pairs as the ones that are able to achieve 100% 
classification accuracy in both training and testing subsets. Once these marker pairs were 
determined, we move on to identify which regions formed by these marker pairs (boxes) 
are significantly different between the two groups. 
3.4.3.2 Old versus young 
The first dataset we analyzed aims to find differences in the composition of immune cell 
types between old and young healthy donors [137]. Peripheral blood mononuclear cell 
(PBMC) samples from 34 healthy old donors (ages 60 and above) and 22 healthy young 
donors (ages 19 to 35) were taken, and their cellular composition were quantified by flow 
cytometry. In total, 16 markers were measured: Ki67, CD95, CD127, CD57, CD3, 
CD45RA, CD8, CD14, CCR4, CD27, CD11b, PD-1, CD4, CD28, CCR7, and a viability 
dye (live/dead). We first manually gated for the live cells (Fig. B4) which were used as 
input for our method. At this stage, about 20% of samples (4 young samples and 6 old 
samples) were randomly chosen as a cross validation set. We determined the optimal 
number of bins in remaining training dataset to be 5 (as the total number of samples in 
training set is 46, Fig. 3.3b), then we applied SVM classification based on the binning 
results of all possible pairs of markers. In total, we identified two pairs of markers (CD8 - 
CCR7, CD3 - CD4) that are able to classify old and young donors with 100% accuracy 
both in training and testing dataset (Fig. B5). Scatterplots of CD8 vs. CCR7 and CD3 vs. 
CD4 for randomly selected old and young donors are shown in Figure B6 and B7. Boxes 





identified. We selected the two boxes that are most different between old and young donors 
for demonstration below; remaining results can be found in supplementary information 
(Fig. B8 – B10).  
3.4.3.3 Naïve CD8+ T cells are found significantly decreased in elderly donors using 
only CD8 and CCR7 expression.  
We first look at box B55 which contains cells whose expression of both CD8 and CCR7 
are in the top 20% (i.e., CD8high CCR7high, Fig. 3.4a). We find that percentage of cells inside 
box B55 decrease significantly in old donors (Fig. 3.4b). On the other hand, mean 
fluorescence intensity (MFI) of cells inside box B55 are similar among donors for all 
markers, indicating cells inside box B55 are homogeneous across all samples (Fig. 3.4c). 
Notice that CD3 and CD45RA MFI levels are high for all samples, and since cells inside 
box B55 already express highest 20% of both CD8 and CCR7, one possibility is that cells 
inside B55 are naïve CD8+ T cells. Indeed, cells in B55 agrees well with manually gated 
naïve CD8 cells (Fig. B11 & B12a) on single cell level. In addition, when comparing the 
expression of CD45RA and CCR7 between cells in B55 and manually gated CD8 naïve 
and memory cell types, we find that cells in B55 match well with naïve cells for young 
donors with slightly higher variation on CD45RA (Fig. 3.4d). Cells in B55 express higher 
variation in CD45RA for older donors, which is expected since box B55 was selected 
without expression information of CD45RA (Fig. 3.4e). Together, these results suggest 
that cells inside box B55 resemble naïve CD8+ T cells. Decreasing of naïve CD8+ T cells 
with ageing is a well-known observation in immunology [138] and is also identified in this 
dataset (Fig. B12b). In addition, we found that the abundancy of effector memory (TEM) 
and effector memory RA+ (TEMRA) CD8+ T cells are increased in old donors, as suggested 






Figure 3.4 Naïve CD8+ T cells were identified by our method as significantly decreased in old donors using 
only two markers: CD8 and CCR7. (a) An example showing scatter plot of CD8 vs. CCR7 with box B55 
highlighted. (b) Boxplot of cell percentage inside box B55 between the two groups of donors. Each dot is a 
donor. (c) Scatter plot of mean fluorescent intensity (MFI) of each donor, each point shows a donor (purple: 





T cells. Each symbol shows a donor (young donors in d and old donors in e), vertical and horizontal error 
bars show standard deviation of CCR7 and CD45RA intensity respectively.  
3.4.3.4 Distinction between naïve and memory CD8+ T cells is blurred in old donors  
Next, we analyzed cells inside box B52 (CD8highCCR7intermediate/low). The percentage of cells 
inside box B52 (Fig. 3.5a) was found to be increased in the old group (Fig. 3.5b). Similar 
to box B55, the MFI of cells in box B52 for all samples were at similar levels for most 
markers, indicating a homogeneous cell subset is identified among all donors (Fig. 3.5c). 
Notice that box B52 lies in between two peaks (Fig. 3.5a) which is a region often neglected 
or assigned to one of the peaks by manual gating, and we have shown above that cells in 
peak above B52 (i.e., B55) resemble naïve CD8 T cells and cells in peak below B52 (i.e., 
B51) resemble memory CD8 T cells (TEM and TEMRA). We hence infer that cells in B52 
are transition cells between naïve and memory cells which increases with ageing. Figure 







Figure 3.5 An intermediate cell region which is often neglected by gating methods is identified as 
significantly increased in old donors. (a) An example of scatter plot of CD8 vs. CCR7 with box B52 
highlighted. (b) Boxplot of cell percentage inside box B52 between the two groups of donors. Each dot is a 
donor. (c) Scatter plot of mean fluorescent intensity (MFI) of each donor, each point shows a donor (purple: 
young, orange: old). (d) & (e) MFI of CD45RA vs. MFI of CCR7 for cells in B52, naïve, and memory CD8 
T cells. Each symbol shows a donor (young donors in D and old donors in E), vertical and horizontal error 






3.4.3.5 CD4 versus CD8 
Next, we applied our method to a mass cytometry dataset that originally aims to identify 
immune signatures among 8 types of human tissues: cord blood, PBMC, liver, spleen, skin, 
lung, tonsil, and colon [134]. There are in total 35 samples, 3 to 6 samples for each type of 
tissue (see Methods). The marker panel used for mass cytometry contains 41 markers with 
a focus on the function (cytokine expression) of T cells (a full list of all 41 markers can be 
found in supplementary information and [134]). Instead of differentiating the 8 types of 
tissues, here we tried to classify CD4+ cells from CD8+ cells in all types of tissues. This is 
a good test for our method since there exists great within-group variance (different tissues) 
in the two groups we’re comparing, and we aim to find patterns that are consistent / similar 
across all types of tissues but are significantly different between CD4+ and CD8+ cells. 
Like the previous dataset, we divide these tissue samples into training and testing sets as 
well. From the 35 CD4 samples, 5 samples are randomly selected to be cross validation 
set; and the same was done for the 35 CD8 samples separately. Since there are in total 60 
samples in training set (30 for each cell type), the number of bins to use is 5 (Fig. 3.3b). 
We identified 7 pairs of markers that were able to classify CD4+ and CD8+ cells with 100% 
accuracy for both training and cross validation datasets. Only 1 marker pair (CCR10 vs. 
CCR9) out of the 7 contains purely trafficking markers. This indicates that CD4+ and CD8+ 
T cells can be more easily differentiated by their function and lineage markers than 
trafficking markers, which is consistent with the results in the original paper [134]. We 
selected one of the seven marker pairs: Interleukin (IL)-2 vs. CD25 to show in Figure 3.6. 
The pattern formed by CD4 cells is distinct from CD8 cells in that CD4 cells express 
significantly more IL-2 and slightly more CD25 in all types of tissues, which agrees with 





percentage of cells in box B13 (red shaded region in Fig 3.6, IL-2 low and CD25 
intermediate) is significantly higher in CD8 cells, which is a subtle difference that would 
be missed by algorithms based on a peak finding.  
 
Figure 3.6 Patterns formed by IL-2 vs. CD25 is distinct between CD4 and CD8 cells. One randomly chosen 
sample for each tissue is shown. The same sample for each type of tissue is chosen to illustrate both CD4 and 





significantly higher in CD8 cells comparing to CD4 cells. Cells inside box B13 also express CD45RA, TNF, 
and CD127 (Fig. B12). 
3.5 Discussion 
The complexity of cytometry data has increased significantly in the last few years due to 
the advancement in experimental techniques that enable measurements of dozens of 
parameters on each cell for millions of cells [5]. Novel analysis algorithms are being 
introduced at a rapid pace to deal with this data deluge that identifies clusters of cells and 
project the high dimensional information graphically in innovative ways. However, these 
graphics are not directly interpretable and translatable into hypotheses and actions by 
biomedical researchers and clinicians. There is also the flaw that nearest neighbors are not 
meaningful in high dimensions, which is a phenomenon referred to as the “curse of 
dimensionality” [11, 77]. Here we introduce a simpler, alternative approach we term 
CytoBinning. Our analysis approach combines automation of a more traditional workflow 
(as advocated in [11]) and machine learning which links the high dimensional data back to 
two biomarkers which can be represented as 2D scatter plots. The 2D scatter plot outputs 
are designed to be directly interpretable by biomedical researchers and clinicians, who have 
an established intuition for the meaning of these graphics.  Thus, we are able to leverage 
their existing expertise in interpreting these kinds of scatterplots. When the differences in 
phenotype are small, CytoBinning is able to further focus the researcher or clinician’s 
attention by identifying, which specific regions of the scatter plot exhibits the most notable 
differences between two groups of donors, allowing subtle shifts in the immune phenotype 





In contrast to automated gating methods that focus on the exact position of density peaks 
or the number of groups formed by cells, CytoBinning doesn’t estimate the probability 
density distribution of cells, and thus its findings are not limited to regions with high cell 
density or sensitive to shifts in calibration. Instead, it extracts the pattern of 2D dot-plots 
and represents it with a sequence of cell percentages. This enables the comparison across 
samples measured in different experiments (given the markers are the same and they are 
measured in the same channel respectively). In addition, CytoBinning does not require any 
a priori biological understanding to guide the path of analysis. Conversely, it provides a 
list of important marker pairs and related important cell sub-regions for biological 
researchers to subsequently interrogate.  
In the first public dataset we analyzed, which compares lymphocyte populations in old and 
young healthy donors, CytoBinning automatically discovered a decrease of naïve CD8+ T 
cells in the elderly, a well-known yet subtle phenotype. In addition, CytoBinning identified 
a region in the scatterplot of relatively low cell density between two well-established cell 
clusters which is increased with ageing as a new area of interest for the biological 
researcher. Two markers (CD8 and CCR7) are sufficient to pinpoint this subset of cells 
which resides between naïve and memory CD8+ T cells and is not associated with a local 
peak in cell density in the scatterplot.  Such an area would be missed by both manual gating 
and density-based algorithms, or by focusing exclusively on peaks in density.  
The second public dataset we analyzed was even higher dimensional, based on mass 
cytometry from eight types of human tissues. CytoBinning analysis of CD4+ vs. CD8+ T 
cells automatically discovered higher expression of IL-2 in CD4+ T cells as we would 





human tissues studied. In addition, CytoBinning correctly identified that CD25 is also more 
highly expressed in CD4+ T cells [139]. This difference in CD25 and IL-2 was consistent 
among all types of tissues, which is known and therefore obvious to a biological researcher. 
However, it also demonstrates the power of our method as this marker pair was re-
discovered without prior knowledge from a heterogeneous dataset incorporating 35 
samples from 8 different tissues, each labelled with 41 markers. Hence, in addition to 
avoiding the pitfalls of density-based approaches, when applied to very high-dimensional 
datasets CytoBinning is able to select the salient markers which discriminate between 
groups of samples. 
In summary, CytoBinning as a robust, automated approach to analyze high throughput 
cytometry data presented in familiar and interpretable 2D scatter plots. While simultaneous 
assessment of all markers is an important vision and challenge, in the interim there is a 
need to facilitate interpretation of high-dimensional data given the evident gap between our 
technological ability to acquire this information and our ability to understand it. 
CytoBinning fills the void between conventional manual analysis and complex automated 
analysis to extract deep content in scatterplots which can be later cascaded into more 
complicated clustering or classification algorithms to obtain novel biological insights. This 
has particular potential value in clinical and biological research settings where high-
dimensional data is increasingly available and commonly not fully understood. 
CytoBinning is able to identify the most important markers, while also highlighting novel 
cell populations that distinguish comparator datasets even if these are to be found in areas 





complexity gap in the interpretation of high-dimensional data in a wide range of biomedical 
and clinical settings. 
3.6 Methods 
3.6.1 Binning 
The binning we used in our method has been previously proposed to estimate mutual 
information (MI) [135]. Given bin number b, equally populated bins are drawn based on 
single cell expression of marker A and marker B independently. These bins are then 
overlaid on each other so that a grid is formed with b2 regions (boxes). Percentage of cells 
inside each box is then an estimation of the joint probability P(Ai, Bj), where i and j are the 
corresponding bins this box locates at. For a random distribution where marker A and 
marker B is not correlated in any way, P(Ai, Bj) should be approximately the same in for 
every box. This is not true if marker A and marker B is related in any way (i.e., their mutual 
information is not zero, this relationship can be both linear and nonlinear). We use all P(Ai, 
Bj)s as a coarse-grained representation of the point pattern between single cell expression 
of marker A and marker B. (Fig. 3.1) In our method this binning is done for every pair of 
markers.  
3.6.2 Determine appropriate number of bins 
We deduced a relationship between the maximum number of bins with zero false positive 
rate (FPR) and the number of samples used in classification using our synthetic data. The 
relationship we found is:  
𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑖𝑛𝑠 =  round(√𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑎𝑖𝑛𝑖𝑛𝑔 𝑠𝑎𝑚𝑝𝑙𝑒𝑠/2) 
Thus, for a given dataset, an estimation of the number of bins to be used is achieved. In 





1. For a given number of bins, apply the afore-mentioned binning method to one pair 
of markers. Each sample is now represented by the vector of P(Ai, Bj). 
2. Randomly divide all samples into two groups. 
3. Apply SVM classification (ksvm function in R package ks, with linear kernel and 
C=10) on the randomly divided groups. 
4. Repeat step 2 & 3 for 100 iterations, record the frequency when classification 
accuracy achieved 100% in step 3.  
5. Repeat step 1 to 4 for all marker pairs, calculate the mean frequency of one pair 
achieving 100% accuracy. This frequency is used as an estimation of FPR. 
6. Repeat steps above for all numbers of bins.   
3.6.3 Log ratio transformation 
The percentages of cells in each box obtained with CytoBinning is compositional as they 
add up to 100. To get rid of this dependency, we divide the percentages by their median 
before taking log with base 2 for every sample and every marker pair. 
3.6.4 Selecting important marker pairs 
Once the number of bins is determined, we divide all samples into a training set (about 
80% of total samples) and testing set (the remaining 20% of all samples). SVM is applied 
to the training set and classification boundary obtained for every pair of markers. We use 
the obtained classification boundary to predict the cross-validation set. Pairs that reached 






3.6.5 Selecting important boxes 
We combined boxes formed by all selected marker pairs and applied statistical test 
(Wilcox) for the percentage of cells in each box. We then corrected the p values for multiple 
comparisons with Bonferroni correction, and boxes with p-value <0.001 after correction 
are selected as important boxes. Important marker pairs selected above without any 
important boxes are eliminated from the important marker pair list. 
3.6.6 Dataset 1: Comparing old and young healthy PBMCs 
Overview of samples. This dataset is published in reference [59] and downloaded at Flow 
Repository (http://flowrepository.org) website [140]. These samples were processed in two 
experiments, with 19 samples from young donors and 20 samples from old donors 
processed in the first experiment, and the remaining samples processed in the second 
experiment. The panel of markers was kept the same for both experiments. In total, 16 
markers are measured: Ki67, CD95, CD127, CD57, CD3, CD45RA, CD8, CD14, CCR4, 
CD27, CD11b, PD-1, CD4, CD28, CCR7 and a viability dye (live/dead). Details of sample 
storage and processing can be found in [59].  
Pre-processing. Downloaded FACS files were first compensated based on the spill matrix 
in the FCS files, and then manually gated to get live cells (Fig. S4). Logicle transformation 
was performed with w=0.5, t=262144, and m=4.5 using logicleTransform function in 
flowCore package with R. 
3.6.7 Dataset 2: Comparing CD4 and CD8 T cells in various types of tissues 
The dataset used for the demonstration was first published in [134] and downloaded from 
flow repository website (https://flowrepository.org/) [140]. Tissue types, number of 
samples, and the reason for surgery are listed in Table 1. Immune cells were isolated from 





cytometry experiment. Two panels of antibodies were used for staining, each containing 
41 markers. The two panels were named as “Function” and “Traffic” according to the 
antibodies included in it. We only used function panel in this paper. Details of experimental 
process and the lists of antibodies can be found in [134]. The downloaded samples from 
flow repository are FACS files, pre-gated to major immune types (e.g. CD4, CD8, NKT, 
etc.). We used only CD4 and CD8 cells. We performed logicle transformation using 
logicleTransform in R package flowCore, with parameters w = 0.25, t= 16409, m =4.5, and 
a=0 according to [134]. The logicle transformed data were then saved as text files for 
further analysis. 
 
Table 3-1 Summary of sample information 
Tissue type Number of samples Reason for surgery 
Cord Blood 5 Healthy donation at neonate 
PBMC 4 Healthy donation 
Tonsil 5 Tonsillar Hypertrophy 
Spleen 3 
Splenectomy (Due to Distal 
Pancreatectomy) 
Colon 6 Routine Colonoscopy 
Skin 5 
Abdominoplasty or Mastectomy 
- Invasive Ductal carcinoma 
Lung 4 Lung cancer resection 







Chapter 4 Feature selection with CytoBinning in mass cytometry 
data 
4.1 Overview 
In this chapter, I try to tackle feature selection problem in mass cytometry data. Since the 
informative feature in cytometry data reside not in single measurements but the point 
patterns formed by multiple measurements, I first define features for cytometry data as the 
patterns in 2D scatterplots between two measurements. Using CytoBinning, I developed 
and introduced in Chapter 3; I was able to quantify these point patterns and select features 
accordingly. The experimental data were obtained from the online repository: 
https://flowrepository.org/. 
4.2 Abstract 
Mass cytometry provides the potential to measure up to 100 different protein expressions 
simultaneously on a single cell level. To keep up with the high dimensionality of 
measurements, most analysis methods aim to utilize all measurements simultaneously by 
engaging sophisticated high dimensional algorithms. However, the real number of 
measurements that are directly related to the question of interest is much lower than the 
total number of measurements, i.e. a large number of measurements are either irrelevant or 
redundant, resulting in information overload and noise. Hence, feature selection methods 
are much needed for mass cytometry data. The difficulty in selecting features for mass 
cytometry data is that the valuable information resides not in single marker expression but 
the point pattern formed by expression of multiple markers which is hard to quantify. Here, 
I apply the binning method – CytoBinning, introduced in Chapter 3 – to quantify 
information in point patterns hence enable feature selection for mass cytometry data. I 





select meaningful features (i.e. marker pairs) within the dataset that are able to classify 
eight types of human tissues simultaneously. In addition, novel tissue-specific profiles are 
identified when combining information contained in markers from selected pairs.  
4.3 Introduction 
Mass cytometry is a relatively new technique that enables simultaneous measurements of 
more than 40 cellular parameters at a single-cell level. It outputs data in a format similar to 
flow cytometry but offers the potential of much higher dimensionality. In contrast to flow 
cytometry, it does not suffer from between channel fluorescence leaking that plagues flow 
cytometry data and hence doesn’t need compensation. On the other hand, it is able to 
measure far more cells (on the magnitude of millions) comparing to other high-content 
single cell measurement techniques like cellular imaging and single-cell RNA sequencing. 
These features make mass cytometry a perfect tool to investigate cellular heterogeneity as 
we often see in the immune system, tumor cells, etc. [79, 80, 141]. The rapidly increasing 
number of measurements, on the other hand, poses great challenges in analyzing mass 
cytometry data and also increases the probability of information overload. 
In recent years, analysis methods specifically designed for mass cytometry dataset are 
rapidly emerging [5]. Most of these methods aim to fully embrace the high dimensionality 
provided by mass cytometry by utilizing all measurements simultaneously with the same 
weights. For example, SPADE [75], as one of the most well-known methods for mass 
cytometry analysis, uses an agglomerative clustering algorithm to divide cells into different 
groups and then applies a minimum spanning tree (MST) based algorithm to visualize the 
clustering results. SPADE has been successfully applied to several mass cytometry datasets 





for cell type discovery and then calculates properties of these cell subtypes and use them 
to determine a list of cell subtypes with significantly different frequencies between two 
sample groups [85]. There is also an algorithm called PhenoGraph that applies k nearest 
neighbors (k-NN) to identify cell subtypes in a given sample [86]. On the other hand, 
clustering based methods that are developed for flow cytometry datasets, like FLAME [58], 
flowSOM [62], etc. have also been successfully applied to mass cytometry datasets [87, 
88]. One problem of using all measurements simultaneously without weighting is that the 
definition of distance and density become less meaningful with the increase of dimension 
due to “curse of dimensionality” [77, 142]. In addition, in real datasets, the number of 
measurements that are directly related to the question of interest is often much smaller than 
the total number of measurements due to redundant measurements (e.g., markers that have 
similar biological functions) and irrelevant measurements (e.g., not known before 
experiment). Hence feature selection methods are much in need to pre-process mass 
cytometry data before distance, and density-based methods can be applied. Nevertheless, 
since the valuable information in mass cytometry data exists not in single measurement but 
the content of point patterns formed by multiple measurements, it is hard to quantify 
meaningful features for mass cytometry data. 
Here we define features of mass cytometry data as the 2D point pattern formed by two 
measurements. We use CytoBinning – the binning method we proposed in Chapter 3 – to 
quantify content in a point pattern into a vector of cell percentages. In this way, direct 
comparisons between point patterns are made possible, and important features are selected 
accordingly. We demonstrate our method with a publicly available mass cytometry dataset 





any prior biological information about immune signatures in different types of tissues, we 
are able to select five pairs of markers whose point patterns are distinct among different 
types of tissues. In addition, we show tissue-specific trafficking features for immune cells 
in different types of tissues with a combination of only six markers. 
4.4 Results 
We demonstrate our method using a publicly available mass cytometry dataset first 
published in [134]. In this dataset, a total of 35 samples collected from 8 types of human 
tissues were measured using mass cytometry with two marker panels. Both panels contain 
41 cellular markers; the first panel includes mostly trafficking and surface markers while 
the second panel contains both surface markers and intracellular cytokines (see Methods). 
The first panel is called “trafficking panel” while the second is called “function panel” 
according to [134]. Table 1 summarizes the types of tissues, number of samples for each 
tissue type and the source of tissue samples. For illustration purpose, here we focus on 
CD4+ T cells that were manually gated by the authors of reference [134] with the traffic 
panel, and our goal is to identify tissue-specific trafficking profiles within CD4+ T cells. 
Using CytoBinning, we show that we are able to simultaneously classify the 8 types of 
tissues with only 2 markers (we will refer to them as marker pairs). In total, we identified 
5 such marker pairs that enable simultaneous classification. There are only 6 distinct 
markers in these 5 marker pairs. t-SNE analysis based on these 6 markers reveals point 
patterns with tissue-specific signatures.  
4.4.1 An overview of CytoBinning 
The binning method we use in this Chapter – CytoBinning – is first proposed in Chapter 3 





scatterplots with percentile-based binning. To illustrate this with mass cytometry data, we 
selected two patients with similar but distinct patterns between CD45RO and CCR7 
expression (Fig 4.1a and 4.1c). The point pattern shown in Figure 4.1a contains three 
clusters, one big cluster on the upper left corner and two relatively smaller clusters on the 
upper right and lower right corner. While the pattern in Figure 4.1c is similar to 4.1a, they 
are different in that there are only two clusters in 4.1c. Instead of two distinct clusters, the 
lower right cluster has a thick and long tail that extends upwardly. As illustrated in Figure 
4.1a, CytoBinning first divides cells into a pre-defined number of bins (3 bins in Fig 4.1) 
based on the expression profile of the two markers independently; every bin contains the 
same number of cells. The bins are then combined so that the scatterplot is further divided 
into smaller boxes, and the percentage of cells in each box is calculated. These percentages 
change with the patterns in a scatterplot. We use these percentages as a coarse-grained 
representation of the point patterns in a scatterplot. CytoBinning is able to capture the 
subtle difference between different patterns as well as prominent features of a pattern. As 
shown in Figure 4.1, the distinct upper left and lower right clusters in both patient samples 
are captured by the two boxes with largest cell percentage (upper left and lower right box, 
Fig 4.1b, 4.1d). For pattern in Figure 4.1a, the third cluster (upper right) is cut into multiple 
regions with majority of the cluster inside the middle and middle right box, which reflects 
the shift between the center of the upper left and upper right cluster (Fig 4.1b). Since the 
patterns are different between Figure 4.1a and 4.1c, the CytoBinning representation is also 
different, with cell percentages in the four lower right boxes more homogeneous in Figure 
4.1d comparing to Figure 4.1b, corresponding to the wider cluster in the lower right region 






Figure 4.1 An illustration of CytoBinning and how it can represent the subtle difference between two similar 
patterns. a) An example of percentile based binning as a representation of 2D point-pattern (number of bins 
= 3). b) The corresponding representation is shown in heatmap for a). c) A similar but distinct point pattern 
to a). d) The corresponding representation is shown in heatmap for c).  
4.4.2 CytoBinning is able to identify key differences among CD4 T cells in eight 
types of human tissues 
Our analysis revealed 5 marker pairs (features) that are able to simultaneously classify the 
8 types of human tissues with less than one error on average (see Methods and Fig C1): 
PD-1 & CCR7, CCR7 & CD161, CCR5 & CD27, CCR7 & CD27, and CXCR6 & CCR5. 





Figure 4.2a, figure C4, figure C7, figure C10 and figure C11 illustrate point patterns formed 
by each marker pair respectively. We select the marker pair with the lowest number of 
average error – PD-1 & CCR7 – to discuss in detail here. Results for the other four marker 
pairs can be found in Appendix C.   
The scatterplots in Figure 4.2a shows randomly selected examples of PD-1 and CCR7 
expression pattern in different types of tissues. Indeed, these patterns appear different from 
tissue to tissue. Even though patterns of cord blood, liver, PBMC samples look similar to 
each other at first glance, they are indeed distinct from each other. The PBMC sample has 
a longer tail along CCR7 axis – comparing to cord blood and liver samples. Moreover, the 
liver sample has a wider spread in the lower right corner which has high expression of PD-
1 and low expression of CCR7. In particular, we notice that compared to other tissues, 
tonsil has a unique cell subtype that is PD-1high and CCR7- (highlighted in orange circle in 
Fig 4.2a). To validate this subtype, we manually gated for it (Fig C2a), calculated 
percentage of PD-1high CCR7- cells in each sample, and compared their percentage across 
tissue types. The results show that this subtype is indeed highly expressed in tonsil samples, 
but are almost not seen in other tissue types except lung and skin (Fig C2b). To better 
understand the PD-1high CCR7- subtype, we calculated their mean expression level of other 
markers expressed by cells in this subtype and identified that they also express CXCR4, 
CXCR5, CD27, CD69, ICOS and CD95 (Fig C3). Even though the simultaneous tissue 
type classification is achieved with cell percentages in all the 25 boxes, we show that with 
cell percentage in the two most important boxes in classification (B15, shaded in blue in 
Fig 4.2a; and B54, shaded in red in Fig 4.2a) one can already get a reasonably good 






Figure 4.2 Distinct patterns across eight types of human tissues are observed with marker pair PD-1 & CCR7. 
a) Scatterplot showing single cell expression pattern formed by CCR7 and PD-1. Solid black lines are 
thresholds determined by CytoBinning. The shaded areas are the two most important boxes in classifying 
tissue types (blue: B15, red: B54). The region labeled with the orange circle is a cell subset express a high 
level of PD-1 and express little CCR7. This cell subset is not observed in other tissue types except tonsil. b) 
Plot of cell percentage in box B54 (shaded in red) and box B15 (shaded in blue). Each color and shape denotes 
one type of tissues.  
Similarly, results can be seen from the other four marker pairs (Appendix C). For example, 





and a higher level of CD27+CCR5+ cells in lung tissues (Fig C7 – C9) and validated it with 
manual gating. However, deeper biological insights cannot be generated from these 
observations since not all samples are collected from healthy donors. 
4.4.3 New insights can be identified by combining selected marker pairs 
After selection of marker pairs whose patterns are distinct across different tissue types, we 
combined these marker pairs to gain new insights of the dataset. In particular, we combined 
the 6 distinct markers in the 5 marker pairs we selected and performed t-SNE analysis on 
all samples combined (the samples are down-sampled before combining, with 250 cells 
randomly selected from each sample). We found that, as shown in Figure 4.3, the resulting 
2D scatterplot shows distinct tissue-related clusters. CD4+ T cells in cord blood, PBMC, 
and liver tissues are mixed and form a big cluster, cells in lymphoid tissues (spleen and 
tonsil) stay close together with cells in tonsil form a distinct small cluster. Cells in skin, 
lung, and colon are close together with some mixtures. In addition, we notice that cells in 
colon samples are divided into two clusters (Fig 4.3a). Both clusters express CD161 (Fig 
4.3c). However, the expression level of CCR7 are differentiated between these two 
clusters, with one cluster express higher level of CCR7 than the other (Fig 4.3b). Also, the 
highest level of CCR7 expression is observed in blood samples (cord blood and PBMC) 
and liver samples. This suggests there are more naïve CD4 T cells in circulation than in 
resident tissues. Fig 4.3b also shows the transition of CCR7+ to CCR7- from left to right, 






Figure 4.3 Separation of tissue types can be observed in t-SNE plot generated by the expression level of the 
6 selected markers (PD-1, CCR7, CCR5, CD27, CD161, and CXCR6). a) The contours are manually drawn 
to show the related clusters of cells. Each point is a single cell, and different color indicates cell in different 
types of tissues. b) The same scatter plot as in a) with color coding of CCR7 expression level. c) Similar to 
b), with the expression level of CD161. 
4.4.4 Distinct cytokine secretion patterns across human tissues can be illustrated 
with 8 markers 
Next, we applied similar analysis to CD4+ T cells measured with function panel. Similarly, 





human tissues with less than 1.5 errors on average (but larger than 1 error) – CXCR6 & 
CCR9, CXCR6 & CD161, CXCR6 & CXCR3, PD-1 & CCR5, and CCR2 & CCR6. Note 
that they are all surface markers. We combined the unique markers from these 5 pairs and 
again performed t-SNE analysis based on all samples combined (the samples are down-
sampled before combining, with 250 cells randomly selected from each sample). As with 
the traffic panel, the t-SNE plot can be coarsely divided into 4 big regions: blood (cord 
blood and PBMC) and liver –right, secondary lymphoid tissues (tonsil and spleen) – center 
top, skin and lung – middle left, and colon – top left and bottom center (Fig 4.4a). In 
addition, we showed cytokine expression levels in t-SNE scatter plot (Fig 4.4b) divided 
into 3 levels: 0 to 1, 1 to 2 and 2 to 3. The expression level of different cytokines varies 
significantly, with IFNγ and Granulocyte-Monocyte Colony-Stimulating Factor (GM-CSF) 
most highly expressed and the expression of other cytokines much lower and sparse. In 
addition, cytokine secretions are localized related to tissue types. For example, both IFNγ 
and GM-CSF are mainly expressed by CD4 cells in colon, lung, and skin. Moreover, both 
IL-17A and IL-22 are mainly expressed by CD4 cells in colon and skin. Similar results 
were reported in reference [134] with the use of all 41 markers simultaneously. In 
comparison, our method is able to achieve better tissue distinctions. As discussed above, 
CD4 cells in colon tend to form two groups where one group express mid-level of CCR7 
and the other group do not express CCR7. We observed two groups of CD4 cells in colon 
with function panel as well, where one group (bottom center) doesn’t express any cytokines 
comparing to the other group (upper left). It is possible that the group of cells with low to 
no cytokine expression are the same as the CCR7 expressing group (naïve) identified with 





samples and lymphoid samples) are also the regions with higher CCR7 expression 
observed in Figure 4.3. However, since the function panel does not contain CCR7, we are 
not able to verify this. 
 
Figure 4.4 Tissue-specific profiles can be observed in t-SNE plot generated by the expression level of the 8 
selected markers (CXCR6, CCR9, CD161, CXCR3, PD-1, CCR5, CCR2, and CCR6) in function panel. a) t-
SNE plots labeled in red by cells in each tissue type. b) Expression of cytokines. The expression level is 







Mass cytometry expands the horizon of cytometry by enabling simultaneous measurements 
of a large number of markers and hence provides an opportunity to discover new features 
and cell types. However, the large number of measurements can also raise problems 
because of information overload and “curse of dimension”. Currently, the state-of-art 
methods incorporate all markers simultaneously via sophisticated algorithms with the 
assumption that all markers are equally important, even though the importance of markers 
varies based on the biological question and some markers could be completely irrelevant. 
The lack of dimension reduction/feature selection methods designed for mass cytometry 
data is in part due to the fact that unlike other single-cell data, meaningful information 
within mass cytometry data comes from the point patterns formed by multiple 
measurements which is difficult to quantify. Here, we aim to tackle the feature selection 
problem by define features as point pattern in pairwise scatterplots, and we propose a 
binning method – CytoBinning – to quantify point patterns and enable direct comparison 
of patterns.  
With a publicly available dataset that tries to identify the immune signature in different 
types of human tissues, we demonstrated the use of CytoBinning for feature selection in 
mass cytometry data. We identified five marker pairs that are able to simultaneously 
classify all eight types of tissues. In particular, we discovered a cell subset that is unique 
to CD4 cells in tonsil samples: PD-1highCCR7-. This subset also expresses CXCR4, 
CXCR5, CD27, CD69, ICOS, and CD95. However, since the tonsil samples are collected 
from tonsil hypertrophy patients, we do not know if this unique cell subset is due to the 
disease or a signature of CD4 cells in tonsil. Similar discoveries are made for the other 





addition, we identified a cell subset CD27+CCR5+ that is high in CD4 cells from lung 
samples. This cell subset also expresses CD29, CXCR4, and CD45RO. Again, because 
these lung tissues are collected from lung cancer resection, it is impossible to tell whether 
this cell subset is unique to CD4 cells in lung or is induced by tumor as CCR5 is related to 
cancer therapy.  
Combining the markers selected by CytoBinning, we were able to recapitulate the uneven 
distribution of helper T cells in different human tissues with only 8 markers instead of all 
41 markers as was done in the original publication and we achieved better tissue separation 
with the selected 8 markers. Also, we also illustrated the diversity of memory cells across 
different human tissues. What’s more, these analysis results were achieved without any 
prior biological background and hence is unbiased. In all, our simple method is able to 
obtain comparable analysis results as the more sophisticated high-dimensional analysis 
method used in the original paper, and also because the straightforwardness of our method, 
we are able to provide easy to interpret and test results (such as the PD-1highCCR7- subset 
that is unique to tonsil samples).   
We have shown that CytoBinning is able to detect subtle changes in patterns. However 
since it is designed to detect differences in overall patterns, it is indifferent to the position 
and scale of patterns. Hence, for example, if one sample contains only PD-1+CCR7+ cells 
and the other contains only PD-1-CCR7- cells, and they both form the same pattern (e.g. a 
single cluster), CytoBinning is not able to detect that. Nevertheless, if there exist small 
differences (for example a tail or thick outliers, etc.) CytoBinning will be able to identify 
them. In addition, we argue that if two markers form the same pattern (e.g. one large 





show in patterns when these markers are pairing with other markers and can then be 
identified with CytoBinning.  
All in all, we defined informative features in mass cytometry dataset as point patter in a 
2D scatterplot and proposed a binning method – CytoBinning – to quantify contents in 
scatterplots. We demonstrated with a publicly available dataset that our method is able to 
recapitulate, without any prior biological background, analysis results obtained with more 
sophisticated high-dimensional analysis guided by expertise in immunology. In addition, 
our method has the advantage of easy interpretation and the ability to generate testable 
hypotheses. With moderate modification, our method can be applied to other comparative 
studies (two or multiple groups), or serve as a fast screening of datasets to quickly identify 
driving differences without diving into more complicated and time-consuming algorithms.  
4.6 Methods 
4.6.1 Experimental procedures and pre-processing 
The dataset used for the demonstration was first published in [134] and downloaded from 
flow repository website (https://flowrepository.org/) [140]. Tissue types, number of 
samples, and the reason for surgery is listed in Table 1. Immune cells were isolated from 
collected tissues and cryopreserved. They were then thawed and washed for mass 
cytometry experiment. Two panels of antibodies were used for staining, each containing 
41 markers. The two panels were named as “Function” and “Traffic” according to the 
antibodies included in it. Details of experimental process and the lists of antibodies can be 
found in [134]. The downloaded samples from flow repository are FACS files, pre-gated 
to major immune types (e.g. CD4, CD8, NKT, etc.). We performed logicle transformation 





=4.5, and a=0 according to [134]. The logicle transformed data were then saved as text files 
for further analysis. 
Table 4-1 Summary of sample information 
Tissue type Number of samples Reason for surgery 
Cord Blood 5 Healthy donation at neonate 
PBMC 4 Healthy donation 
Tonsil 5 Tonsillar Hypertrophy 
Spleen 3 Splenectomy (Due to Distal Pancreatectomy) 
Colon 6 Routine Colonoscopy 
Skin 5 
Abdominoplasty or Mastectomy - Invasive Ductal 
carcinoma 
Lung 4 Lung cancer resection 
Liver 3 Liver transplantation 
  
Markers in traffic panel: 
CD45, CD14, CD57, TCR, CD3, HLA-DR, CD29, CD38, CD69, CD62L, CD8, CD45RO, CLA, CD4, 
CD103, CCR4, CD25, CD49a, CCR10, CXCR6, CD19, CD27, CD56, ICOS, PD-1, CD161, CCR9, CXCR3, 
CD95, CD31, CXCR5, CD49d, CCR2, Intergrin7, CCR5, CCR6, CD45RA, CCR7, CX3CR1, CXCR4, 
CD127 
 
Markers in function panel: 
CD45, CD14, CD57, TCR, IFN, TNF, IL-8, Granzyme B, IL-17F, CD45RA, CLA, CTLA.4, IL-2,  
CD25, CD103, CCR10, CXCR6, IL-5, CD19, CD56, IntegrinB7, PD-1, IL-9, CCR9, CXCR3, CD127, 
Mip1b, CXCR5, CD161, CCR2, IL-4, IL-10, CCR6, GM-CSF, CCR4, IL-22, CCR5, IL-17A 
4.6.2 CytoBinning 
In this paper, we used CytoBinning with 5 bins. For a given marker pair A & B, equally 
populated bins are drawn based on single cell expression of marker A and marker B 
independently. These bins are then overlaid on each other so that a grid is formed with 25 
(52) regions (boxes). Percentage of cells inside each box is then an estimation of the joint 
probability P(Ai, Bj), where i and j are the corresponding bins this box locates at (1 ≤ i, j ≤ 
5). For a random distribution where marker A and marker B is not correlated in any way, 
P(Ai, Bj) should be approximately the same in for every box. This is not true if marker A 
and marker B is related in any way (i.e., their mutual information is not zero, this 





representation of the point pattern between single cell expression of marker A and marker 
B. This binning process is repeated for every possible marker pairs in the dataset. 
4.6.3 Marker pair selection 
For each marker pair, multi-class SVM is applied to the binning results in R. We used svm 
function in package e1071 with linear kernel, cost = 1 and gamma = 0.01. We randomly 
divided the 35 samples into 7 groups and performed 7-fold cross-validation based on the 
dividing. The error rate of the classification was calculated as the average cross-validation 
error rate. Marker pairs with error rate < 0.2 (less than 1 error in average) were selected as 
important marker pairs. 
4.6.4 t-SNE plots 
After marker pair selection, we picked out unique markers within these pairs and performed 
tsne in R with tsne function in package tsne. We randomly selected 250 cells from each 
sample and concatenated them together before performing tsne (the number of cells for 






Chapter 5 Conclusion and Discussion 
5.1 Overview 
Advancements in experimental technologies have changed the landscape of research in 
biology. As the data becoming increasingly high content and throughput, traditional 
manual-based analysis regime has passed, and computer-based automated analysis 
methods that are able to handle high-dimensional, single-cell data are on the rise. However, 
these methods often use all measurements simultaneously without weighting. This can 
result in problems such as misinterpretation of datasets due to noisy and irrelevant 
measurements, and less meaningful results due to the “curse of dimensionality”. In this 
dissertation, my goal is to develop analysis methods that are complex and multi-
dimensional to automatically extract meaningful information out of biological datasets, but 
not so high-dimensional and complicated so that straightforward interpretation can still be 
achieved.  
5.1 Conclusion 
5.1.1 Identify stable classification boundaries based on typical cells 
In Chapter 2, I presented a pipeline for analyzing high-throughput imaging data that tackles 
cell-to-cell variability in a mono-state cell population by capturing the typical features of 
cells. I demonstrated this approach using a screening dataset that aims to identify potential 
drug (siRNA) hits for a premature ageing disease (progeria) [109]. The pipeline starts with 
the selection of typical control cells (which I defined as cells close to the mean of a single 
peak multi-variate distribution, see section in Appendix A4), followed by the computation 
of a stable classification boundary between two reference conditions (e.g. healthy and 





phenotypes. Each cell in all siRNA perturbations is then compared to this classification 
boundary. Cells on the same side with typical healthy control cells were considered as 
“healthy-like”, and the fraction of “healthy-like” cells was used as a new metric for analysis 
of the screen. Moreover, potential drug hits were identified as siRNA perturbations that 
significantly increase the fraction of healthy-like cells in the population comparing to 
diseased controls (Fig 2.3). The classification boundary built with typical cells captured 
the direction where progeria cells are most significantly different from healthy cells. The 
underlying biological assumption is that – by muting one of the ubiquitin proteins, progeria 
cells would become healthier or worse (due to the loss of house-keeping protein). However, 
siRNA perturbation can also drive cells to a state that is completely different from healthy 
or progeria controls. I tested that by calculating the position of each cell in the direction 
parallel to the classification boundary. Moreover, I found that siRNA perturbed samples 
fell nicely into a line along the direction of classification boundary (Fig 2.5).  
5.1.2 CytoBinning as a new method to identify meaningful differences in 2D point 
patterns 
In Chapter 3, I introduced a binning method – CytoBinning – that can quantify information 
in 2D point patterns (Fig 3.1). The binning was done based on density distribution of single 
measurements. The bins of two measurements were then combined to get a grid that maps 
the point pattern formed by these two measurements. Percentage of cells inside each box 
of the grid was then calculated. Since these percentages change with the point pattern, they 
can be used as a numeric presentation of the pattern. I showed with synthetic datasets that 
CytoBinning can help identify both significant (Fig 3.2) and subtle differences (Fig B3) of 
point patterns, and the same can be achieved in real biological datasets (Fig 4.1). For 





of samples to be classified. If the two groups contain an equal number of samples, a good 
estimation of the bin number can be obtained by this formula: 
𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑖𝑛𝑠 =  𝑟𝑜𝑢𝑛𝑑(√𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑎𝑖𝑛𝑖𝑛𝑔 𝑠𝑎𝑚𝑝𝑙𝑒𝑠/2).  
In addition, I used a publicly available dataset that aims to find the difference of immune 
signature in peripheral blood mononuclear cells (PBMC) between old and young healthy 
donors [59] to demonstrate how to use CytoBinning for comparative studies in Chapter 3. 
I showed that CytoBinning was able to re-identify the decrease of naïve CD8 T cells in 
elderlies (Fig 3.4). In addition, CytoBinning found a new cell sub-region whose cell 
frequency increases with ageing. This sub-region resides in the valley between two well-
defined peaks – naïve CD8 T cells and memory CD8 T cells – which may be a transition 
cell state from naïve to memory.  
5.1.3 CytoBinning can be used for feature selection in high-dimensional data  
In Chapter 4, I demonstrated how to use CytoBinning for feature selection with a publicly 
available mass cytometry dataset that measures immune cells in eight types of human 
tissues [134]. The original publication managed to clarify tissue-specific features of 
immune cell composition with all 41 markers that were measured in the experiment. Since 
the expression level of individual markers is not meaningful in cytometry data, I defined 
features of mass cytometry data as the point patterns formed by two markers. With 
CytoBinning, I was able to select 5 important features (i.e., 5 marker pairs) that provide 
tissue-specific information of immune cell composition. There are only 6 unique markers 
in the 5 marker pairs, and I showed that with only the 6 markers tissue-specific features as 
identified in the original publication could be re-identified. In addition, I found that cells 





by CytoBinning (Fig 4.2, Fig C4, Fig C7, Fig C10-11), and cell phenotypes that are unique 
to or overexpressed in particular tissue types can be found. For example, a cell phenotype 
– PD-1high CCR7low – was found to be unique to immune cells in tonsil tissues (Fig C2).   
5.2 Discussion 
5.2.1 Heterogeneity: important feature or byproduct of complex systems? 
We know that single cells are heterogeneous, not two cells are the same. As the 
measurement of more and more single cell features are made available by experiments, 
cellular heterogeneity becomes more and more apparent. However this is a paradox since 
random events are prevalent, differences are guaranteed to be found when examined 
closely enough. Hence there has been the question: “Do differences make a difference?” 
[9]. Moreover, it has been suggested that only heterogeneity that has biologically functional 
differences should be considered meaningful. Nevertheless, biologically functional 
differences are abundant as well. Since living organisms deal with environmental stress 
constantly, cells with the same genomic and epigenetic features could develop different 
features in response to slightly different environmental cues. Understanding heterogeneity 
is important, it helps us to get deeper insights into how living systems respond to its 
surroundings by regulating itself. For example, our immune cells are famously 
heterogeneous. There are at least tens of immune phenotypes that have been validated 
experimentally, and they each have distinct functions – e.g., Th1 cells are in charge of 
defense over intracellular bacteria, Th2 cells help fight against the extracellular parasite, 
Th17 cells are responsible for defense against fungi infection. Moreover, all these subsets 
can be involved in autoimmunity. In addition, our immune system protects us from various 





a trace in our immune system in the form of “memory cells”, and as we age our immune 
system collects a history of antigen attacks in our body, hence no two people have the same 
repertoire of immune cell types. The immune system is a great example of how 
heterogeneous single cells can be, and how the heterogeneity can result from a dynamical 
response to the environment. Moreover, a better understanding of heterogeneity in immune 
cells can help us understand how our immune system work and how to restore it when it is 
not working properly.  
On the other hand, even though cellular heterogeneity can be meaningful and ubiquitous, 
sometimes it is the similarity shared by cells in a single phenotype that’s more important, 
especially in cultured cell lines where macroscopic and genetic variables are carefully 
controlled. One argument for the importance of similarity is that there are countless reasons 
for the cells to be heterogeneous that have nothing to do with the biological process of 
interest (e.g., fluctuation in the local distribution of chemicals, local cell density, etc.). 
Since it is nearly impossible to account for all possible reasons, focusing on heterogeneity 
could result in misleading results. Hence the typical behavior that can be observed in the 
majority of cells in response to the targeted perturbation should be of real importance. For 
example, in RNAi perturbation studies (Chapter 2), researchers often add RNAi to a group 
of cells that belong to the same phenotype (cultured from the same progenitor in the same 
macroscopic condition) and studies how these cells respond to the perturbation. That is 
where the notion of “typical cells” comes in. The definition of “typical cells” (i.e. typical 
behaviors) enables the characterization of typical behaviors shared by the majority of cells, 
which should be a more direct representation of cellular response. In addition, typical cells 





5.2.2 High dimensional data: divide and conquer 
Biological research today produce high-content, high-throughput data in large volume. One 
particular challenge in analyzing these datasets is the high-dimensionality. To make full 
use of the information-rich data, biological society has been embracing high-
dimensionality with more and more algorithms that can handle all the parameters 
simultaneously have been developed. However, fully embracing high-dimensionality can 
be problematic. On the one hand, the definition of distance and density is not meaningful 
in high-dimensional space which could lead to inaccurate results for distance/density based 
algorithms [11]. In addition, cell states may be a continuum instead of distinct stages and 
cells that are in between two high-density regions (i.e., the clusters found by most 
clustering algorithms) also have potential biological significance [76]. On the other hand, 
information overload is prevalent as much more parameters are measured experimentally 
than the intrinsic dimension of the question of interest. Dimension reduction and feature 
selection methods have been recruited to tackle this problem. However, some of these 
methods make strong assumptions about the datasets (e.g., PCA assumes linearity of the 
data) that are not always satisfied; and almost all methods aim to find one particular 
subspace that best captures the content of the whole dataset which will possibly undermine 
subtle signals. Dimension reduction methods often mix all parameters in finding optimal 
subspace, and the resulting dimension reduced space is a combination of all parameters. 
This is a problem for biological data analysis because the explicit interpretation of resulting 
features which is lost in parameter combination is crucial to the understanding of biological 
questions. My approach to tackling this problem is to divide high dimensional space into 
not one but multiple lower dimensional subspaces. These subspaces add up to the whole 





Chapter 2, instead of combining all available measurements, I divided them into four 
subspaces based on the fluorescent staining. In so doing, the minor signal in DNA damage 
(γH2AX) could be kept from being overshadowed by the strong signal in progerin 
expression. Another commonly used method to deal with information overload in high 
dimensional data is feature selection. Instead of finding a subspace by combining features, 
feature selection methods select meaningful features separately. However, for some 
datasets (like cytometry data), instead of individual parameters, the correlation between 
two parameters is where the true information lies. Feature selection methods then rely on 
correlation measurements to assess the importance of parameters. However, to-date the 
state-of-art measurement of the correlation between two parameters are still correlation 
coefficients and mutual information which give only a gloss estimate of how much the two 
parameters are related instead of how the two parameters are related. CytoBinning fills the 
gap by providing a more detailed measurement that can quantify how two parameters are 
related (Fig 3.1, Fig 4.1). In addition, by dividing high-dimensional datasets into 2D facets 
and considering them one by one, it is possible to select all meaningful signals, both 
significant and subtle (as shown in Chapter 3). Also as CytoBinning only mix two 
parameters at a time, interpretation of its results is more straightforward comparing to the 
more sophisticated and complex algorithms. The usage of CytoBinning is not limited to 
cytometry data, in fact, it can be applied to any single cell data where the correlation 
between two parameters is of interest (e.g., single cell RNA sequencing, or even point 





5.2.3 Next step: Application to clinical datasets 
CytoBinning could be applied to large clinical cytometry datasets since it is 
computationally efficient and parallelizable. The overall goal is to further validate the 
method and mine novel biological insights based on these datasets. There are two large 
clinical flow cytometry datasets that are made available to our lab. The first clinical trial 
attempts to generate hypotheses of immune mechanisms in an inflammatory eye disease 
(uveitis). With the help of CytoBinning, my collaborators hope to identify novel cell 
subtypes that play a role in the development of this disease. The second dataset contains 
blood samples from over 1,000 healthy donors, and the goal is to use CytoBinning to map 
the trace of ageing in peripheral immune cells [143].  
5.2.4 Generalization: CytoBinning as a tool for point pattern analysis 
In addition to analyzing cytometry data, CytoBinning can potentially be used as a general 
method to quantify how two parameters are correlated. Comparing to conventional 
measurements, CytoBinning outputs a vector that contains information about the patterns 
of point distribution, whereas correlation coefficients and mutual information (MI) only 
gives one number indicating the degree of relationship between two parameters. As a result, 
CytoBinning can be used to better estimate the similarity between two relations (e.g. 
similarity between the expression pattern of gene A and gene B and the expression pattern 
of gene A and gene C). This is important because two parameters can form different point 
patterns but still have the same mutual information (Fig 5.1). Moreover, in examples like 
reconstructing gene networks, two genes are considered connected/ similar if they are both 
highly correlated with the same gene. However, this should not be the case if the correlation 
patterns are different. Since neither correlation coefficients nor MI provides information 






Figure 5.1 Two different point patterns with the same value of mutual information (0.23). 
To illustrate how CytoBinning can be used to distinguish point patterns, I generated eight 
synthetic patterns (Fig 5.2, ten samples/ replicates for each pattern, 1,000 points in each 
sample) and applied CytoBinning to cluster them. The results show that CytoBinning is 
able to correctly cluster five out of the eight patterns, but the other three patterns (circle, 
random, two circles) are mixed (Fig 5.3).  
 
Figure 5.2 Examples of the eight simulated patterns. Circle: x, y-axes are both randomly sampled from 
distribution N(0, 2). Random: x, y-axes are randomly sampled from a uniform distribution ranging from 0 to 





and y is sampled from N(0, 1). Three Circles: the bottom two clusters (400 points in each cluster) are sampled 
from a normal distribution centered around (-2, 0), (2, 0) respectively with standard deviation equals 1. And 
the top cluster is sampled from a normal distribution centered (0, 1) with standard deviation 1. Parabola: x 
values are sampled from N(0, 2), y = x^2 + noise where noise is sampled from N(0, 0.5). Down Parabola: the 
same as parabola, except y = -x^2 + noise. Straight Line: 𝑥 ∈ 𝑁(0, 2), y = x + 1 + noise, 𝑛𝑜𝑖𝑠𝑒 ∈ 𝑁(0, 0.25). 
Sine: 𝑥 ∈ 𝑁(0, 2), y = sin(x) + noise, 𝑛𝑜𝑖𝑠𝑒 ∈ 𝑁(0, 0.5) 
 
Figure 5.3 Clustering results of the eight patterns based on CytoBinning results (3 bins). Patterns are labeled 
by different colors (circle: red, random: yellow, two circles: green, three circles: magenta, parabola: black, 
down parabola: cyan, straight line: blue, and sine: cyan).  
The possible reason CytoBinning fails to distinguish “circle”, “random” and “two circles” 
could be that these three patterns are topologically similar (i.e., they are all symmetric to 
both axes). To test this hypothesis, I created subtle asymmetric features in these patterns 
(Fig 5.4. A small cluster is added to the upper right region of Circle pattern, and lower left 
region of the Random pattern. And the right cluster in Two Circles pattern is shifted 
upwards. These changes should break similarity shared by the three types of patterns.), and 
clustered the patterns with added asymmetry. CytoBinning is able to differentiate these 





a small cluster in the upper right region of Circle pattern, the small cluster was added to 
the lower left region (similar to what I did to Random pattern, Fig 5.6), then Circle pattern 
and Random pattern still hold topological similarity and cannot be distinguished by 
CytoBinning (Fig 5.7). Hence we infer that it is the intrinsic similarities between patterns 
instead of symmetry of pattern itself that impedes correct clustering of pattern “Circle”, 
“Random”, and “Tow Circles”. In other words, CytoBinning would fail to recognize 
different point patterns only when they share global similarities. 
 
Figure 5.4 Examples of patterns with added features (lower row) comparing to original patterns (upper row). 
Circle v2: 1,000 points in total, for 900 points 𝑥, 𝑦 ∈ 𝑁(0, 2). And for the rest 100 points 𝑥, 𝑦 ∈ 𝑁(1, 0.5),. 
Random v2: 1,000 points in total, for 900 points, 𝑥, 𝑦 ∈ 𝑢𝑛𝑖𝑓𝑜𝑟𝑚(0, 2); and for the rest 100 points 𝑥, 𝑦 ∈
𝑢𝑛𝑖𝑓𝑜𝑟𝑚(0.2, 0.5). Tow Circles v2: same as Two Circles, except the center of the right cluster is shifted up 







Figure 5.5 Clustering results of patterns with added asymmetrical features. The three patterns are largely 
separated (Circle: red, Two Circles: green, Random: yellow) with only one mistake.  
 
Figure 5.6 Example of point patterns with added features. Random v2 and Two Circles v2 are generated in 
the same way described in Fig 4. For Circle v3, similar to Circle v2, except the small cluster is now centered 






Figure 5.7 Clustering results with the feature added in Circle pattern moved to lower left region (Circle: red, 
Random: yellow, Two Circles: green).  
One additional advantage of CytoBinning is that it is invariant under order-preserving 
transformations of parameters. For example, cytometry data always requires a careful 
transformation step before data analysis because the expression of surface markers tends 
to have large ranges. Figure 5.8a and Figure 5.8b show the same scatterplot before and 
after logicle transformation. The patterns look dramatically different, and algorithms based 
on the exact value of parameters would be completely confused. However, CytoBinning is 
able to give the same analysis results for both scatterplots (Fig 5.8c and 5.8d), showing that 
CytoBinning does not depend on the exact value of each parameter to measure the patterns, 






Figure 5.8 The results of CytoBinning is invariant under order-preserve transformations. a)  and b) scatterplot 
of the expression level between CCR7 and CD45RO of the SAME sample (taken from the dataset used in 
Chapter 4). c) and d) heatmap showing CytoBinning results of the corresponding point patterns.  
Thanks to this invariant feature, CytoBinning can be applied to not only data analysis but 
also image analysis. For example, in neural imaging experiments, researchers often record 
neurons (points) that fire (light up) together under certain stimulations. Clarify the patterns 
of neurons firing together help the understanding of how neural circuits are connected to 
each other. CytoBinning can help with this problem by providing quantifiable 





Appendix A Supplementary Information for Chapter 2 
Typical healthy and progeria cell nuclei 
 
Figure A1. Representative images of typical healthy (top row) and progeria (bottom row) nuclei.  
Images are shown in four different channels: progerin, DAPI, lamin B1, and γH2AX. The outline of each 
nucleus (shown in green) was first extracted from the DAPI channel (nuclear shape) and then mapped onto 
the other three channels. As the images show, typical progeria nuclei have pronounced progerin expression, 
blebbed nuclear outlines, decreased lamin B1 expression, and high levels of DNA damage (γH2AX). 
A.1 Sorting out the mismatch of images across different channels  
In Figure 2.1 (a), Figure 2.6 and Figure A1, we noticed that nucleus in Lamin B1 channel 
tends to be larger than its counterpart in DAPI channel. In addition, there is also a shift in 
the image when we tried to overlay the outline segmented from DAPI channel directly onto 
Lamin B1 channel. Since our intensity measurements (measurements for Lamin B1, 
Progerin and γH2AX channel) are based on the outlines segmented in DAPI channel (we 
did this because cells used in our experiment are perturbed in lamin B1, progerin, and 
γH2AX expression, causing them not reliable for outline segmentation), these two 





measurements between their values calculated based on outline segmented from DAPI 
channel and outline segmented in lamin B1 channel. A random sample of nuclei in GFP-
progerin repressed control are used for this comparison, and four measurements (square 
root of area, boundary point intensity, mean intensity and standard deviation of intensity) 
are compared. Plotted in Figure A2 are the results. Each dot in Figure A2 represents a 
nucleus. As shown in Figure A2 (a), the size of nucleus measured in Lamin B1 channel is 
constantly larger than DAPI channel, with the average nuclear radius calculated in Lamin 
B1 channel ~ 600 nm longer than in DAPI channel. This difference may be due to the fact 
that DAPI attaches to DNA while Lamin B1 stain directly attaches to lamina that supports 
nuclear membrane. As to the shifting, since different cameras are used to capture images 
in different channels, even though the alignment of cameras was auto-corrected, there can 
still be slight shifts of direction. As shown in Figure A2 (b) – (c), the three intensity 
measurements are highly correlated between measurements calculated based on DAPI 
outline or Lamin B1 outline with correlation coefficients almost 1 (p-value close to 0) for 
mean intensity and boundary point intensity. These results suggest the shift in direction is 
small and intensity measurement based on DAPI outline is a reliable replacement for direct 
measurement based on outlines segmented in lamin B1 channel. Since Lamin B1 (as well 
as progerin and γH2AX) is perturbed as its expression level decreases when progerin exists 
leading some nuclei invisible in lamin B1 channel, we performed lamin B1 (as well as 






Figure A2. Comparison between measurements obtained from outlines segmented in DAPI vs. Lamin 
B1 channels. Corresponding correlation coefficients are shown in the top left corner of each panel. 
BPintensity stands for boundary point intensity, which measures mean fluorescent intensity along the nuclear 
boundary; meanIntensity stands for mean intensity inside nucleus, and stdIntensity is the standard deviation 
of fluorescent intensity inside nucleus boundary.   
A.2 Image processing and feature selection 
The raw data for image-based HTS consists of fluorescence microscopy images. We 





analyzed nuclear shapes extracted with an active contour algorithm [123], from which we 
determined 12 shape metrics. Out of these, 5 measurements are global metrics, i.e. 
parameters that describe the overall shape of the boundary (area, perimeter, eccentricity, 
major and minor axis length), while the remaining 7 measurements are local metrics, 
sensitive to the local features of the shape (number of invaginations, standard deviation of 
the curvature, mean curvature, solidity, mean negative curvature, circularity, and 
tortuosity). For analysis, an online open source package 
(http://downloads.openmicroscopy.org/bio-formats/5.1.2/) was incorporated into the 
nuclear shape extraction algorithm [123] to read flex format images. Furthermore, to detect 
and remove overlapping nuclei from multiple cells, we set up outlier detection thresholds 
for area and solidity at two standard deviations from the mean and discarded segmented 
nuclear outlines with area or solidity beyond the thresholds (about 6% of nuclei were 
discarded at this stage). The nuclear outlines extracted in the DAPI channel were mapped 
to the other 3 channels for analysis of fluorescence intensity, as shown by the green 
boundaries in Figure A1. In each of the 3 other channels, we determined 3 metrics as basic 
characteristics of the intensity distribution in each nucleus: mean intensity, the standard 
deviation of intensity, and mean intensity along the boundary. Therefore, in total, we 
obtained 21 metrics for each nucleus, of which 12 represent shape features and 9 represent 
3 metrics for each of the 3 channels label lamin B1, progerin, and DNA damage (γH2AX). 
       As a starting point, to select meaningful metrics that differ between GFP-progerin 
expressing and repressed controls, we analyzed each metric separately using F-scores 
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where 𝑥𝑖
(+/−)
 is the mean of the ith measurement for GFP-progerin expressing and 
repressed controls, respectively; 𝑥?̅? is the mean of the ith measurement for both controls 
combined, and 𝑛+/−  is the number of cells in GPF-progerin expressing and repressed 
controls. Using this procedure, we removed 6 shape metrics (eccentricity, minor axis 
length, major axis length, mean curvature, area, and perimeter), which yielded very low F-
scores (<0.003), from further analysis. The F-scores for the included shape metrics ranged 
from 0.5 to 17.  
A.3 Determination of parameters used in the selection of typical control cells 
Typical cells for control cell type A are defined as cells that are closest to the center of the 
multi-dimensional distribution of all cells in type A. Hence, there are two parameters to be 
determined before typical cell selection: the definition of center, and the number of typical 
cells to be selected. In this paper, we tested 3 definitions of center: the mean, the median, 
and the global peak of each distribution. The peak of distribution was calculated using 
.find_peaks() function in R package openCyto [68]. We also tested 8 different numbers of 
typical cells: 100, 200, 300, 500, 1000, 2000, 3000, and 5000. 1500 cells that are next 
closest to the center (compare to typical cells) were selected as cross-validation set (CV). 
The distance between each cell and the center of distribution was calculated using L1 
Manhattan distance. Typical cells were selected independently in each channel, thus 
different cells may be selected as typical cells in different channels. We applied support 
vector machine (SVM) to classify typical healthy and typical progeria cells selected using 
all cells numbers and corresponding to all 3 definitions of center (in total 3 x 8=24 different 





cells. The accuracy of the training set (dashed lines) and cross-validation set (solid line) 
for each condition in replicate plate 1 were plotted in Figure A3. We concluded from the 
results of all replicate plates that using mean as the center definition and choosing 300 






Figure SA3. Comparison of different center definition: mean (pink), median (green), peak (blue); and 
different typical cell numbers in plate 1. For reference, we also included randomly selected cells (purple). 
The vertical axis shows the accuracy of classification, and the horizontal axis is the selected typical cell 
number. Each subfigure plots results in one channel. The dashed line shows accuracy for the training set, and 
the solid line shows cross-validation set. Notice that randomly selected cells consistently behave worst, and 
for all channels, mean and peak behaved equally well in this replicate, but overall mean behaves the best. 
A.4 Relative weights of each measurement in the 4 channels 
 
Figure A4. Weights of each measurement in all channels, plates are labeled with different colors. The 





healthy vs. typical progeria cells. Sign of the weights indicates in which control type the very measurement 
is higher. The negative sign means it’s higher in progeria controls, and vice versa. For example, solidity in 
shape channel has a positive sign, which means its value is higher in healthy control cells. And all 
measurements in progerin channel have a negative sign; this is to say all the 3 measurements have a higher 
value in progeria controls, which is what we expected. Solidity is the most important measurement in shape 
channel. Weights for intensity measurements are quite similar with only small differences and fluctuates over 
different plates. 
A.5 Calculation of healthy-like cell percentage in each channel 
 
Figure SA5. Probability density distribution of all cells in GFP-progerin repressed (green) and GFP-





vertical line indicates the classification boundary located at x=0. We show here the combination of cells in 
12 GFP-progerin repressed control samples (green) and 12 GFP-progerin expressing control samples (red). 
As expected, the progerin channel is the most distinctive between GFP-progerin repressed and expressing 
controls. On the bottom right of each panel, we show the average percentage of healthy-like (green) and 
progeria-like (red) cells in each channel, calculated from the 4 replicate plates. 
 
Figure A6. An example of healthy-like cell percentage calculation for one siRNA: TRIM2. Plotted here 
are the probability density distributions of all cells in TRIM2 sample in plate 1. Vertical lines are 





like) distance to the classification boundary with the standard deviations calculated from the 4 replicate 
plates. This average was later used for siRNA hits identification. 
A.6 Table of selected siRNA hits 
siRNA hits in each channel. Numbers in parenthesis show the percentage of healthy-like cells averaged 
over 4 independent replicate plates per siRNA well. Percentage of healthy-like cells of each channel in 
progeria controls are listed under channel name. 





ASB12 (80%)     UBE2D2 (79%)     SKP2 (76%)     LOC554251 (76%)     





UBE2T (84%)     CDC34 (82%)    KUA-UEV (81%)  UBE2O (81%)    UBE2L6 
(73%)     PHF21B (73%)     RNF39 (71%)   FBXO8 (71%)    HERC4 (70%)     
CUL5 (69%)     RNF122 (69%)  TRIM2 (68%)     FBXO28 (68%)    SMURF1 
(68%)     UBE3B (68%)      FBXL11 (68%)    RNF44 (68%)    HERC3 (67%)    
HECTD1 (67%)   UBE1L (66%)     HERC5 (66%)    PHF20 (66%)      PHF11 
(65%)     FLJ25076 (65%)    PHF17 (65%)     FBXO38 (64%)   NDP52 (64%)    
UBE2U (64%)     WWP1 (64%)     HERC2 (64%)    ITCH (63%)      RNF180 
(62%)     UBE2N (61%)    TRIM55 (59%)     ZMYND11 (58%)    CUL7 (58%)    
DCUN1D4 (58%)   VPS41 (58%)   PRICKLE1 (57%)  UBE2M (57%)   TRIM52 
(56%)    SOCS2 (56%)     UBE2D3 (56%)   UBE2E2 (56%)     RNF12 (56%)     
PDZRN3 (54%)   LOC554251 (54%)   LMO6 (53%)     ARIH1 (53%)     
UBE2Q2 (52%)   HERC6 (51%)     UBE3A (51%)     DCUN1D1 (50%)    
UBE2E3 (50%)      WWP2 (50%)    UBE2V2 (50%)    UBE3C (50%)    CBL 
(49%)        TRIP12 (48%)      RNF8 (48%)   HECTD3 (46%)    CUL4B (45%)    
INTS12 (45%)     NEDD4L (45%)      CUL2 (45%)     DTX4 (44%)        39876 
(43%)       UBE2D1 (43%)    RFPL2 (43%)     ZNRF2 (42%)    BMI1 (41%)   





TIP120A (79%)    WSB1 (70%)    UBE2G2 (64%)    WWP2 (62%)     TRIM2 
(59%)    LOC554251 (55%)  FBXO38 (52%)   RNF39 (50%)      TRIM55 (49%)   
MLLT6 (45%)   FBXO17 (44%)        FLJ25076 (44%)    HERC3 (43%)    CUL3 
(43%)      UBE2D2 (40%)     FBXL13 (39%)    TRIP12 (38%)      UBE1C (37%)     
ASB5 (36%)          SMURF1 (33%)   RNF150 (33%)     RNF44 (32%)   FBXL11 
(31%)   PHF20L1 (30%)   RNF32 (28%)     ASB12 (27%)   TRIM8 (26%)    





WWP2 (86%)    WSB1 (81%)      ZNF330 (78%)   RFPL4B (77%)     WDR24 
(75%)  
A.7 Comparison with another method 
We compared the results of our method with another multi-dimensional analysis method 





To analyze our data using the method in [34], we first randomly selected 5,000 cells (about 
25%) from both GFP-progerin expressing and repressed controls respectively. We pooled 
these 10,000 cells together and clustered them with GMM as described in [34]. In total, we 
identified 9 (8) clusters in progerin and γH2AX (lamin B1) channel; these were used as 
reference models for siRNA perturbation samples. We then computed the probability of 
each cell belonging to one of these 9 (8) clusters. The expectation of the proportion of cells 
inside each cluster for each perturbation is then calculated based on these probabilities. 
Using an expected fraction of cells in each cluster as a vector, the distance between each 
perturbation to GFP-progerin repressed (healthy-like) controls are calculated using KL 
divergence. The inverse of this divergence is then used as the metric to select important 
perturbations, the larger the metric, the more similar to the healthy-like controls, hence the 
more important the perturbation. We then compared our metric (percentage of healthy-like 
cells) with this metric, and we found that they correlate well with each other.  
 
Figure A7. Comparison between our metric (healthy-like cell percentage, y-axis) and metric derived using 
the method proposed in [34] (x-axis) in lamin B1, progerin and γH2AX channel. The two metrics correlate 
well in all channels, with Spearman correlation coefficient 0.98 for γH2AX channel, 0.91 for lamin B1 





A.8 List of screened siRNAs 
UBE2C SMURF1 HERC3 UBE2W DCUN1D3 BIRC6 CUL3 
ITCH DCUN1D2 CUL1 UBE2O UBE2V1 UBE1C UBE2E3 
UBE2U KUA-UEV EDD1 HIP2 UBE2V2 DCUN1D5 UBE2J2 
HECW1 HUWE1 CAND2 UBE3B UBE2A UBE2R2 
AKTIP UBE2D1 UBE3A TIP120A KIAA0317 
HECTD1 UBE2T HERC2 UBE2N UBE1L UBE1 
UBE2D3 NEDD4 UBE2E2 HECTD3 UBE2E1 UBE3C 
TRIP12 HECTD2 UBE2D4 DCUN1D4 CDC34 FLJ34154 
UBE2Z UBE2L3 HERC1 HACE1 UBE1DC1 UBE2M UBE2I 
UBE2Q2 TSG101 UBE2G2 CUL4A HERC4 CUL4B 
UBE2L6 DCUN1D1 CUL2 HERC5 UBE2NL CUL7 UBE2S 
UEVLD UBE2F HERC6 WWP1 SMURF2 NEDD4L HECW2 
UBE2B UBE2J1 FLJ25076 UBE2Q1 UBE1L2 UBE2G1 FBXL15  
UBE2H FBXO18 CUL5 LOC554251 ARIH1 FBXL19 UBE2D2 WSB1 
WWP2  FBXL7 C10ORF46 ASB18 
FBXL16 FBXO27 FBXW10 FBXO42 FBXO21 FBXO40 
FBXO30 FBXO17 FBXL10 SKP2 SOCS7 ASB12  FBXL11 
WSB2             FBXL20 SOCS2 FBXO43 LOC200933 ASB13 SPSB1
 SOCS6 FBXO6 FBXL8 ASB16 LRRC29 FBXW8
 ASB9 FBXO4 FBXO16 ASB14 FBXW11 ASB6 
RAB40C FBXW2 SPSB3 FBXO31 FBXO9 FBXL3P SPSB2
 WDR71 FBXO41 SOCS5 FBXL13 ASB11 FBXO5
 FBXL17 FBXO28 FBXO46 
LOC342897 FBXL18 SOCS3 FBXO15 FBXO3 FBXO22
 FBXO11 FBXL14 FBXO7 FBXO25 RAB40A
 FBXL2 ASB5 CISH ASB8 FBXW9 
LOC652759 TULP4 NLRC5 FBXO8 CCNF FBXO44
 LL0XNC01-237H1.1 ASB2 FBXO24 LOC440456 FBXO2
 FBXO38 BTRC ASB7 FBXL12 FBXL3A 
ASB4 FBXO33 LGR6 FBXL6 NEURL2 ASB15 FBXO36
 FBXW5 SOCS1 FLJ10916 FBXW12 FBXL4
 FBXO32 SPSB4 FBXW7 FBXO39 
SHFM3 ASB10 FBXL5 ASB3 FBXO10 FBXL22 FBXO47
 RAB40B FBXO34 MDM2 SOCS4 PRPF19 ASB17
 TRIM6-TRIM34 ASB1 ZMYND11 
JARID1B RNF123 RKHD1 TRIM67 TRIM75 PHF17 OIT3
 MGRN1 PHF7 TRIM39 RBX1 LOC653111 LOC642678
 3/8/2009 BIRC3 MIB2 
PHF11 TRIM60 LOC644006 PHF6 TRIM42 BAHD1 RNF7
 WDSUB1 TRIM41 RNF133 HRC MYCBP2 PHF20L1
 RNF152 TRIM62 RNF125 
TRIM8 RNF122 TRIM63 RFPL4B WDR24 DTX4
 PCGF1 TRIM3 KIAA1718 RNF32 PRICKLE1 CBL





RNF39 RNF12 PDZRN3 C6ORF49 TRIM26 PHF21B ZNF645
 RNF5 INTS12 ZNF592 CHD5 RNF180 UNKL MID2
 ZNF313 RNF185 
RNF135 ZNRF2 PHF5A C20ORF18 3/4/2009 ANKIB1
 PHF15 BRCA1 LOC92312 ZFAND6 PHF21A HR
 MLLT6 TRIM14 ZNRF3 NDP52 
LOC643904 TRIM40 LOC399937 TRIM43 LMO6 TRIM52
 RNF144 LONRF1 SH3RF2 RNF150 PHF23 RNF25
 RUFY1 ZNF330 UBR2 TRIM2 
RFPL2 PHF16 ZNF179 RAD18 CBLC RNF44 TRIM55 BRPF3










Appendix B Supplementary Information for Chapter 3 
 
Figure B1. Scatter plots of simulated point patterns. First two rows show point pattern A; the lower two 
rows show point pattern B. Two major clusters in both point pattern A and B are generated from the same 
distributions. The third cluster of point pattern A, located on the center right, consists of about 10 to 20% of 







Figure B2. Heatmap for a percentage of cells inside each box with 6 bins. Percentage of cells in box B16 
(which corresponds to the third cluster in point pattern B) is significantly different between these two point 
patterns. This is not seen with only 3 bins. However, with 20 samples, analysis results using 6 bins is not 






Figure B3. With 6 bins, both different between pattern A and pattern B can be found by CytoBinning. 
 
 






Figure B5. Select important marker pairs for the first dataset (old vs. young). Ten samples are randomly 
selected as cross-validation dataset (4 in young group and 6 in the old group). SVM classification was used 
to separate old and young samples with binning results for each marker pair separately. Two marker pairs are 
able to achieve 100% classification accuracy for both training and cross-validation dataset (CD4 vs. CD3 and 






Figure B6. Scatterplots of CD8 vs. CCR7 for two randomly selected young donors (up) and two 






Figure B7. Scatterplots of CD4 vs. CD3 for two randomly selected young donors (up) and two 






Figure B8. Illustration of box B25 formed by CD4 and CD3. a) The position of box B25. b) Percentage 
of cells in B25 is higher in young donors. c) Scatter plot of mean fluorescent intensity (MFI) for all donors 
and all markers. This suggests cells in B25 are CD3+, CD8+, and CD45RA+. d) An example showing how 
cells in B25 (green) compare to manually gated naïve CD8 cells. e) Cells in B25 are divided into two 
groups: CCR7+ (expression of CCR7>1) and CCR7- (expression of CCR7<1). The boxplots show that 






Figure B9. Illustration of box B55 formed by CD4 and CD3. a) The position of box B55. Cells in B55 
express the highest 20% of both CD3 and CD4. Hence they might be CD4 T cells. b) Percentage of cells in 
B55 is higher in old donors. c) Scatter plot of mean fluorescent intensity (MFI) for all donors and all markers. 






Figure B10. Illustration of box B22 formed by CD4 and CD3. a) The position of box B22. b) Percentage 
of cells in B55 is higher in old donors. c) Scatter plot of mean fluorescent intensity (MFI) for all donors and 
all markers. It suggests cells in B22 might be CD11b+, CD14+, and CD45RA+. 













Figure B12. a) Overlay of cells in B55 on CD8 naïve and memory cell types for one donor. b) Boxplot of 










Figure B13. Illustration of box B51 formed by CD8 and CCR7. a) The position of box B51. b) Boxplot 
of cell percentage in B51 between young and old donors. c) Scatter plot of mean fluorescent intensity (MFI) 
for all donors and all markers. d & e) MFI of CD45RA vs. MFI of CCR7 for cells in B51, naïve and memory 
CD8 T cells. Each symbol shows a donor (young donors in d and old donors in e), vertical and horizontal 
errorbars show the standard deviation of CCR7 and CD45RA intensity respectively. 
List of markers measured in CD4 vs CD8 dataset 
CD45, CD14, CD57, TCRgD, IFNg, TNFa, IL.8, GranzymeB, IL17F, CD45RA, CLA, CTLA.4, IL2,  CD25, 
CD103, CCR10, CXCR6, IL5, CD19, CD56, IntegrinB7, PD-1, IL9, CCR9, CXCR3, CD127, Mip1b, 











Appendix C Supplementary Information of Chapter 4 
 
Figure C1. Important marker pairs are selected based on lowest training and testing errors. This 
example demonstrates the average training and testing error for a 7-fold cross validation based on multi-class 
Support Vector Machine (SVM) classification. Each training set contains 30 samples, and each testing set 






Figure C2. Manual gating validates the PD-1high CCR7- cell subset is highly overexpressed in tonsil 
samples. a) Example showing manual gating for cell subsets PD-1high CCR7- (highlighted in black boxes) in 






Figure C3. Mean marker expression of manually gated CCR7-PD-1high cells. The dark row of CB4 
indicates that in this cord blood sample there are no CCR7-PD-1high cells. 
 
 
Figure C4. Patterns formed by CCR7 and CD161 expression are distinct among different types of 
tissues. The black lines are binning thresholds determined by CytoBinning. Five bins are used to divide these 
patterns. Cord blood, PBMC and liver samples look similar at first glance, however, if observe closely, 
PBMC express more CD161-CCR7+ and CCR7+CD161+ cells than cord blood, and liver express more 
CD161+CCR7- cells than both PBMC and cord blood. In addition, there’s a cell phenotype: CD161+CCR7+, 






Figure C5. Manual gating validated that CD161+ CCR7+ cell subset is highly expressed in colon 
samples comparing to other types of tissues. a) Example showing manual gating for cell subsets CD161+ 
CCR7+ (highlighted in black boxes) in different types of tissues. b) Boxplot showing percentage of CD161+ 






Figure C6. Mean marker expression level of CD161+CCR7+ cells. In addition to CD161 and CCR7, 
these cells also express CD27, CXCR4, and CD45RO (except for cord blood samples). 
 
 
Figure C7. Patterns formed by CCR5 and CD27 expression are distinct among different types of 
tissues. The black lines are binning thresholds determined by CytoBinning. Five bins are used to divide these 
patterns. A cell phenotype CD27+CCR5+ is identified to be highly overexpressed by CD4 T cells in lung. 
Since the lung samples in this dataset are collected from lung cancer resection, we’re not sure if the 






Figure C8. Manual gating validated that CD27+CCR5+ cell subset is highly expressed in lung samples 
comparing to other types of tissues. a) Example showing manual gating for cell subsets CD27+CCR5+ 
(highlighted in black boxes) in different types of tissues. b) Boxplot showing percentage of CD27+ CCR5+ 






Figure C9. Mean marker expression level of CD27+CCR5+ cells. In addition to CD27 and CCR5, these 




Figure C10. Patterns formed by CCR7 and CD27 expression are distinct among different types of tissues. 






Figure C11. Patterns formed by CCR5 and CXCR6 expression are distinct among different types of 














Appendix D Package ‘RefCellScreening’ 
Type Package 
Title Identify important siRNA hits using typical cells 
Version 0.0.0.900 
Date 2018-04-16 
Author Yang Shen <shenyang@umd.edu> 
Description This package contains functions for typical cell selection and batch processing 
of samples in high-throughput screening data 
Imports data.table, kernlab, ks 
Needs Compilation no 
typical_cell_selection    selects typical cells 
Description 
This function selects typical cells and returns selected typical cells as a matrix 
Usage 
typical_cell_selection (indata, 1000, features, method='peak') 
Arguments 
input   Input matrix that contains all cells 
number  The number of typical cells to select 
index Indices of measurements based on which typical cells are selected, should 
be a vector of integers 
method  Methods to define the center of typical cells, can choose from "mean" and 
"peak" 
Values 
A list contains two elements, the first element is a matrix contain typical cells, and the 
second element is a vector of index for typical cells 
 
appends    append element to a list object 
Description 
This function appends a new element to an existing list object at the end (the original list 









to_add  The element to be added to the list 
Value 
A new list with the element added at the end 
 
combine_data   combine all data files within a certain directory 
Description 
This function combines all data files in a given folder 
Usage 
combine_data(directory, pattern = NULL) 
Arguments 
directory  The directory of the folder that stores all the data files to be combined 
pattern  An optional regular expression. Only files match this expression with be 
combined. The default value is NULL.  
Value 
A data frame that contains all data 
 
SVM   performs SVM to classify data points in two matrices 
Description 
This function applies SVM in kernlab package to classify two groups of data points stored 





healthy  Matrix of healthy cells to be classified 
disease  Matrix of diseased cells to be classified 
feature_index  A vector contains index of measurements used in classification, should be 
a vector of integers; length must be larger than 1 
Values 
accuracy  Accuracy of the classification 
weightnorm  Normalized weights of each feature. Negative weights are higher in disease 
matrix 
center  The center (average) of all data points (healthy and disease combined). Can 





std  The standard deviation of all data points (healthy and disease combined). 
Can be used to normalize test datasets 
SVM_bn  adjusted constant for calculating the distance between data point to 
classification boundary in test data points 
 
SVM_cv  performs SVM classification and testing together 
Description 
This function applies SVM in kernlab package to classify two groups of data points stored 





controls  Training matrix of healthy cells to be classified 
exper   Training matrix of diseased cells to be classified 
feature_index  A vector contains index of measurements used in classification, should be 
a vector of integers; length must be larger than 1 
test.control  Testing matrix of healthy cells 
test.exp  Testing matrix of diseased cells 
Values 
accuracy  Classificaiton accuracy of the training dataset 
test   Classification accuracy of the test dataset 
weight  Normalized weights of the features 
 
projection project additional data points along the direction of the classification 
boundary 
Description 
This function projects additional data points along the direction of classification boundary 
after normalizing it based on the center and std of classification data (used in SVM), 
calculates the length of projection and percentage of cells along the same direction of the 
classification boundary 
Usage 
projection(to_be_normed, center, std, weight) 
Arguments 





center    Center of typical cells, output from SVM() 
std    Standard deviations of typical cells, output from SVM() 
weight  Direction of boundary plane given by SVM(), weight should be 
formatted as a n by 1 matrix, n is the number of dimensions 
Values 
projected  A list of projected distance between each test data point to the classification 
boundary 
percent  percentage of data points in a to_be_normed matrix that has a positive 
distance to the classification boundary 
 
batch_projection batch projection of data in siRNA files to classification boundary 
Description 
This function projects data in multiple data files to the direction of classification boundary 




directory  Directory of the folder that contains all data files to be projected 
index   A vector of the index for features to be used for projection 
center   Center of typical cells, outputs of SVM() 
std   Standard deviations of typical cells, outputs of SVM() 
weights  Weights of each feature (i.e., the direction of the classification boundary), 
outputs of SVM() 
Values 
percentages  A vector of the percentage of cells with a positive projection for each data 
file 
cell.counts  A vector of cell numbers in each data file 
names   A vector of names for each data file 
 
hits_identification  Identify important siRNA hits 
Description 
This function identifies important siRNA hits as the ones with the percentage of healthy-






hits_identification(disease_percent, siRNA_percent, std_siRNA_percent, siRNA_number, 
siRNA_name, number_of_plates) 
Arguments 
disease_percent  A vector of healthy-like cell percentage in disease control samples 
siRNA_percent  A vector of healthy-like cell percentage in siRNA samples 
std_siRNA_percent  A vector of standard deviations of each siRNA sample across 
replicate experiments 
siRNA_number  A vector of the ratio between the number of cells in each siRNA 
sample and mean cell numbers in healthy control samples 
siRNA_name   A character vector contains the names of each siRNA 
number_of_plates  The number of replicate experiments 
Value 












Author Yang Shen <shenyang@umd.edu> 
Description This package contains functions to perform CytoBinning 
Imports flowCore, kernlab, ks  
Needs Compilation no 
 
preprocess  perform compensation and logicle transformation 
Description 
This function performs logicle transformation on all FCS files in a folder and outputs 
transformed data in text format 
Usage 
preprocess = function(input.directory, output.directory, marker.index, marker.names) 
Arguments 
input.directory  Directory of the folder contains all fcs files 
output.directory  Directory of the folder to store all transformed data in text format 
marker.index   Indices of markers that need to be logicle transformed 




CytoBinning  perform CytoBinning on all files in a folder 
Description 
This function performs CytoBinning on all data files in a folder and output a matrix where 
each row is the binning result for a data file 
Usage 
CytoBinning(bin.number, marker.names, input.dir, output.dir) 
Arguments 
bin.number   A vector of the selected number of bins 
marker.names  A vector contains names of markers to be used in binning 





output.dir  Directory of the folder that contains binning results, each file stores 




SVM   performs SVM to classify data points in two matrices 
Description 
This function applies SVM in kernlab package to classify two groups of data points stored 





healthy  Matrix of healthy cells to be classified 
disease  Matrix of diseased cells to be classified 
feature_index  A vector contains an index of measurements used in classification, should 
be a vector of integers; length must be larger than 1 
Values 
accuracy  Accuracy of the classification 
weightnorm  Normalized weights of each feature. Negative weights are higher in disease 
matrix 
center  The center (average) of all data points (healthy and disease combined). Can 
be used to normalize test datasets 
std  The standard deviation of all data points (healthy and disease combined). 
Can be used to normalize test datasets 
SVM_bn  adjusted constant for calculating the distance between data point to 







Appendix F Between and within cell line heterogeneity in 
breast tumor: insights from tumor cell stiffness 
F.1 Overview 
The experiments and data pre-processing were performed by members in Professor Josef 
A. Käs’s laboratory at Leipzig University in Germany. I designed downstream analysis 
approach, performed analysis and wrote the manuscript. 
F.2 Abstract 
Cellular heterogeneity in tumor cells is a well-established phenomenon. Genetic and 
phenotypic cell-to-cell variability has been observed in numerous studies both within the 
same type of cancer cells and across different types of cancers. Here we show that similar 
heterogeneity can also be seen in mechanical properties of cells both within and between 
breast tumor cell lines. In particular, we identified two clusters within MDA-231 cells, with 
cells in one cluster softer than the other. Since stiffness of tumor cells can be an indicator 
of malignancy potential, this result suggests that metastatic abilities could vary within the 
same tumor cell line. In addition, we show that MDA-231 and MDA-436 cells are more 
different from each other than from MCF-10A cells in their mechanical properties, 
suggesting the existence of different paths to metastasis and the possibility of 
differentiating and understanding these paths with mechanical properties of single cells.  
F.3 Introduction 
Recognized as early as 1958 [145], genetic heterogeneity is a well-established phenomenon 
in tumor cells, especially during metastatic stages [92, 146-148]. Studies have shown that 





[149]. Such high level of heterogeneity has been accused of being the reason why cancer 
is hard to cure [150-152]. However, to-date the reason and extent of tumor cell 
heterogeneity is still not well-understood [92]. Two main theories have been proposed to 
explain the origin of tumor cells heterogeneity: cancer stem cell [153] and clonal evolution 
[150]. These two theories try to explain the heterogeneity in ecological and evolutional 
aspects respectively, and there has been evidence for each theory [154]. Variations in gene 
expression lead to molecular variations which in turn affect cellular function and other 
properties. One of the most important impacts may be cellular stiffness. Changes in actin 
expression and cytoskeleton organization are related to the fact that metastatic tumor cells 
are softer than their benign counterparts as well as normal cells [155-157]. Since metastasis 
is responsible for more than 90% of cancer fatality [158], great effort has been made to 
study the properties of metastatic tumor cells and how mechanical properties of tumor cell 
affect its metastatic ability.  
Multiple experimental tools have been applied to study cell stiffness, such as atomic force 
microscope (AFM) [159], quantitative deformability cytometry (q-DC) [160], microfluidic 
optical cell stretcher [161], etc. Using these tools, a large volume of evidence has been 
identified linking lower stiffness of tumor cells to higher metastatic ability [155]. In 
addition, studies have suggested the potential of using mechanical properties as a 
biomarker of metastasis [162] and for cancer diagnosis [163]. Even though single-cell level 
measurements can be achieved using these techniques, most studies still perform average 
based analysis on these data, causing possible oversimplification of the results. 
In this paper, we use a microfluidic optical cell stretcher to measure mechanical properties 





data analysis, we show that heterogeneity of cellular stiffness exists both within and 
between cell lines. In particular, we observed two groups of MDA-231 cells. Cells in one 
of the groups are significantly softer than the other. In addition, we found that although 
MDA-231 and MDA-436 are both triple-negative cell lines with the metastatic tendency, 
they are quite distinct: more different from each other than from nonmalignant cell line 
MCF-10A. 
F.4 Results 
We used a Microfluidic Optical Cell Stretcher to mechanically stretch individual tumor 
cells and measure their stiffness [164, 165]. Suspended single cells were trapped for 1 
second and subsequently stretched for 2 seconds and then relaxed in trapping condition for 
another 2 seconds (Fig F1). Images of cells were taken at the rate of 30 frames per second, 
and the length of long axis was measured in each frame for each individual cell. In this 
paper, we use only two mechanical features calculated from these measurements: 1. 
Normalized long axis deformation at the end of stretch (Deformation EOS), and 2. 
Normalized long axis deformation during the relaxation period (Relaxation EOE) (Fig F1). 
The value of EOS is reversely proportional to Young’s modulus, where higher EOS value 
indicates lower Young’s modulus (easier to stretch). On the other hand, EOE is a 
measurement of the ability of a cell to restore its shape, where the higher absolute value of 
EOE suggests greater ability to restore original shape. Together, these two features give a 
good representation of the stiffness of a single cell.  
Using this technique, we measured cells from three different breast cancer cell lines: MCF-
10A, MDA-231, and MDA-436. MCF-10A is a non-malignant and non-metastatic cell line 





are both triple negative breast cancer cell lines (i.e. they do not express estrogen receptors, 
progesterone receptors nor HER2), they both have metastatic potential with MDA-231 
considered more malignant than MDA-436 [166].  
 
Figure F1. An illustration of the data and features calculated from the data (adapted from [164]).  
F.4.1 Two subgroups observed in MDA-231 cells 
We first identified two subgroups within MDA-231 cells, one subgroup (cluster 2, Fig F2) 
have higher deformation at the end of stretch (EOS) and higher absolute value of relaxation 
at the end of the experiment (EOE) than cluster 1 (Fig F2). Higher absolute values of both 
EOS and EOE indicates cells in cluster 2 are more elastic (easier to stretch and easier to 
restore original shape) comparing to cluster 1 which overlaps with MDA-436 and MCF-






Figure F2. Two clusters of MDA-231 cells are observed. a) Scatterplot of Relaxation EOE vs. Deformation 
EOS for MDA-231 cells. The two subgroups are labeled by different colors (red: cluster 1, blue: cluster 2). 
b) Boxplot comparing relaxation at the end of experiment between cluster 1 and cluster 2 of MDA-231 cells. 
c) Boxplot comparing deformation at the end of stretch between the two subgroups of MDA-231 cells. 
F.4.2 The more elastic group does not exist in E-cadherin labeled MDA-231 cells  
E-cadherin is an important cellular marker for cell-cell adherence. Metastatic tumor cells 
like MDA-231 cells express limited E-cadherin and hence are less adhesive. In our 
experiment, we also measured mechanical properties for MDA-231 cells that are labeled 
with E-cadherin antibodies. Surprisingly, different properties are observed between the E-
cadherin labeled and original MDA-231 cells. In particular, E-cadherin labeled MDA-231 
cells only formed one cluster instead of two clusters as is observed in unlabeled MDA-231 
cells. The labeled 231 cells overlap with cluster 1 of MDA-231 cells which is the less 






Figure F3. MCF-10A, MDA-436, and E-cadherin labeled MDA-231 cells all overlap with cluster 1 (the 
less elastic group) in unlabeled MDA-231 cells. a) Scatterplot of Relaxation EOE vs Deformation EOE for 
MCF-10A (red), MDA-231 (green) and MDA-436 (blue) cells. b) Scatterplot of Relaxation EOE vs. 
Deformation EOE for E-cadherin labeled (blue) and unlabeled (red) MDA-231 cells. 
F.4.3 MDA-231 and MDA-436 cells are more different from each other than from 
MCF-10A cells 
We showed above that there is a subgroup in MDA-231 cells that greatly overlap with 
MCF-10A and MDA-436 cells. We then move to ask the question that are these 
overlapping phenotypes similar to each other or are they separable on single cell level? To 
answer this question, we applied k nearest neighbors (k-NN) algorithm for a pairwise 
classification of the three phenotypes. We first divided the cells into two groups: train and 
test. Phenotype labels are provided for cells in train group but not for the test group. Then, 
given the position of a single cell in the test group, k-NN identifies its nearest k neighbors 
within the training group. The k neighbors then take a vote with their phenotype, and the 
cell from test group is assigned to the phenotype that has highest votes. After classification, 
we calculated the sensitivity (true positive rate) and specificity (true negative rate) for each 
pair of classification. We found that classification between MCF-10A and MDA-436 cells 





This indicates that the distinction between MCF-10A and MDA-436 cells are less clear 
than the other two pairs. Indeed, F1 score (a measure of classification result, the higher the 
score the better the classification, the maximum F1 score is 1) is much lower for MCF-10A 
and MDA-436 cells for all tested values of k (Fig F4c). This result is expected given that 
MDA-436 is only a mildly malignant cell line. Since both MDA-436 and MDA-231 cell 
lines are malignant, it is reasonable to expect they would be similar as well. However, this 
is not what we observed. Based on the classification results, classification between cluster 
1 of MDA-231 and MDA-436 cells has the highest level of F1 scores (Fig F4c) – which is 
even higher than the classification between MCF-10A and MDA-231 cells. Similar results 
are obtained with a different classification algorithm (SVM), where the classification 
between MDA-231 and MDA-436 cells also has the highest F1 value (Table F1). SVM 
takes a different approach in classification and aims to find the linear plane that best 
separates two groups to classify. In addition, when all the four phenotypes are classified 
simultaneously, MDA-436 cells are less likely to be miss-classified as MDA-231 cells than 
as MCF-10A cells and vice versa (Fig F5). Together, these results suggest that cells in 
cluster 1 of MDA-231 are more different from MDA-436 cells than from MCF-10A cells.  
 
Figure F4. Pairwise k-NN classification results show that MDA-231 and MDA-436 cells are more 





comparisons versus different values of k. b) Specificity (true negative rate) for the three comparisons versus 
different values of k. c) F1 score for the three comparisons versus different values of k.  
Table F1. Pairwise classification results by support vector machine (SVM). 
 Sensitivity Specificity F1 
MCF-10A (positive) vs MDA-
231 cluster 1 (negative) 
0.69 0.68 0.68 
MCF-10A (positive) vs MDA-
436 (negative) 
0.63 0.61 0.60 
MDA-231 cluster 1 (positive) 
vs MDA-436 (negative) 
0.76 0.74 0.74 
 
 
Figure F5. k-NN classification results of E-cadherin added MDA-231 cells (Ecad), MCF-10A cells, 
cluster 1 in MDA-231 cells and MDA-436 cells, with k = 10. MDA-231 and MDA-436 cells are less likely 
to be miss-classified as each other than as MCF-10A cells.  
F.5 Discussion 
Mechanical properties of tumors cells are important indicators of their malignancy. Studies 
have shown that metastatic tumor cells are on average softer than non-metastatic ones. In 
this paper, we illustrated the heterogeneity of tumor cell stiffness both within and between 
cell lines. With only mechanical properties, we show that there are two distinct clusters 





MDA-436 cells, and cells in the other cluster are softer (easier to deform and restore to 
original shape) than the other. In addition, we found that the two malignant cell lines: 
MDA-231 and MDA-436 are more different from each other than from the nonmalignant 
MCF-10A cell line.   
Heterogeneity within MDA-231 cell line has been shown before based on their molecular 
expressions. For example, it has been shown that there are two distinct subgroups of MDA-
231 cells which differ significantly in the cell surface density of various cytokine receptors 
(CCR5, CXCR3, CXCR1) [167]. In particular, CXCR3 was found to be overexpressed in 
metastatic tumor cells, and drugs targeting CXCR3 decreased tumor cell migration [168]. 
Hence our results agree with previous findings. Additional experiments can be performed 
to validate the two mechanically distinct subtypes of MDA-231 cells and whether this 
separation agrees with their cytokine receptor expression. 
We also identified heterogeneity between triple negative breast cancer (TNBC) cell lines, 
i.e., we found that MDA-231 and MDA-436 cells are quite distinct from each other, even 
more so than from the nonmalignant MCF-10A cell line. This finding is feasible from the 
perspective of the classical clonal evolution model. Assuming the genetic and (more 
importantly) the phenotypic characteristics of normal breast tissue are similar among all 
women. Thus, both patients from which the MDA-231 and MDA-436 cell lines are derived 
had initially breast tissue which is very similar to the MCF-10A tissue. From this healthy 
starting population of cells, different paths can be taken to reach a metastatic phenotype. It 
seems actually unlikely that two completely different patients accumulate the exact same 
cancer cell phenotype with the same optical stretching characteristics. What’s more, our 





cancer are currently considered to have a very poor prognosis. However, there has been an 
emerging trend to regard TNBC as a heterogeneous group of patients with some actually 
having not such a bad prognosis. Furthermore, TNBCs can have very different molecular 
characteristics, potentially rendering some tumors more suitable to targeted therapies. It is 
of paramount clinical importance to identify those patients. The present data is intriguing 
in that it shows, that two TNBC cell lines (which would be put into one prognostic basket 
clinically) are indeed very different. It is interesting to speculate whether optical stretching 
analysis could be used to differentiate those TNBC cases with a better prognosis (i.e., a 
lower rate of relapse and distant metastasis) from those with a worse prognosis. 
In addition, our findings on the between cell line heterogeneity is an indication that average 
based analysis method would oversimplify tumor cell data. If one only looks at the 
scatterplot as in figure 3a, one would conclude that MCF-10A, MDA-436 and cluster 1 of 
MDA-231 cells are similar to each other with the probably minor difference in the average 
values. However, when classified with a more sophisticated algorithm like k-NN, 
reasonably good classification accuracy was achieved. That is to say, even though cells 
from the three cell lines overlap on at a higher level, locally cells from a certain cell line 
are more close to cells from the same cell line than from other cell lines. This cannot be 
found if averaging methods were used. 
Lastly, we found that E-cadherin labeled MDA-231 cells have different phenotype profiles 
comparing to the unlabeled cells. We reason that this is because binding of the antibody to 
the E-cadherin receptor simulates cell-cell binding, which causes cadherin clustering and 





labeling would change the properties of cells be labeled, and a label-free measuring 
mechanism would give better / more accurate results. 
In all, we illustrated within and between cell line tumor cell heterogeneity with only cellular 
mechanical properties. Our results have great implications for future studies on how a 
change in chemokine receptor expression correlates with tumor cell stiffness and how 
differentiating mechanical properties of cancer cells could help identify triple negative 
breast cancer patients with better prognosis.  
F.6 Methods 
F.6.1 Experimental procedures 
Suspended single cells were trapped for 1 second and subsequently stretched for 2 seconds 
and then relaxed in trapping condition for another 2 seconds (Fig F1). Images of cells were 
taken at the rate of 30 frames per second, and the length of long axis was measured in each 
frame for each individual cell.  
F.6.2 Data analysis 
The two clusters of MDA-231 cells were clustered using kmeans() function in R (version 
3.0.3) with 2 centers, 1,000 iterations, and 50 random initial conditions. For kNN 
classification, 1,200 cells were first randomly selected from each cell line. From the 1,200 
cells, 200 were randomly selected as a testing set, and the remaining 1,000 were used as a 
training set for each cell line. The classification was done separately for each pair of cell 
line using knn() function in R with 8 different values of k (2, 3, 5, 7, 10, 20, 50, 100). 
Similarly, simultaneous classification of the four cell lines was done. After classification, 
false positive rate was calculated as FPR = (false positives) / (false positives + true 





negatives). Finally, pairwise SVM classifications were done based on all the 1,200 
randomly selected cells using ksvm() function with linear kernel and C=10 in R package 











1. Chattopadhyay, P.K. and M. Roederer, A mine is a terrible thing to waste: high 
content, single cell technologies for comprehensive immune analysis. Am J 
Transplant, 2015. 15(5): p. 1155-61. 
2. Gattinoni, L., et al., A human memory T cell subset with stem cell-like properties. 
Nat Med, 2011. 17(10): p. 1290-7. 
3. Johnston, R.J., et al., Bcl6 and Blimp-1 are reciprocal and antagonistic regulators 
of T follicular helper cell differentiation. Science, 2009. 325(5943): p. 1006-10. 
4. Park, H., et al., A distinct lineage of CD4 T cells regulates tissue inflammation by 
producing interleukin 17. Nat Immunol, 2005. 6(11): p. 1133-41. 
5. Saeys, Y., S.V. Gassen, and B.N. Lambrecht, Computational flow cytometry: 
helping to make sense of high-dimensional immunology data. Nat Rev Immunol, 
2016. 16(7): p. 449-62. 
6. Tanner, S.D., et al., An introduction to mass cytometry: fundamentals and 
applications. Cancer Immunol Immunother, 2013. 62(5): p. 955-65. 
7. Genovesio, A., et al., Automated genome-wide visual profiling of cellular proteins 
involved in HIV infection. J Biomol Screen, 2011. 16(9): p. 945-58. 
8. Kalisky, T., et al., A brief review of single-cell transcriptomic technologies. Brief 
Funct Genomics, 2018. 17(1): p. 64-76. 
9. Altschuler, S.J. and L.F. Wu, Cellular heterogeneity: do differences make a 
difference? Cell, 2010. 141(4): p. 559-63. 
10. Aggarwal, C.C., A. Hinneburg, and D.A. Keim. On the Surprising Behavior of 
Distance Metrics in High Dimensional Space. 2001. Berlin, Heidelberg %@ 978-
3-540-44503-6: Springer Berlin Heidelberg. 
11. Orlova, D.Y., L.A. Herzenberg, and G. Walther, Science not art: statistically sound 
methods for identifying subsets in multi-dimensional flow and mass cytometry data 
sets. Nature Reviews Immunology, 2018. 18(1): p. 77 %@ 1474-1741. 
12. Macarron, R., et al., Impact of high-throughput screening in biomedical research. 
Nat Rev Drug Discov, 2011. 10(3): p. 188-95. 
13. Inglese, J., C.E. Shamu, and R.K. Guy, Reporting data from high-throughput 
screening of small-molecule libraries. Nat Chem Biol, 2007. 3(8): p. 438-41. 
14. Mohr, S., C. Bakal, and N. Perrimon, Genomic screening with RNAi: results and 
challenges. Annu Rev Biochem, 2010. 79: p. 37-64. 
15. Boutros, M., F. Heigwer, and C. Laufer, Microscopy-Based High-Content 
Screening. Cell, 2015. 163(6): p. 1314-25. 
16. Mattiazzi Usaj, M., et al., High-Content Screening for Quantitative Cell Biology. 
Trends Cell Biol, 2016. 26(8): p. 598-611. 
17. Zanella, F., J.B. Lorens, and W. Link, High content screening: seeing is believing. 
Trends Biotechnol, 2010. 28(5): p. 237-245 %@ 0167-7799. 
18. Motti, D., et al., High Content Screening of Mammalian Primary Cortical Neurons. 
Methods Mol Biol, 2018. 1683: p. 293-304. 
19. Zhou, T., et al., High-Content Screening in hPSC-Neural Progenitors Identifies 
Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and 





20. Johnston, R.L., et al., High content screening application for cell-type specific 
behaviour in heterogeneous primary breast epithelial subpopulations. Breast 
Cancer Res, 2016. 18(1): p. 18. 
21. Tolosa, L., M.J. Gomez-Lechon, and M.T. Donato, High-content screening 
technology for studying drug-induced hepatotoxicity in cell models. Arch Toxicol, 
2015. 89(7): p. 1007-22. 
22. Collins, T.J., ImageJ for microscopy. Biotechniques, 2007. 43(1 Suppl): p. 25-30. 
23. Schneider, C.A., W.S. Rasband, and K.W. Eliceiri, NIH Image to ImageJ: 25 years 
of image analysis. Nature Methods, 2012. 9(7): p. 671-5. 
24. Schindelin, J., et al., Fiji: an open-source platform for biological-image analysis. 
Nature Methods, 2012. 9(7): p. 676-82. 
25. Carpenter, A.E., et al., CellProfiler: image analysis software for identifying and 
quantifying cell phenotypes. Genome Biol, 2006. 7(10): p. R100. 
26. Lamprecht, M.R., D.M. Sabatini, and A.E. Carpenter, CellProfiler: free, versatile 
software for automated biological image analysis. Biotechniques, 2007. 42(1): p. 
71-5. 
27. Soliman, K., CellProfiler: Novel Automated Image Segmentation Procedure for 
Super-Resolution Microscopy. Biol Proced Online, 2015. 17: p. 11. 
28. Kamentsky, L., et al., Improved structure, function and compatibility for 
CellProfiler: modular high-throughput image analysis software. Bioinformatics, 
2011. 27(8): p. 1179-80. 
29. Eliceiri, K.W., et al., Biological imaging software tools. Nature Methods, 2012. 
9(7): p. 697-710. 
30. Singh, S., A.E. Carpenter, and A. Genovesio, Increasing the Content of High-
Content Screening: An Overview. J Biomol Screen, 2014. 19(5): p. 640-50. 
31. Grys, B.T., et al., Machine learning and computer vision approaches for 
phenotypic profiling. J Cell Biol, 2017. 216(1): p. 65-71. 
32. Loo, L.H., L.F. Wu, and S.J. Altschuler, Image-based multivariate profiling of drug 
responses from single cells. Nature Methods, 2007. 4(5): p. 445-453. 
33. Shariff, A., et al., Automated image analysis for high-content screening and 
analysis. J Biomol Screen, 2010. 15(7): p. 726-34. 
34. Slack, M.D., et al., Characterizing heterogeneous cellular responses to 
perturbations. Proc Natl Acad Sci U S A, 2008. 105(49): p. 19306-11. 
35. Kraus, O.Z., et al., Automated analysis of high-content microscopy data with deep 
learning. Mol Syst Biol, 2017. 13(4): p. 924. 
36. Aghaeepour, N. and R. Brinkman, Computational analysis of high-dimensional 
flow cytometric data for diagnosis and discovery. Curr Top Microbiol Immunol, 
2014. 377: p. 159-75. 
37. Chattopadhyay, P.K. and M. Roederer, Cytometry: today's technology and 
tomorrow's horizons. Methods, 2012. 57(3): p. 251-8. 
38. Adan, A., et al., Flow cytometry: basic principles and applications. Crit Rev 
Biotechnol, 2017. 37(2): p. 163-176. 
39. Shapiro, H.M., Practical Flow Cytometry2005: John Wiley & Sons, Inc. 
40. Spidlen, J., et al., Data File Standard for Flow Cytometry, version FCS 3.1. 





41. Seamer, L.C., et al., Proposed new data file standard for flow cytometry, version 
FCS 3.0. Cytometry, 1997. 28(2): p. 118-22. 
42. Herzenberg, L.A., et al., Interpreting flow cytometry data: a guide for the 
perplexed. Nat Immunol, 2006. 7(7): p. 681-5. 
43. Parks, D.R., M. Roederer, and W.A. Moore, A new "Logicle" display method avoids 
deceptive effects of logarithmic scaling for low signals and compensated data. 
Cytometry A, 2006. 69(6): p. 541-51. 
44. Hahne, F., et al., Per-channel basis normalization methods for flow cytometry data. 
Cytometry A, 2010. 77(2): p. 121-31. 
45. Hahne, F., et al., flowCore: a Bioconductor package for high throughput flow 
cytometry. BMC Bioinformatics, 2009. 10: p. 106. 
46. Maecker, H.T., J.P. McCoy, and R. Nussenblatt, Standardizing 
immunophenotyping for the Human Immunology Project. Nat Rev Immunol, 2012. 
12(3): p. 191-200. 
47. Pachon, G., I. Caragol, and J. Petriz, Subjectivity and flow cytometric variability. 
Nat Rev Immunol, 2012. 12(5): p. 396; author reply 396. 
48. Gouttefangeas, C., et al., Data analysis as a source of variability of the HLA-
peptide multimer assay: from manual gating to automated recognition of cell 
clusters. Cancer Immunol Immunother, 2015. 64(5): p. 585-98. 
49. Pedreira, C.E., et al., Overview of clinical flow cytometry data analysis: recent 
advances and future challenges. Trends Biotechnol, 2013. 31(7): p. 415-25. 
50. Lugli, E., M. Roederer, and A. Cossarizza, Data analysis in flow cytometry: the 
future just started. Cytometry A, 2010. 77(7): p. 705-13. 
51. Kvistborg, P., et al., Thinking outside the gate: single-cell assessments in multiple 
dimensions. Immunity, 2015. 42(4): p. 591-2. 
52. Bashashati, A. and R.R. Brinkman, A survey of flow cytometry data analysis 
methods. Adv Bioinformatics, 2009: p. 584603. 
53. Aghaeepour, N., et al., Critical assessment of automated flow cytometry data 
analysis techniques. Nature Methods, 2013. 10(3): p. 228-38. 
54. Malek, M., et al., flowDensity: reproducing manual gating of flow cytometry data 
by automated density-based cell population identification. Bioinformatics, 2015. 
31(4): p. 606-7. 
55. Aghaeepour, N., et al., Early immunologic correlates of HIV protection can be 
identified from computational analysis of complex multivariate T-cell flow 
cytometry assays. Bioinformatics, 2012. 28(7): p. 1009-16. 
56. Ge, Y. and S.C. Sealfon, flowPeaks: a fast unsupervised clustering for flow 
cytometry data via K-means and density peak finding. Bioinformatics, 2012. 
28(15): p. 2052-8. 
57. Aghaeepour, N., et al., Rapid cell population identification in flow cytometry data. 
Cytometry A, 2011. 79(1): p. 6-13. 
58. Pyne, S., et al., Automated high-dimensional flow cytometric data analysis. Proc 
Natl Acad Sci U S A, 2009. 106(21): p. 8519-24. 
59. Rebhahn, J.A., et al., Competitive SWIFT cluster templates enhance detection of 
aging changes. Cytometry A, 2016. 89(1): p. 59-70. 
60. Lo, K., et al., flowClust: a Bioconductor package for automated gating of flow 





61. Lo, K., R.R. Brinkman, and R. Gottardo, Automated gating of flow cytometry data 
via robust model-based clustering. Cytometry A, 2008. 73(4): p. 321-32. 
62. Van Gassen, S., et al., FlowSOM: Using self-organizing maps for visualization and 
interpretation of cytometry data. Cytometry A, 2015. 87(7): p. 636-45. 
63. Van Gassen, S., et al., FloReMi: Flow density survival regression using minimal 
feature redundancy. Cytometry A, 2016. 89(1): p. 22-9. 
64. Anchang, B., et al., CCAST: a model-based gating strategy to isolate homogeneous 
subpopulations in a heterogeneous population of single cells. PLoS Comput Biol, 
2014. 10(7): p. e1003664. 
65. O'Neill, K., et al., Deep profiling of multitube flow cytometry data. Bioinformatics, 
2015. 31(10): p. 1623-31. 
66. Roederer, M., et al., Probability binning comparison: a metric for quantitating 
multivariate distribution differences. Cytometry, 2001. 45(1): p. 47-55. 
67. Roederer, M. and R.R. Hardy, Frequency difference gating: a multivariate method 
for identifying subsets that differ between samples. Cytometry, 2001. 45(1): p. 56-
64. 
68. Finak, G., et al., OpenCyto: An Open Source Infrastructure for Scalable, Robust, 
Reproducible, and Automated, End-to-End Flow Cytometry Data Analysis. PLoS 
Comput Biol, 2014. 10(8). 
69. O'Neill, K., et al., Enhanced flowType/RchyOptimyx: a BioConductor pipeline for 
discovery in high-dimensional cytometry data. Bioinformatics, 2014. 30(9): p. 
1329-30. 
70. Aghaeepour, N., et al., RchyOptimyx: cellular hierarchy optimization for flow 
cytometry. Cytometry A, 2012. 81(12): p. 1022-30. 
71. Courtot, M., et al., flowCL: ontology-based cell population labelling in flow 
cytometry. Bioinformatics, 2015. 31(8): p. 1337-9. 
72. Lin, L., et al., Identification and visualization of multidimensional antigen-specific 
T-cell populations in polychromatic cytometry data. Cytometry A, 2015. 87(7): p. 
675-82. 
73. Amir el, A.D., et al., viSNE enables visualization of high dimensional single-cell 
data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol, 2013. 
31(6): p. 545-52. 
74. Carter, K.M., et al., Information preserving component analysis: Data projections 
for flow cytometry analysis. IEEE Journal of Selected Topics in Signal Processing, 
2009. 3(1): p. 148-158 %@ 1932-4553. 
75. Qiu, P., et al., Extracting a cellular hierarchy from high-dimensional cytometry 
data with SPADE. Nat Biotechnol, 2011. 29(10): p. 886-91. 
76. Nicol, B., et al., An intermediate level of CD161 expression defines a novel 
activated, inflammatory, and pathogenic subset of CD8(+) T cells involved in 
multiple sclerosis. J Autoimmun, 2017. 
77. Beyer, K.G., J.; Ramakrishnan, R.; Shaft, U., When is "nearest neighbor" 
meaningful? Lecture Notes in Computer Science, 1999. 1540: p. 217-235. 
78. Bandura, D.R., et al., Mass cytometry: technique for real time single cell 
multitarget immunoassay based on inductively coupled plasma time-of-flight mass 





79. Spitzer, M.H. and G.P. Nolan, Mass Cytometry: Single Cells, Many Features. Cell, 
2016. 165(4): p. 780-91. 
80. Ornatsky, O., et al., Highly multiparametric analysis by mass cytometry. J Immunol 
Methods, 2010. 361(1-2): p. 1-20. 
81. Bendall, S.C., et al., A deep profiler's guide to cytometry. Trends Immunol, 2012. 
33(7): p. 323-32. 
82. Bendall, S.C., et al., Single-cell mass cytometry of differential immune and drug 
responses across a human hematopoietic continuum. Science, 2011. 332(6030): p. 
687-96. 
83. Horowitz, A., et al., Genetic and environmental determinants of human NK cell 
diversity revealed by mass cytometry. Sci Transl Med, 2013. 5(208): p. 208ra145. 
84. Lujan, E., et al., Early reprogramming regulators identified by prospective 
isolation and mass cytometry. Nature, 2015. 521(7552): p. 352-6. 
85. Bruggner, R.V., et al., Automated identification of stratifying signatures in cellular 
subpopulations. Proc Natl Acad Sci U S A, 2014. 111(26): p. E2770-7. 
86. Levine, J.H., et al., Data-Driven Phenotypic Dissection of AML Reveals 
Progenitor-like Cells that Correlate with Prognosis. Cell, 2015. 162(1): p. 184-97. 
87. Abraham, Y., et al., Exploring Glucocorticoid Receptor Agonists Mechanism of 
Action Through Mass Cytometry and Radial Visualizations. Cytometry B Clin 
Cytom, 2017. 92(1): p. 42-56. 
88. Kunicki, M.A., et al., Identity and Diversity of Human Peripheral Th and T 
Regulatory Cells Defined by Single-Cell Mass Cytometry. J Immunol, 2018. 
200(1): p. 336-346. 
89. Maaten, L.v.d. and G. Hinton, Visualizing data using t-SNE. Journal of machine 
learning research, 2008. 9(Nov): p. 2579-2605. 
90. Cheng, Y., et al., Categorical Analysis of Human T Cell Heterogeneity with One-
Dimensional Soli-Expression by Nonlinear Stochastic Embedding. J Immunol, 
2016. 196(2): p. 924-32. 
91. Dexter, D.L., et al., Heterogeneity of tumor cells from a single mouse mammary 
tumor. Cancer Res, 1978. 38(10): p. 3174-81. 
92. Alizadeh, A.A., et al., Toward understanding and exploiting tumor heterogeneity. 
Nat Med, 2015. 21(8): p. 846-53. 
93. Fodor, I.K., A survey of dimension reduction techniques, 2002, Lawrence 
Livermore National Lab., CA (US). 
94. Houle, M.E., et al. Can shared-neighbor distances defeat the curse of 
dimensionality? in International Conference on Scientific and Statistical Database 
Management. 2010. Springer. 
95. Kiefer, J., et al., High-throughput siRNA screening as a method of perturbation of 
biological systems and identification of targeted pathways coupled with compound 
screening. Methods Mol Biol, 2009. 563: p. 275-87. 
96. Varma, H., D.C. Lo, and B.R. Stockwell, High-Throughput and High-Content 
Screening for Huntington's Disease Therapeutics, in Neurobiology of Huntington's 
Disease: Applications to Drug Discovery, D.C. Lo and R.E. Hughes, Editors. 2011: 
Boca Raton (FL). 
97. Liberali, P., B. Snijder, and L. Pelkmans, Single-cell and multivariate approaches 





98. Kozak, K., et al., Data mining techniques in high content screening: a survey. J 
Comput Sci Syst Biol, 2009. 2(04): p. 219-39. 
99. Meijering, E., et al., Imagining the future of bioimage analysis. Nat Biotechnol, 
2016. 34(12): p. 1250-1255. 
100. Jones, T.R., et al., Scoring diverse cellular morphologies in image-based screens 
with iterative feedback and machine learning. Proc Natl Acad Sci U S A, 2009. 
106(6): p. 1826-31. 
101. Ramo, P., et al., CellClassifier: supervised learning of cellular phenotypes. 
Bioinformatics, 2009. 25(22): p. 3028-30. 
102. Horvath, P., et al., Machine Learning Improves the Precision and Robustness of 
High-Content Screens: Using Nonlinear Multiparametric Methods to Analyze 
Screening Results. J Biomol Screen, 2011. 16(9): p. 1059-1067. 
103. Zhong, R., et al., iScreen: Image-Based High-Content RNAi Screening Analysis 
Tools. J Biomol Screen, 2015. 20(8): p. 998-1002. 
104. Perlman, Z.E., et al., Multidimensional drug profiling by automated microscopy. 
Science, 2004. 306(5699): p. 1194-1198. 
105. Jones, T.R., et al. Methods for high-content, high-throughput image-based cell 
screening. in Proceedings of the Workshop on Microscopic Image Analysis with 
Applications in Biology. 2006. 
106. Birmingham, A., et al., Statistical methods for analysis of high-throughput RNA 
interference screens. Nature Methods, 2009. 6(8): p. 569-75. 
107. Kummel, A., et al., Comparison of multivariate data analysis strategies for high-
content screening. J Biomol Screen, 2011. 16(3): p. 338-47. 
108. Verschuuren, M., et al., Accurate Detection of Dysmorphic Nuclei Using Dynamic 
Programming and Supervised Classification. PLoS One, 2017. 12(1). 
109. Kubben, N., et al., Repression of the Antioxidant NRF2 Pathway in Premature 
Aging. Cell, 2016. 165(6): p. 1361-1374. 
110. Capell, B.C. and F.S. Collins, Human laminopathies: nuclei gone genetically awry. 
Nat Rev Genet, 2006. 7(12): p. 940-52. 
111. Capell, B.C., et al., Inhibiting farnesylation of progerin prevents the characteristic 
nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U 
S A, 2005. 102(36): p. 12879-84. 
112. Kudlow, B.A., B.K. Kennedy, and R.J. Monnat Jr, Werner and Hutchinson–Gilford 
progeria syndromes: mechanistic basis of human progeroid diseases. Nature 
Reviews Molecular Cell Biology, 2007. 8(5): p. 394. 
113. Brassard, J.A., et al., Hutchinson–Gilford progeria syndrome as a model for 
vascular aging. Biogerontology, 2016. 17(1): p. 129-145. 
114. Scaffidi, P. and T. Misteli, Reversal of the cellular phenotype in the premature 
aging disease Hutchinson-Gilford progeria syndrome. Molecular Biology of the 
Cell, 2004. 15: p. 120a-120a. 
115. Zwerger, M., C.Y. Ho, and J. Lammerding, Nuclear Mechanics in Disease. Annual 
Review of Biomedical Engineering, Vol 13, 2011. 13: p. 397-428. 
116. Allsopp, R.C., et al., Telomere Length Predicts Replicative Capacity of Human 





117. Cao, K., et al., Progerin and telomere dysfunction collaborate to trigger cellular 
senescence in normal human fibroblasts. Journal of Clinical Investigation, 2011. 
121(7): p. 2833-2844. 
118. Goldman, R.D., et al., Accumulation of mutant lamin A causes progressive changes 
in nuclear architecture in Hutchinson–Gilford progeria syndrome. Proc Natl Acad 
Sci U S A, 2004. 101(24): p. 8963-8968. 
119. Liu, Y.Y., et al., DNA damage responses in progeroid syndromes arise from 
defective maturation of prelamin A. Journal of Cell Science, 2006. 119(22): p. 
4644-4649. 
120. Kubben, N., et al., A high-content imaging-based screening pipeline for the 
systematic identification of anti-progeroid compounds. Methods, 2016. 96: p. 46-
58. 
121. Candia, J., et al., From Cellular Characteristics to Disease Diagnosis: Uncovering 
Phenotypes with Supercells. PLoS Comput Biol, 2013. 9(9). 
122. Goransson, H., et al., Quantification of normal cell fraction and copy number 
neutral LOH in clinical lung cancer samples using SNP array data. PLoS One, 
2009. 4(6): p. e6057. 
123. Driscoll, M.K., et al., Automated image analysis of nuclear shape: what can we 
learn from a prematurely aged cell? Aging (Albany NY), 2012. 4(2): p. 119-32. 
124. Burges, C.J.C., A tutorial on Support Vector Machines for pattern recognition. 
Data Mining and Knowledge Discovery, 1998. 2(2): p. 121-167. 
125. Tung, J.W., et al., Modern flow cytometry: a practical approach. Clin Lab Med, 
2007. 27(3): p. 453-68, v. 
126. Baumgarth, N. and M. Roederer, A practical approach to multicolor flow cytometry 
for immunophenotyping. J Immunol Methods, 2000. 243(1-2): p. 77-97. 
127. Finak, G., et al., Standardizing Flow Cytometry Immunophenotyping Analysis from 
the Human ImmunoPhenotyping Consortium. Sci Rep, 2016. 6: p. 20686. 
128. Santegoets, S.J., et al., Monitoring regulatory T cells in clinical samples: consensus 
on an essential marker set and gating strategy for regulatory T cell analysis by flow 
cytometry. Cancer Immunol Immunother, 2015. 64(10): p. 1271-86. 
129. Pitoiset, F., et al., A standardized flow cytometry procedure for the monitoring of 
regulatory T cells in clinical trials. Cytometry Part B: Clinical Cytometry %@ 
1552-4957, 2018. 
130. Finak, G., et al., OpenCyto: an open source infrastructure for scalable, robust, 
reproducible, and automated, end-to-end flow cytometry data analysis. PLoS 
Comput Biol, 2014. 10(8): p. e1003806. 
131. Spidlen, J., et al., Gating-ML: XML-based gating descriptions in flow cytometry. 
Cytometry A, 2008. 73A(12): p. 1151-7. 
132. Mosmann, T.R., et al., SWIFT-scalable clustering for automated identification of 
rare cell populations in large, high-dimensional flow cytometry datasets, part 2: 
biological evaluation. Cytometry A, 2014. 85(5): p. 422-33. 
133. Qian, Y., et al., Elucidation of seventeen human peripheral blood B-cell subsets 
and quantification of the tetanus response using a density-based method for the 
automated identification of cell populations in multidimensional flow cytometry 





134. Wong, M.T., et al., A High-Dimensional Atlas of Human T Cell Diversity Reveals 
Tissue-Specific Trafficking and Cytokine Signatures. Immunity, 2016. 45(2): p. 
442-56. 
135. Bialek, N.S.G.S.A.G.T.W., Estimating mutual information and multi–information 
in large networks. ArXiv preprint, 2005. 
136. Margolin, A.A., et al., ARACNE: an algorithm for the reconstruction of gene 
regulatory networks in a mammalian cellular context. BMC Bioinformatics, 2006. 
7 Suppl 1: p. S7. 
137. Naim, I., et al., SWIFT-scalable clustering for automated identification of rare cell 
populations in large, high-dimensional flow cytometry datasets, part 1: algorithm 
design. Cytometry A, 2014. 85(5): p. 408-21. 
138. Weiskopf, D., B. Weinberger, and B. Grubeck-Loebenstein, The aging of the 
immune system. Transpl Int, 2009. 22(11): p. 1041-50. 
139. Nelson, B.H., IL-2, regulatory T cells, and tolerance. J Immunol, 2004. 172(7): p. 
3983-8. 
140. Spidlen, J., et al., FlowRepository: a resource of annotated flow cytometry datasets 
associated with peer-reviewed publications. Cytometry A, 2012. 81(9): p. 727-31. 
141. Di Palma, S. and B. Bodenmiller, Unraveling cell populations in tumors by single-
cell mass cytometry. Curr Opin Biotechnol, 2015. 31: p. 122-9. 
142. Orlova, D.Y., L.A. Herzenberg, and G. Walther, Science not art: statistically sound 
methods for identifying subsets in multi-dimensional flow and mass cytometry data 
sets. Nature Reviews Immunology, 2017. 18: p. 77. 
143. Patin, E., et al., Natural variation in the parameters of innate immune cells is 
preferentially driven by genetic factors. Nat Immunol, 2018. 19(3): p. 302. 
144. Chen, Y.-W. and C.-J. Lin, Combining SVMs with various feature selection 
strategies, in Feature extraction2006, Springer. p. 315-324. 
145. Huxley, J., Biological aspects of cancer1958: Harcourt, Brace. 
146. Torres, L., et al., Intratumor genomic heterogeneity in breast cancer with clonal 
divergence between primary carcinomas and lymph node metastases. Breast 
Cancer Res Treat, 2007. 102(2): p. 143-55. 
147. Park, S.Y., et al., Cellular and genetic diversity in the progression of in situ human 
breast carcinomas to an invasive phenotype. Journal of Clinical Investigation, 
2010. 120(2): p. 636-44. 
148. Patel, A.P., et al., Single-cell RNA-seq highlights intratumoral heterogeneity in 
primary glioblastoma. Science, 2014. 344(6190): p. 1396-401. 
149. Cleary, A.S., et al., Tumour cell heterogeneity maintained by cooperating 
subclones in Wnt-driven mammary cancers. Nature, 2014. 508(7494): p. 113-7. 
150. McGranahan, N. and C. Swanton, Clonal Heterogeneity and Tumor Evolution: 
Past, Present, and the Future. Cell, 2017. 168(4): p. 613-628. 
151. Mann, K.M., et al., Analyzing tumor heterogeneity and driver genes in single 
myeloid leukemia cells with SBCapSeq. Nat Biotechnol, 2016. 34(9): p. 962-72. 
152. Koren, S. and M. Bentires-Alj, Breast Tumor Heterogeneity: Source of Fitness, 
Hurdle for Therapy. Mol Cell, 2015. 60(4): p. 537-46. 
153. Magee, J.A., E. Piskounova, and S.J. Morrison, Cancer stem cells: impact, 





154. Shackleton, M., et al., Heterogeneity in cancer: cancer stem cells versus clonal 
evolution. Cell, 2009. 138(5): p. 822-9. 
155. Lekka, M., et al., Cancer cell recognition--mechanical phenotype. Micron, 2012. 
43(12): p. 1259-66. 
156. Plodinec, M., et al., The nanomechanical signature of breast cancer. Nat 
Nanotechnol, 2012. 7(11): p. 757-65. 
157. Swaminathan, V., et al., Mechanical stiffness grades metastatic potential in patient 
tumor cells and in cancer cell lines. Cancer Res, 2011. 71(15): p. 5075-80. 
158. Wirtz, D., K. Konstantopoulos, and P.C. Searson, The physics of cancer: the role 
of physical interactions and mechanical forces in metastasis. Nat Rev Cancer, 
2011. 11(7): p. 512-22. 
159. Hayashi, K. and M. Iwata, Stiffness of cancer cells measured with an AFM 
indentation method. J Mech Behav Biomed Mater, 2015. 49: p. 105-11. 
160. Nyberg, K.D., et al., Quantitative Deformability Cytometry: Rapid, Calibrated 
Measurements of Cell Mechanical Properties. Biophysical Journal, 2017. 113(7): 
p. 1574-1584. 
161. Farzbod, A. and H. Moon, Integration of reconfigurable potentiometric 
electrochemical sensors into a digital microfluidic platform. Biosens Bioelectron, 
2018. 106: p. 37-42. 
162. Xu, W., et al., Cell stiffness is a biomarker of the metastatic potential of ovarian 
cancer cells. PLoS One, 2012. 7(10): p. e46609. 
163. Remmerbach, T.W., et al., Oral cancer diagnosis by mechanical phenotyping. 
Cancer Res, 2009. 69(5): p. 1728-32. 
164. Kiessling, T.R., et al., Analysis of multiple physical parameters for mechanical 
phenotyping of living cells. Eur Biophys J, 2013. 42(5): p. 383-94. 
165. Lincoln, B., et al., Reconfigurable microfluidic integration of a dual-beam laser 
trap with biomedical applications. Biomed Microdevices, 2007. 9(5): p. 703-10. 
166. Bianchini, G., et al., Triple-negative breast cancer: challenges and opportunities 
of a heterogeneous disease. Nat Rev Clin Oncol, 2016. 13(11): p. 674-690. 
167. Norton, K.A., A.S. Popel, and N.B. Pandey, Heterogeneity of chemokine cell-
surface receptor expression in triple-negative breast cancer. Am J Cancer Res, 
2015. 5(4): p. 1295-307. 
168. Zhu, G., et al., CXCR3 as a molecular target in breast cancer metastasis: inhibition 
of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget, 
2015. 6(41): p. 43408. 
 
 
